Analysis of the structure and function of the S.pombe DNA ligase I protein Cdc17 by Martin, Ina Verena
Analysis of the Structure and Function of the 
S. pombe DNA ligase I Protein Cdc17 
MA 
Ina Verena Martin 
Thesis presented for the Degree of 
Doctor of Philosophy 
at the University of Edinburgh 
April 2002 
"The best way to have a good idea is to have lots of ideas." 
Linus Pauling, 1901-1994 
For Mum and Dad 
Acknowledgements 
Firstly, I thank my supervisor Stuart MacNeill for his continuous support, advice and 
helpful discussions throughout this project and for critical reading of the manuscript. 
Thanks are due to all members of the MacNeill lab, especially Leo Ciufo, Jess 
Worthington, Fiona Gray and Javier Sanchez Garcia for their advice, assistance and 
helpful discussions mostly administered over a cup of tea. I would also like to thank 
members of the Adachi, Hardwick and Ohkura labs for helping me in various ways. 
Special thanks to Joan Davidson for superb technical support. 
I am indebted to the Darwin Trust of Edinburgh for financial support. 
Many thanks also go to my second supervisor David Dryden for his continuous 
support and for encouraging me to do a PhD in the first place. 
And not the least, I am thanking my family and friends for their never-ending 
encouragment and love. 
iv 
Abstract 
DNA ligases join breaks in double-stranded DNA and are therefore crucial enzymes 
in all aspects of DNA metabolism. Eukaryotic DNA ligase I homologues belong to 
the family of ATP-dependent ligases and join Okazaki fragments generated on the 
lagging strand during chromosomal DNA replication. DNA ligase I enzymes consist 
of C-terminal catalytic domains conserved across all ATP-dependent ligases, a 
middle conserved domain of unknown function and N-terminal extensions, which 
share a conserved PCNA binding motif, but otherwise show very limited sequence 
similarity. 
In this work structure-function analyses on the DNA ligase I homologue Cdc17 of 
Schizosaccharomyces pombe were performed. The presence of the middle conserved 
non-catalytic domain in addition to the catalytic domains was found to be essential 
for rescue of a cdcl 7 deletion strain. The N-terminal domain targets the enzyme to 
the nucleus and mitochondria and essential residues were identified which are 
required for targeting to both cellular compartments. Evidence suggests that 
mitochondrial Cdc 17 function is required for survival of S. pombe. The PCNA 
binding motif is functional in vivo since its absence reduces cell viability. Despite 
these identified functions overexpression of truncations lacking the N-terminal 
domain can complement a cdcl 7 deletion strain. 
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1. Introduction 
1.1 Eukaryotic DNA replication 
1.1.1 Overview 
Chromosomal DNA replication in eukaryotes is a crucial event in the cell cycle that 
is responsible for the accurate and efficient duplication of the genome prior to cell 
division. The duplication of the genetic material occurs during S phase of the 
eukaryotic cell cycle and it is separated from mitosis through the gap phases GI and 
G2. DNA replication involves the highly co-ordinated action of multiple replication 
proteins at the replication fork through a complex network of protein-protein 
interactions. DNA synthesis is coupled to cell cycle progression and DNA repair in 
order to ensure that the complete genome is replicated once and only once, thus 
maintaining genome integrity. 
Initiation of DNA replication is regulated by the cell cycle machinery and is brought 
about through the dynamic assembly and disassembly of protein complexes at sites 
of replication initiation. Synthesis of eukaryotic DNA is achieved by numerous 
replication forks initiating at multiple specific sites scattered throughout each 
chromosome. The mode of DNA replication is semi-discontinuous: the leading 
strand is synthesised continuously whereas the lagging strand is formed as small 
DNA intermediates, termed Okazaki fragments, which are subsequently joined 
together. The mechanisms of leading strand synthesis and that of each Okazaki 
fragment are very similar: a protein-complex sometimes referred to as the primosome 
produces an RNA-DNA primer which is then elongated by a replicative DNA 
polymeras e- containing protein complex. Finally, the Okazaki fragment intermediates 
are processed to form a continuous DNA strand (reviewed in Davey and O'Donnell, 
2000). 
Much of what is known about the mechanisms of DNA replication is derived from 
work on the model DNA replication system Simian virus 40 (SV40) using purified 
cellular replication proteins (reviewed in Hassell and Brinton, 1996 and Waga and 
Stillman, 1998). Complementing these studies, genetical and biochemical analyses of 
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yeast DNA replication proteins, have greatly extended the current understanding of 
the molecular basis of the replication process (reviewed in MacNeill and Burgers, 
2000). 
1.1.2 Initiation 
DNA synthesis starts from multiple specific sites on each chromosome known as 
origins of replication, on. Eukaryotic ori are bound by multi-protein origin-
recognition-complexes (ORC). ORC were first described as six-subunit complexes in 
budding yeast (Bell and Stillman, 1992) and were shown to be present at origin DNA 
throughout the cell cycle (Liang and Stillman, 1997). Identification of ORC subunits 
in other organisms have demonstrated that ORC seem to be conserved across 
eukaryotes (Gavin et al., 1995) and the six-subunit ORC of S. pombe and humans, 
among other species, have been purified (Moon et at., 1999, Vashee et al., 2001). 
In S. cerevisiae ORC bind to Cdc6p, another essential DNA replication initiation 
protein (Liang et al., 1995). In conjunction with the Cdtl protein, the so-called 
rninichromosome-maintenance (MCM) proteins are recruited to ORC (Tanaka et al., 
1997, Nishitani et al., 2000, Maiorano et al., 2000). At this stage the origin DNA 
becomes 'licensed' for DNA replication. Coupled to cell cycle signals, which, in S. 
cerevisiae, include the Cdc45 protein and the action of the Cdc7/Dbf4 kinase and S-
phase cyclin-dependent protein kinases (CDK), this pre-replicative-complex (pre-
RC, consisting of ORC, Cdc6, Cdtl, MCM proteins and possibly several additional 
factors) is likely to trigger initiation of DNA replication (reviewed in Dutta and Bell, 
1997, Lei and Tye, 2001). Recent reports showed that ori in budding and fission 
yeast have a single precise start site adjacent to the ORC binding site from where 
DNA replication begins (Bielinsky and Gerbi, 1999, Gomez and Antequera, 1999). 
After origin DNA has become licensed for replication, a first step would seem to be 
the local unwinding of DNA around the origin, resulting in a 'replication bubble' 
(see Figure 1.1, bottom panel). In in vitro replication of SV40 DNA, T-antigen 
incorporates two functions: it serves as an initiator protein and acts as a helicase, 
opening up the DNA (reviewed in Hassell and Brinton, 1996). The identity of the 
unwinding helicase in eukaryotic cells is not yet clear although evidence accumulates 
that the six-associating-MCM proteins could carry out the helicase function (Ishimi, 
1997, Labib et al., 2000, reviewed in Labib and Diffley, 2001). In the SV40 system, 
the single-stranded-binding protein RPA coats the helicase-unwound DNA and 
stabilises it. Furthermore, it stimulates the helicase activity of SV40 T-antigen and 
interacts with the DNA polymerase a (p01 (x)/primase-complex which subsequently 
primes DNA synthesis (see below and reviewed in Waga and Stillman, 1998). Figure 













Figure 1.1: Schematic representation of initiation of yeast DNA replication. ORC is bound to origin 
DNA throughout the cell cycle. In G  assembly of the pre-RC begins with binding of Cdc6 and Cdt! 
to ORC and is complete with subsequent recruitment of the MCM proteins. Following phosphorylation 
of the MCM-complex during S-phase by Cdc7-Dbf4 kinase and removal of Cdc6 and Cdtl other 
replication factors, like Cdc45, RPA and pol a/primase, triggers initiation of DNA synthesis. See text 
for further details. 
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1.1.3 Elongation 
After initiation of DNA replication at the on, DNA synthesis proceeds 
bidirectionally with replication forks moving away from the origin in either 
direction. The leading strands are synthesised continuously in the 5'—>3' direction 
whereas the lagging strands are generated discontinuously through the formation of 
Okazaki fragments. Interestingly, the two strands are synthesised co-ordinately 
(Kornberg and Baker, 1992, Lee et al., 1998). 
DNA synthesis of the leading strand as well as that of each Okazaki fragment on the 
lagging strand is catalysed by the primase subunits of poi a/primase, which generate 
a short RNA primer that is then elongated with deoxynucleotides by pol a (Waga et 
al., 1994). Pol a/primase is the only protein complex capable of synthesising DNA 
de novo. Since p01 a/primase is a nonprocessive enzyme and has no proofreading 
activity, bulk DNA synthesis is carried out by another DNA polymerase, namely poi 
(and/or pol c, see below). The 3' termini of the RNA-DNA primers, which are also 
called initiator DNAs (iDNA), are recognised by RF-C (Tsurimoto and Stillman, 
1990) which then promotes a process called polymerase switching (Tsurimoto and 
Stillman, 1991b). The clamp-loader RF-C binds at the primer-template junction and 
loads PCNA (the sliding clamp) onto the DNA in an ATP-dependent manner, 
thereby displacing pol a/primase (Tsurimoto and Stillman, 1991b). PCNA, 
encircling the DNA, in turn then tethers the replicative DNA polymerase ö (or poi ) 
to the site of DNA synthesis (Tsurimoto and Stillman, 1991a), completing the 
assembly of the DNA polymerase ö holoenzyme (which consists of pol 6, RF-C and 
PCNA). Through association with PCNA, DNA polymerase ö (or pol c) is able to 
synthesise the leading and lagging strand highly processively (Prelich et al., 1987b; 
Bauer and Burgers, 1988a). The RF-C-mediated polymerase switch occurs during the 
priming of the leading strand and during synthesis of every Okazaki fragment 
(Tsurimoto and Stillman, 1991b; Waga and Stillman, 1994; reviewed in Waga and 
Stillman, 1998). Recent in vitro binding experiments suggest that RPA plays a 
crucial role in triggering the polymerase switch by serving as a binding partner at the 
replication fork which pot a, RF-C and pol 5 compete for (Yuzhakov et al., 1999). 
On the lagging strand DNA synthesis of the Okazaki fragment continues at least until 
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the polymerase encounters the preceding Okazaki fragment. The final processing of 
Okazaki fragments, which is the subject of the next section, results in the formation 
of a continuous DNA strand. 
Figure 1.2 summarises the priming and elongation steps of DNA replication. 
The role of pot E in DNA replication is not yet clear. Although dispensable for in 
vitro replication of SV40 DNA by human cell extracts (Lee et al., 1991b) it is 
required for DNA replication in budding and fission yeast (Budd and Campbell, 
1993; d'Urso and Nurse, 1997). However, recent reports showed that in budding 
yeast the essential function of the pot c homologue resides in the C-terminal domain 
which does not contain the polymerase and 3'—>5' exonuclease motifs (Dua et al., 
1999, Kesti et al., 1999). On the other hand, earlier studies have shown that the 
exonuclease function of pot E is active during S. cerevisiae DNA replication 
(Morrison and Sugino, 1994, Shcherbakova and Pavlov, 1996) suggesting that maybe 
pot 5 can substitute for non-functional pot c. It has been suggested that poi 5 and pot 
replicate different strands (Karthikeyan et al., 2000) or that pot c may be involved 
in early steps of DNA replication since it has been shown that pot E dissociates from 
origin DNA and associates with non-origin DNA during S phase (Aparicio et al., 
1997). Pot ö, on the other hand, may function during Okazaki fragment processing 
since it interacts with proteins involved in this process (Kang et al., 2000). More 
work will be necessary to establish the precise roles of DNA polymerases 8 and 
during DNA replication. 
Further understanding of details of the events that are taking place during eukaryotic 
DNA replication may in the future come from the study of archaebacteria. Their 
replication proteins are generally more closely related to eukaryotes than eubacteria, 
but fewer proteins seem to perform the same functions (reviewed in MacNeill, 
2001a). 
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Figure 1.2: Schematic representation of polymerase switching. The RNA-DNA primer is synthesised 
by pot a/primase. RF-C binds to the 3' end of the initiator DNA, thereby replacing poi alprimase, and 
loads PCNA onto the DNA. This is followed by recruitment of DNA polymerase ö and subsequent 
processive DNA synthesis. Single stranded DNA is coated by RPA. See text for further details. 
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1.1.4 Okazaki fragment processing 
1.1.4.1 Introduction 
During DNA replication the lagging strand is synthesised discontinuously through a 
series of discrete Okazaki fragments, which is a consequence of the unique 5' - 3' 
directionality of the replicative polymerases. The synthesis of these short DNA 
stretches as intermediates in DNA replication were first discovered in prokaryotes 
(Okazaki et al., 1968) and later in mammalian, viral and fungal systems (reviewed in 
Edenberg and Huberman, 1975, Nasmyth, 1977). In prokaryotes Okazaki fragments 
are -4000 nucleotides in size, whereas in eukaryotes Okazaki fragments are only 50-
150 nucleotides long (reviewed in Edenberg and Huberman, 1975). 
Like the leading strand, each Okazaki fragment is initiated by primase synthesising a 
short stretch of around 10 ribonucleotides which is extended by pot a. for a further 
-30 deoxyribonucleotides (Waga and Stillman, 1998). Since pot a lacks 
proofreading activity, which ensues in primed DNA being error-prone, it needs to be 
removed in a process termed Okazaki fragment maturation or processing. The 
efficient maturation of Okazaki fragments is vital for maintaining a cell's genomic 
integrity, requiring a highly co-ordinated interplay between the participating proteins. 
For example yeast have a genome size of--15 Mb and Okazaki fragments are <150 
nucleotides long. Consequently, around 100,000 Okazaki fragments are produced 
during S phase - which lasts only -20 minutes. Each of these must be processed. 
Okazaki fragment maturation involves RNA-DNA primer removal, error-free 
replacement synthesis and sealing of the resultant nick between adjacent Okazaki 
fragments. 
The next section describes DNA replication proteins involved in Okazaki fragment 
processing in addition to PCNA and pot 5 and the following section introduces a 
current model of the mechanisms entailed in the maturation of Okazaki fragments. 
LV 
1.1.42 FEW, RNase HI and Dna2 
Through analysis of SV40 DNA replication, FEN1 and RNase HI were identified as 
having necessary activities during DNA replication (Waga et al., 1994, Waga and 
Stillman, 1994) and it is likely that they are required for maturation of Okazaki 
fragments (see next section). In conjunction with a DNA polymerase and DNA ligase 
I these two factors were capable of completing lagging strand replication on model 
Okazaki fragment substrates (Turchi et al., 1994). FEN1 is a structure-specific 
endonuclease which cleaves at branched DNA structures that have a single stranded 
5' flap. In addition, it has exonucleolytic activity acting primarily at a nick (reviewed 
in Lieber, 1997). RNase HI is a ribonuclease which has RNA-DNA junction-specific 
RNase activity (Murante et al., 1998). The fact that yeast strains deleted for the 
FEN1 and/or RNase HI homologues Rad27p and RNase H(35), respectively, are still 
viable - although the phenotype of a rad27A strain is consistent with a role for FEN1 
in DNA replication - suggests the existence of another nucleolytic activity capable of 
assisting in the removal of RNA-DNA primers (Sommers et al., 1995, Qiu et al., 
1999). 
The Dna2 enzyme which comprises DNA helicase and single-stranded DNA 
endonuclease activities seems a suitable candidate. Dna2 was discovered as a protein 
in S. cerevisiae that is essential for DNA replication (Budd and Campbell, 1995) and 
it functions late during S phase (Fiorentino and Crabtree, 1997). Dna2 is essential for 
viability in the yeasts S. pombe and S. cerevisiae (Kang et al., 2000, Budd and 
Campbell, 1995) and is conserved in humans, A. thaliana, X laevis and C. elegans 
(Eki et al., 1996, Liu et al., 2000). Recent studies have identified the endonuclease 
activity of Dna2 to be essential for viability, whereas the helicase activity is not (Lee 
et al., 2000, Budd et al., 2000). Strong indications that Dna2 may function in 
maturation of Okazaki fragments came from the finding that the yeast protein 
interacts genetically and biochemically with the FEN1 homologue Rad27p (Budd 
and Campbell, 1997, Kang et al., 2000). Furthermore, yeast Dna2 genetically 
interacts with the DNA polymerase ö B- and C-subunits, DNA ligase I and each of 
the three subunits of the single-stranded binding protein RPA (Kang et al., 2000, Bae 
et al., 2001). 
1.1.4.3 A model for maturation of Okazaki fragments 
Recent in vitro studies on Dna2p and other replication factors in S. cerevisiae gave 
novel insights into the mechanisms of Okazaki fragment maturation in yeast, from 
which a new model emerged (Bae and Seo, 2000, Bae et al., 2001). In this model, 
when pol 6/PCNA encounter the adjacent Okazaki fragment, it carries out 
displacement synthesis of the downstream RNA-DNA primer thereby forming a 5' 
RNA-DNA flap structure. When the nascent flap structure reaches a critical size, 
RPA forms a complex with the DNA portion of the primer and recruits Dna2 onto 
the flap. At this point Dna2 may contact pol 6 subunits which could possibly result in 
a cessation of displacement synthesis. Dna2 cleaves off the RNA portion of the 
initiator DNA. Dissociation of the cleaved iDNA, RPA, Dna2 and pol 6 leaves 
behind PCNA, encircling the double-stranded DNA at the site of the shortened flap. 
PCNA can then tether FEN1 to the remaining flap structure and stimulate its 
endonucleolytic activity to produce a nick between two neighbouring Okazaki 
fragments. DNA ligase I then seals this nick to produce a continuous DNA strand. 
This model justifies several observations. Firstly, the prerequisite that RPA must coat 
the primed DNA before Dna2 action can occur could account for continuation of 
displacement synthesis by pol 6 until the erroneous RNA-DNA primer is completely 
removed. In that way accurate duplication of the primer region by pol 6 is assured. 
The sequential action of Dna2 before FEN1 could explain why Dna2 activity is an 
essential step which creates the substrate for FEN 1. In the absence of FEN 1 other 
members of the FEN 1-family of structure-specific nucleases may substitute for its 
function. This model does not include RNase HI, however. Either RNase HI 
functioning together with FEN 1 is part of an alternative or parallel minor pathway of 
Okazaki fragment processing or it plays a more important role in Okazaki fragment 
processing of higher eukaryotes. 
The above described model awaits further in vivo studies to support its validity but, 
so far, provides the most convincing interpretation of the gathered evidence. Figure 
1.3 gives an outline of the model for processing Okazaki fragments as suggested by 
Seo and co-workers and reviewed in MacNeill, 2001b. 
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Figure 1.3: A mode! for Okazaki fragment processing according to the Seo lab (see text for 
references). The RNA portion of the previous Okazaki fragment is denoted as a zigzag line. 
Displacement synthesis by po! 6 generates a flap structure and renders the primer single-stranded. RPA 
binds to the primer DNA, recruits Dna2 which then cleaves off the primer RNA. Dissociation of pol 6, 
Dna2 and RPA allows the association ofFENI with PCNA. FEN  cleaves the flap junction and finally 
DNA ligase I seals the resultant nick between adjacent Okazaki fragments. 
1.1.5 PCNA as a key player in DNA replication 
1.1.5.1 Introduction 
PCNA plays various roles in DNA metabolism being involved in DNA replication, 
DNA repair, recombination, cell cycle regulation and checkpoint control. 
It was originally identified by two different labs. Miyachi et al. (1978) discovered an 
auto-antigen in patients with lupus erythematosus. Since this protein was observed in 
nuclei of dividing cells it was named Proliferating Cell Nuclear Antigen (PCNA). 
Two years later it was discovered as a protein that is synthesised in S-phase (Bravo 
and Celis, 1980). PCNA is required for SV40 replication in vitro (Prelich et al., 
1987a; Prelich et al., 1987b) and one major role that it serves is as a processivity 
factor for DNA polymerase 6 (Tsurimoto and Stillman, 1989) during DNA 
replication (for review see Kelman, 1997). 
Genes encoding PCNA have been cloned and sequenced from a variety of species 
including human (Almendral et al., 1987), S. cerevisiae (Bauer and Burgers, 1990) 
and S. pombe (Waseem et al., 1992). Although there is only moderate sequence 
similarity - 32% - between yeast and mammalian PCNA, they can substitute for one 
another in in vitro replication assays with pol 6 (Bauer and Burgers, 1988a and 
1988b) and human PCNA can complement an S. pombe PCNA deletion (Waseem et 
al., 1992) confirming that they are functional homologues. 
PCNA is an essential protein. Expression of PCNA anti-sense RNA in exponentially 
growing cells causes a suppression of DNA replication and cell cycle progression 
(Jaskulski et al., 1988) and deletion of the PCNA gene in both S. cerevisiae and S. 
pombe is lethal (Bauer and Burgers, 1990; Waseem et al., 1992). 
The crystal structure of yeast and human PCNA has been determined (Krishna et al., 
1994; Gulbis et al., 1996). PCNA is a ring-shaped molecule that can encircle double 
stranded DNA. It forms a stable homotrimer in solution. The trimeric ring has an 
overall six-fold symmetry as each monomer consists of two globular domains of 
related structure. The two domains, which are connected by an extensive loop, called 
the inter-domain connector loop, are structurally almost identical but show no 
sequence homology. The charge distribution in the molecule is highly asymmetric; 
the outer surface is very negatively charged whereas there is a net positive 
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electrostatic potential along the central channel. Eukaryotic PCNA is structurally 
homologous to the E. coli 3 sliding clamp and the T4 gene 45 protein. Although the 
f3 sliding clamp is a homodimer its three dimensional structure is almost exactly 
superimposable on PCNA as each monomer consists of three related domains 
(Kelman and O'Donnell, 1995; for review see Kelman, 1997). 
In the next two sections the clamp-loader RF-C and the replicative DNA polymerase 
enzyme are described briefly and what is known about their interactions with the 
PCNA sliding clamp. The third section deals with proteins involved in DNA 
metabolism and cell cycle progression which bind to PCNA via a conserved PCNA 
binding motif. A short review of what is known about the interaction between PCNA 
and several DNA replication proteins follows. 
1.1.5.2 The clamp-loader replication factor C 
RF-C, also called activator 1, was first identified as an essential factor for in vitro 
SV40 DNA replication (Tsurimoto and Stillman, 1989; Lee et al., 1991a). Its main 
role is to load the DNA polymerase ö processivity factor PCNA onto the DNA. 
RF-C is a five subunit complex consisting of one large subunit -140 kDa in the 
human and -95 kDa in yeast, and four small subunits - 36 kDa to 40 kDa in both 
organisms. The subunits of those two species share between 36 % (large subunit) and 
60 % (hRF-C40 and ScRF-C4, respectively) sequence homology. Genes of all five 
subunits of S. cerevisiae and S. pombe have been identified (reviewed in MacNeill 
and Burgers, 2000). In yeast, all five subunits are essential (Cullmann et al., 1995) 
and are all required to form a stable complex (Uhlmann et al., 1996). Studies in both 
yeasts identified a role for some RF-C subunits in DNA replication checkpoint 
function (Sugimoto et al., 1996, Reynolds et al., 1999). Recently, the crystal 
structure of the E. coli clamp-loader y complex has been solved which offers insights 
into the precise mechanism of clamp loading (Jeruzalmi et al., 200 1) and the crystal 
structure of a small subunit of the archaeal clamp-loader from Pyrococcus furiosus 
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indicates a similar structure (Oyama et al., 2001, reviewed in O'Donnell et al., 
2001). 
The five different subunits have seven different regions of protein sequence 
similarity in common, termed RF-C boxes II to VIII. The large subunit contains an 
additional box, RF-C box I, that shares a region of high similarity both with 
prokaryotic DNA ligases and to a lesser extent with poly(ADP-ribose)polymerases, 
which contain a version of the BRCT motif. A superfamily of proteins sharing this 
motif seems to be involved in DNA-damage responsive checkpoints. The DNA-
binding region maps within this RF-C box I (Fotedar et al., 1996). A PCNA-binding 
domain that is conserved in all five subunits of RF-C has been identified downstream 
of the DNA-binding domain (Fotedar et al., 1996). Deletions into RF-C box II, 
which maps within the PCNA binding domain, in any of the subunits have been 
shown to disrupt the DNA replication function, i.e. loading PCNA onto DNA 
(Uhlmann etal., 1997). 
1.1.5.3 DNA Polymerase 
The well-established role for PCNA is to serve as a processivity factor for DNA 
polymerase ö (Prelich et al., 1987b). Pot 6 possesses 5'—>3' DNA polymerase 
activity and 3'-45' exonuclease activity (Wang, 1991). In addition to DNA 
polymerase a, poi 6 is essential for DNA replication in vitro in the SV40 system and 
in budding yeast (Melendy and Stillman, 1991; Budd and Campbell, 1993). In 
mammalia and yeast, pol 6 comprises at least three subunits - a large catalytic 
subunit (A-subunit) and two or more smaller subunits (B-, C- and D-subunit) 
(reviewed in MacNeill et al., 2001). 
The question of which subunit of pol 6 interacts with PCNA resulting in the 
stimulation of polymerase activity is not solved unambiguously as yet. The catalytic 
subunits of budding yeast and human pol 6 on their own are not stimulated by PCNA 
(Tratner et al., 1997) although there have been studies reporting the direct interaction 
of the mammalian catalytic subunit with PCNA (Zhang et al., 1995, Zhang et al., 
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1999). A heterodimer consisting of the catalytic subunit and the B-subunit is found 
capable of interacting with PCNA resulting in processive DNA synthesis in vitro 
(Burgers and Gerik, 1998; Zhou et al., 1997). In contrast, other recent studies show 
that the formation of an active poi 6 complex, which can be stimulated by PCNA 
requires the presence of the C-subunit as well (Ducoux et al., 2001, Shikata et al., 
2001, see also next section). Several lines of evidence support the existence of 
several distinct binding sites for PCNA within the poi 6 complex. It remains to be 
seen what precise mechanisms underlie the stimulation of pol S activity and if there 
are additional functions to any pol S - PCNA interactions. 
11.5.4 PCNA binding via a conserved motif 
In the past few years PCNA has been found to interact with numerous proteins that 
function in DNA replication, DNA repair and cell cycle regulation. This implies a 
central role for PCNA in linking the diverse protein functions acting at the 
replication fork and in serving as a co-ordinator between DNA metabolic events and 
cell cycle progression. The PCNA-interacting proteins that participate in DNA 
replication and in at least one pathway of DNA repair, are listed in Table 1.1. 
Table 1.1: PCNA-interacting-proteins that are involved in DNA replication, DNA repair and cell 
cycle progression. Most references are listed in Tsurimoto, 1999 and Warbrick, 2000. 1 Niimi et al., 
2001, 2  Kleczkowska etal., 2001, Tsuchimoto etal., 2001 
DNA replication & DNA repair 	 cell cycle progression 
modification 
DNA polymerase S XP-G 	 p21 
RF-C MSH2 	 CDKlcyclin-complexes 
FEN  MLH1 
DNA ligase I MSH32  
S. pombe Cdc24 MSH62  
5-methyltransferase uracil DNA glycosylase 
DNA topoisomerase Il l 	AP endonuclease3  
WRN helicase? 
1161 
Many studies have been carried out to identify the regions of PCNA involved in 
these protein interactions, and naturally the areas within these 
proteins that interact with PCNA in return (reviewed in Warbrick, 2000). In a recent 
report, polymerase 6, RF-C, FEN1, p21 and DNA ligase I were all found to bind to 
part of the inter-domain connector loop and loops on one face of the trimer close to 
the C-terminus (Jonsson et al., 1998). Strikingly, the proteins share versions of a 
conserved amino acid sequence motif— Qxx(IIL)xxFF - which has been shown to be 
at least partly responsible for the interaction with PCNA (Warbrick, 1998). This 
motif was first identified in the protein kinase inhibitor p21 and is hence named the 
6 p21°''-Iike motif. Figure 1.4 shows the structure of PCNA bound to a p21 peptide 
and in Figure 1.5 the sequences around the conserved PCNA-binding motifs of 
several proteins from different species are aligned. Mutational analyses of several 
proteins have shown that alteration of the isoleucine and/or phenylalanine residues 
abolishes PCNA-binding in vitro (Gary et al., 1997, Montecucco et al., 1998). As 
part of this work, the presence of the PCNA binding motif in the fission yeast DNA 
ligase I protein for in vivo function will be assessed (Chapter 4) 
The role of PCNA in DNA replication and its interaction with various proteins is 
reviewed in Tsurirnoto, 1999. 
W.  
Figure 1.4: Structure of human PCNA bound to a p21 peptide (white). PCNA is coloured according 
to its electrostatic potential, with regions of intense positive charge appearing blue and electronegative 




























































































































Figure 1.5: Sequence alignment of 
p21Ctlike PCNA binding motifs of 
a selection of proteins from 
different 	species. 	Conserved 
residues of the motif Qxx(I/L)xxFF 
are shown in bold and its positions 
within the sequence are boxed. The 
numbers denote the amino acid 
position of the first shown residue in 
the protein and an asterisk indicates 



































21 S T 	R 
35 K P K 
334 G S 	T 
334 G S T 
335 T I 	P 
334 S G I 
987 Q Q 	T 
1020 Q Q T 
980 V G 	T 
992 K G K 
141 K R R 
136 K R R 
181 	R K R 
40 S T R 
158 T T R 
149 A G K 
476 A N R 
336 L K K 
357 K P Q 
M 
I 	MS  
H P K K E G K A K 
Q P K L GA E V K 
IS S AS HK SE 
T S M K N K PIE 
K 	TG S L SS A 
K T G S I S S T 
K P VP SS P K K 
Q V V P KT K E  
R L A 	Q EKED 
R L E Q 	E A A G 
E G G 	TN V Y A 
PREY IS G 	K 
I-I SK R R L 	F S 
H SK R R L F C 
K ER KR LA Q A 
A KG PA KR K P 
1KG P1K R K P 
S KG ST K R K S 
Q R K * 
KR K A K * 
G K K * 
G VIP S G K K L 
KR L PA K A KS 
G K N K K S V R S 
G G G N A Q K K P 
RF-C contains distinct sites that mediate an interaction with PCNA. The central 
region of the large subunit Rfc 1, which is homologous to the N-terminal portions of 
Rfc2-Rfc5 and contains RF-C boxes II - VIII, is involved in an interaction with 
PCNA and its loading onto the DNA (Fotedar et at., 1996, see above). 
In collaboration between different labs, another region within the large subunit of 
human RF-C that interacts with PCNA was identified last year (Montecucco et at., 
1998). The extreme N-terminus of hRF-Cp140 contains a version of the p21-like 
PCNA binding motif and an N-terminal fragment binds PCNA (Montecucco et at., 
1998). The precise function of this interaction is not yet clear since a large N-
terminal deletion of human or yeast Rfc 1 including the PCNA binding motif did not 
negatively affect the replication function of the RF-C complex in in vitro assays 
(Uhlmann et at., 1997, Gomes et at., 2000). One possible explanation for interaction 
with PCNA via this motif came from the observation that the motif of human Rfc 1, 
together with a stretch of basic amino acids, which could function as a nuclear 
localisation signal, localised to sites of ongoing DNA replication (Montecucco et al., 
1998). 
PCNA constitutes the processivity factor for DNA polymerase ö converting it from a 
distributive to a processive mode of action. Although contradictory reports exist (see 
previous section) recent evidence suggests that the crucial interaction between the 
p01 5 complex and PCNA may well be mediated via the C-subunit. Po132p, Cdc27 
and p66 show limited sequence similarity but they share the conserved p21'-like 
PCNA-binding motif in their C-termini. All three proteins bind PCNA (Gerik et at., 
1998; Reynolds et at., 2000, Hughes et at., 1999). The assignment of an important 
function for the C-subunit, however, is tempered by the fact that Po132p is not 
essential for cell viability in S. cerevisiae (Gerik et at., 1998). On the other hand, 
fission yeast C-subunit Cdc27 is essential (MacNeill et at., 1996) and the PCNA 
binding motif of Cdc27, which is the C-subunit of S.pombe pot 6, is required for 
protein function in vivo (Reynolds et at., 2000). In keeping with the latter finding are 
recent studies which found the presence of the C-subunit necessary for PCNA-
dependent stimulation of human DNA polymerase 6 activity (Ducoux et at., 2001, 
Shikata et at., 2001). The contradicting results mentioned here could be explained by 
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the presence of several distinct binding sites which had differential affinities for 
PCNA within the complex which contributed to stimulation of pol 6 activity. 
The most detailed studies carried out to date on the interaction with PCNA via the 
conserved motif have been carried out with FEN 1. PCNA has been shown to interact 
with FEN1 and stimulate its endo- and exonucleolytic activities up to 50-fold (Li et 
al., 1995). The PCNA binding site in human FEN1 was shown to be in the C-
terminus where the conserved PCNA binding motif is located (Gary et al., 1997, 
Warbrick et at., 1997) and deletion of the region or mutation of the critical 
phenylalanine residues abolished binding in vitro. The contribution of a functional 
PCNA binding motif to the PCNA-dependent stimulation of FEN1 endonucleolytic 
activity has been found to vary amongst the groups who carried out the studies. For 
example, single and multiple mutations in the PCNA binding motif of human FEN1 
did not have any apparent effect in the ability of FEN1 to cleave a flap-structure 
annealed to a linearised oligomer (Frank et al., 2001). On the other hand, PCNA was 
unable to stimulate the catalytic activities of human FEN 1 deleted for the PCNA 
binding motif on a circular flap template (Stucki et al., 2001). Similar results have 
been obtained with studies of the yeast PCNA and FEN1 homologues Po130p and 
Rad27p. In addition to an important role for the motif in Rad27p to Po130p binding 
and stimulation of its nuclease activity, the authors demonstrated that the protein 
contacts differ slightly depending on whether they are present in solution or 
complexed on the DNA (Gomes and Burgers, 2000). 
The purpose of multiple proteins interacting with PCNA through a conserved motif 
remains unclear. If all these interactions serve physiologically important functions, 
this raises the questions of whether different proteins can bind to PCNA at the same 
time - keeping in mind that the homotrimeric PCNA has potentially three protein-
binding sites, and how the various interactions which occur during DNA replication 
are co-ordinated temporally and spatially. 
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1.2 Eukaryotic DNA ligases 
1.2.1 Introduction 
DNA ligases are critical enzymes in DNA metabolism. They catalyse the joining of 
breaks in duplex DNA. The first DNA joining activities were discovered in E. coil in 
the late sixties and subsequently in mammalia and plants (Newman and Hanawalt, 
1968, Lindahl and Edelman, 1968, Okazaki et al., 1968, reviewed in Lehman, 1974). 
A very important cellular event that requires the action of a DNA ligase is the joining 
of Okazaki fragments (lagging strand intermediates) as well as the ligation of 
adjacent rplicons, which are generated during semi-continuous DNA replication 
(see section 1.1). Other processes dependent on DNA ligases include various DNA 
repair pathways and genetic recombination. Thus, DNA ligases are crucial for the 
maintenance of genomic integrity and stability. 
This chapter describes the characteristics of the two existing families of DNA ligases 
and gives details about the variety of ATP-dependent enzymes. After brief 
summaries of what is known about human DNA ligase III and DNA ligase IV 
proteins, DNA ligase I and its homologues are characterised in greater depth. 
1.2.2 Classification, catalytic mechanism and structural aspects 
DNA ligases fall into two groups based on their co-factor specificities. Generally, 
eubacteria encode DNA ligases that require NAD for activity whereas eukaryotic, 
viral and archaebacterial enzymes utilise ATP as a cofactor. Despite very limited 
sequence similarity between the ATP- and NADtdependent DNA ligases (see 
below) their reaction mechanism is very similar. The catalytic mechanism is outlined 
in Figure 1.6. Briefly, the formation of a phosphodiester bond between 3'-hydroxyl-
and 5'-phosphate-termini at nicked DNA can be divided into three distinct catalytic 
steps. In a first reaction the DNA ligase becomes activated through the adenylation 
of the catalytic site lysine residue resulting in the formation of a covalent enzyme-
AMP complex. The adenyl-group donor is either ATP or NAD and the leaving 
group pyrophosphate or nicotinamide mononucleotide, respectively. Secondly, the 
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AMP moiety is transferred from the ligase molecule to the 5' phosphate group at the 
nick. In a final step, the phosphodiester bond is formed with the concomitant release 
of AMP (reviewed in Lehman, 1974, Timson etal., 2000). 
In ATP-dependent ligases six co-linear sequence motifs (I-VT) have been identified 
five of which participate in making conserved contacts with the ATP molecule. 
These motifs are common to the nucleotidyl transferase superfamily, which also 
include RNA ligases, tRNA ligases and eukaryotic mRNA capping enzymes 
(reviewed in Shuman and Schwer, 1995). Many mutational analyses on the motifs of 
different ligase proteins have been carried out which contributed to clarification of 
the catalytic mechanism (for example Luo and Barany, 1996, Sriskanda and Shuman, 
1998 a and b, reviewed in Timson etal., 2000, Doherty and Suh, 2000) 
Previously, sequence alignments between NAD- and ATP-dependent ligases failed 
to detect any significant sequence similarity apart from motif I which includes the 
active site lysine residue. Consequently it had been speculated that the two classes of 
DNA ligases have evolved independently (Shuman and Schwer, 1995). However, 
crystal structures of the ATP-dependent ligases of bacteriophage T7 (Subramanya et 
al., 1996) and the eukaryotic chiorella virus PBCV-1 (Odell et al., 2000), the related 
GTP-dependent mRNA capping enzyme of PBCV- 1 (Hâkansson et al., 1997) and of 
the NADtdependent ligases of Bacillus stearothermophilus (an N-terminal 
fragment) (Singleton et al., 1999) and Thermus fil[ormis (Lee et al., 2000b) have 
now been solved and comparison of the structures of these three classes of enzymes 
revealed the conservation of a common 'core' structure, which consists of two 
domains with a deep cleft between them. Motifs I - V, situated in the N-terminal 
domain, line the groove between the domains and the active site is located at the base 
of the pocket (reviewed in Timson etal., 2000, Doherty and Suh, 2000). The smaller 
C-terminal domain contains an OB-fold (oligonucleotide-binding), as determined 
from the ligase structures. Backed up by the available structural information the use 
of the recently developed iterative sequence database search PSI-BLAST (Altschul 
and Koonin, 1998) enabled Aravind and Koonin, 1999, to demonstrate a significant 
relationship between ATP- and NADtdependent DNA ligases. Figure 1.7 shows a 
sequence alignment of the conserved motifs I-VT from selected members of the ATP- 
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and NADtdependent DNA ligases as well as the GTP-dependent mRNA capping 
enzymes. Now it appears as if the two classes of DNA ligases may have originated 
from a common ancestor but that, while the core structure remained similar, the 
amino acid sequences diverged greatly - possibly to accommodate the accessibility 
to differing co-factors (Aravind and Koonin, 1999). 
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Figure 1.6: Catalytic mechanism of phosphodiester bond formation by ATP-dependent DNA ligases. 
See text for details. 
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I III lila IV 
Hsl Lig KYIJGQR FILDTEAV CLYAFDLIYLNG EGLMV 
Sp Lig KYDGER FILDCEAV CLFAFDILYLNG EGLMV 
Sc Lig KYDGER LILDCEAV CLFAFDILCYND EGLMV 
1 	Da Lig KYDGER FIVEGEII NVFLFDLMYYEG EGVMV 
Vac Lig KYDGER IVLDSEIV CLFVFDCLYFDG EGLVL 
PBCV Lig KIDGIR EGSDGEIS SYYWFDYVT--- EGVMI 
T7 Lig KYDGVR FMLDGELM HIKLYAILPLHI EGLIV 
Tfi Lig KVDGLS LEVRGEVY TFYALGLGLGLE DGVVL 
2 	Bst Lig KIDGLA LEARGEAF DLFVYGLADAEA DGIVI 
N) 	 Eco Lig KLDGLA LEVRGEVF TFFCYGVGVLEG DGVVI 
01 
Sp CE KSDGIR TLIDGELV RYLVFDCLACDG DGLIF 
3 	Sc CE KTDGLR TLLDGELV RYLMFDCLAING DGLIF 
PBCV CE KTDGIR SIFDGELC AFVLFDAVVVSG DGLII 
V 
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PRFIR- - IREDK 
PRFLR- - IREDK 
PRFIR- -WRP]JK 






WRFLR- - FRDDK 
WEMLR--FRDDK 
WKYIQ- -GRSDK 
Figure 1.7: Sequence alignment of the conserved motifs in DNA ligases (Lig) and mRNA capping enzymes (CE). 1: ATP-dependent DNA ligases, 2: NAD-
dependent ligases, 3: mRNA capping enzymes. Species names: HS1: human DNA ligase I, Sp: Schizosaccharomyces pombe, Sc: Saccharomyces cerevisiae, Da: 
Desulfurolobus ambivalens, Vac: vaccinia virus, PBCV: Chiorella virus, T7: bacteriophage T7, Tfi: Thermus fi1formis, Bst: Bacillus stearothermophilus, Eco: 
Escherichia coli. 
1.2.3 ATP-dependent ligases 
1.2.3.1 Introduction 
As mentioned above, ATP-dependent ligases are encoded by prokaryotic and 
eukaryotic viruses, archaea and eukaryotic species. 
(There are, however, exceptions to this rule. For example, an ATP-dependent ligase 
was identified in the eubacterial obligate parasite Haemophilus influenzae (Cheng 
and Shuman, 1997) and recently an NAD-dependent ligase has been reported from a 
eukaryotic entomopoxvirus (Sriskanda et al., 2001). A likely explanation would be 
that the presence of these untypical DNA ligases in those organisms was a result of 
horizontal gene transfer.) 
All ATP-dependent ligases consist of a core, described in the previous section, which 
constitutes the minimal architecture necessary for phosphodiester bond formation. 
Enzymes from bacteriophages of the T series, i.e. T3, T4, T6 and T7 DNA ligase as 
well as the one from Paramecium bursarium Chiorella virus (PBCV) consist only of 
this core structure. The T7 enzyme can be seen as the archetype of a DNA ligase: it 
consists of 359 amino acids and has a molecular weight of only 41 kDa (see also 
Figure 1.8 b)). N-terminal to the core structure poxviral, archaeal and eukaryotic 
DNA ligase proteins have an additional domain, the precise function of which is not 
known (see below). Exclusive to eukaryotic DNA ligase proteins are further N-
and/or C-terminal domains, which are likely to play regulatory roles or accommodate 
specialised functions. In accordance with this, in many eukaryotic species several 
ligase proteins have been identified. In mammalian cells three different ligase genes, 
LIGJ, LJG3 and LIG4, have been cloned so far and specific cellular functions have 
been assigned to their gene products (see following sections). They share the 
catalytic core and differ in their extensions. In Figure 1.8 a) the domain structure of 
human DNA ligase I, III and IV proteins are shown. Two additional ligase activities 
have been described in humans, designated ligase II and V. It is now clear that DNA 
ligase II is a proteolytic product of DNA ligase III and it remains to be seen if a new 
gene encoding for the DNA ligase V activity will be found (Husain et al., 1995, 
Johnson and Fairman, 1997). 
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I lii lila IV V 	VI 
DNA ligase I 	I 
DNA ligase lIIcx  
DNA ligase IV 	 I 	 I 	I 	I 
•: PCNA binding motif 	Zinc finger 	: BRCT domain 
Figure 1.8 a): Schematic representation of the domain structure of human DNA ligase proteins (for 
reviews see Tomkinson and Levin, 1997 and Tomkinson and Mackey, 1998) 
PCNA-binding motif 
+ 
human DNA ligase I 
S. pombe Cdcl7 
S. cerevisiae Cdc9p 
Methanococcus DNA ligase 
T7 DNA ligase 
I III lila IV V 	VI 
N-terminal 	 conserved non- 	 catalytic 
El domain FM  catalytic domain core 
Figure 1.8 b): Schematic representation of the domain structure of DNA ligase I proteins, the archaeat 
Methanococcus DNA ligase and the bacteriophage T7 DNA ligase. 
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Table 1.2: Properties of mammalian ligase activities (adapted from Tomkinson and Mackey, 1998) 
References are: Barnes etal., 1990,2  Wei et al., 1995. 
Mammalian I' JJJL IVL 
ligase activity 
gene LIG1 LIG3 LIG4 
molecular mass 
substrates: 
oligo(dT)/ + + + 
poly(dA) 
oligo(dT)/ - + + 
poly(rA) 
oligo(rA) + + - 
comments 2 splice variants: 
lila and 111J3 
interacting PCNA, lila: XRCC1 XRCC4 
proteins 
Cellular process replication, BER, lila: ss break repair, NHEJ, V(D)J 
mismatch repair?, BER recombination 
NER? I1IJ3: DNA repair?, 
meiotic 
recombination? 
Sequence comparisons and phylogenetic analyses indicate that archaeal enzymes as 
well as the yeast ligases Cdc9p (S. cerevisiae) and Cdc17 (S. pombe) are most 
closely related to mammalian DNA ligase I (Nakatani et al., 2000). These enzmes 
display a relatively high degree of sequence similarity of a non-catalytic domain, 
located N-terminal to the catalytic domains. This domain will be designated 
conserved non-catalytic domain, or CNCD, in this work. Figure 1.8 b) gives an 
overview of the domain structure of DNA ligase I homologues in comparison to the 
archetype T7 DNA ligase. The characteristics of DNA ligase I proteins will be 
described in greater detail in section 1.2.4. 
I .23.2 DNA ligase II and III 
By the mid-seventies it became apparent that at least two distinct ligase acitivities 
were present in mammalia, DNA ligase I (see section 1.2.4) and DNA ligase II 
(reviewed in Soderhall and Lindahl, 1976). DNA ligase II, a proteolytic product of 
DNA ligase III, was subsequently purified from bovine thymus (Teraoka et al., 
1986). Not until another ten years later was DNA ligase III purified to near 
homogeneity from bovine testes (Husain et al., 1995) and human DNA ligase III 
cDNAs were cloned and sequenced (Chen et al., 1995, Wei et al., 1995). 
Two gene products derive from LIG3 which differ at their C-termini and are the 
result of alternative splicing. DNA ligase lila is ubiquitously expressed and contains 
a BRCT motif at its C-terminus, while DNA ligase III3 is only expressed in testes 
and ovaries (Mackey et al., 1997, Perez-Jannotti et al., 2001). Both isoforms contain 
at its N-terminus a zinc finger, homologous to the one found in poly-(ADP-ribose)-
polymerase (Ikejima etal., 1990, Mackey et al., 1999) and by analogy it is thought to 
function as a nick sensor as well (Caldecott et al., 1996). Expression analyses of 
DNA ligase 111J3 mRNA suggests that this isoform may be specifically involved in 
meiotic recombination (Mackey etal., 1997). 
DNA ligase lila interacts with the XRCC 1 DNA repair protein in vivo and in vitro 
(Caldecott etal., 1994, Caldecott etal., 1995) and the interaction is mediated through 
its unique C-terminus where the BRCT-domains are located (Nash et al., 1997, 
Taylor et al., 1998a). XRCC1 also interacts with DNA polymerase I, which 
participates in BER (base excision repair) and cells lacking XRCC1 are deficient in 
short-patch BER (Caldecott et at., 1996, Cappelli et al., 1997). Furthermore, intact 
XRCC 1 is required for normal cellular levels of DNA ligase III (Ljungquist et al., 
1994, Caldecott et at., 1995). Consequently, DNA ligase lila is most likely to 
function in nuclear base-excision repair (Cappelli et al., 1997). Generally, the base-
excision repair pathway is responsible for repairing DNA damage that is induced by 
reactive oxygen species and small base adducts. After removal of the damaged base 
by a DNA glycosylase and an AP endonuclease, completion of BER can be divided 
into the short-patch pathway, where only one nucleotide is replaced, and the long-
patch pathway, where displacement synthesis of 9-12 nucleotides occurs. DNA 
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ligase IIL'XRCCl participate in short-patch BER (reviewed in Wood, 1996, 
Tomkinson etal., 2001). 
By 1976 a DNA ligase activity had first been described in rat liver mitochondria 
(Levin and Zimmerman, 1976). Recently, several proteins involved in BER have 
been purified from X laevis mitochondria, amongst them a DNA ligase, that has 
been shown to be capable of repairing abasic sites in DNA (Pinz and Bogenhagen, 
1998). The ligase activity of human mitochondria is encoded by the DNA ligase III 
gene and a mitochondrial targeting sequence (MTS) at its N-terminus is responsible 
for directing the enzyme to mitochondria. The same is true for the mitochondrial 
DNA ligase of rodents and Xen opus !aevis (Lakshmipathy and Campbell, 2000, 
Perez-Jannotti et al., 2001). Translation initiation from an upstream start codon 
produces the mitochondrial form whereas translation from the previously identified 
downstream start codon results in the major nuclear form (Lakshmipathy and 
Campbell, 1999, see also section 1.4). Mitochondrial DNA ligase function is 
essential for maintaining mtDNA integrity and stability (Lakshmipathy and 
Campbell, 2001). This suggests, together with the inability to detect any additional 
DNA ligase proteins in mitochondria (Lakshmipathy and Campbell, 2001, Perez-
Jannotti ci' al., 2001) that, in addition to repairing DNA damage created by reactive 
oxygen species, mitochondrial DNA ligase is involved in mtDNA replication. The 
mitochondrial ligase function does not depend on XRCC1 (Lakshmipathy and 
Campbell, 2000). 
The completed genome sequences of the yeasts Schizosaccharomyces pombe and 
Saccharomyces cerevisiae do not reveal any obvious homologues of DNA ligase III. 
1.2.3.3 DNA ligase IV 
The existence of another DNA ligase in humans, DNA ligase IV, was discovered by 
searching for additional proteins which contain a sequence homologous to conserved 
motif VI in human cDNA libraries (Wei et al., 1995). This DNA ligase shares the 
catalytic core with DNA ligases I and III but differs by an extended C-terminus 
harbouring two BRCT domains. The region between those two domains binds to 
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XRCC4 (Grawunder et at., 1997, Critchlow et at., 1997, Grawunder et at., 1998) and 
a crystal structure of the complex has recently been solved (Sibanda et al., 2001). 
Together with DNA-dependent protein kinase (DNA-PK) and the Ku70/Ku80 
heterodimer the DNA ligase IV-XRCC4 complex carries out non-homologous end 
joining (NHEJ), the main pathway in double-strand break repair and V(D)J 
recombination in higher organisms. XRCC4 seems to stabilise DNA ligase IV since 
null cells have greatly reduced levels of DNA ligase IV (Modesti et al., 1999). 
Inactivation of the LIG4 gene in mice leads to lethality in late embryonic stages and 
cultured cells lacking DNA ligase IV are defective in V(D)J recombination and 
display an increased sensitivity to ionising radiation (Barnes et al., 1998, Frank et at., 
1998, Gao etal., 1998). 
Homologues of DNA ligase IV have been identified in the yeasts Saccharomyces 
cerevisiae (Wilson et at., 1997, Teo and Jackson, 1997, Schar et al., 1997, Ramos et 
al., 1998), Candida a!bicans (Andaluz et al., 1996, Andaluz et al., 1999) and 
Schizosaccharomyces pombe (Manolis et at., 2001). A XRCC4 homologue, Lifip, 
has also been identified in budding yeast (Herrmann et at., 1998). As expected, yeast 
DNA ligase IV is an essential component of NHEJ since deletion of the respective 
genes from the chromosomes resulted in cells defective in this process. Yeast genes 
encoding DNA ligase IV are non-essential for growth and display only a slight 
sensitivity to various DNA damaging agents (Wilson et al., 1997, Teo and Jackson, 
1997, Schar et al., 1997, Ramos et al., 1998, Manolis et at., 2001), which indicates 
that another pathway, most probably homologous recombination, is the major 
mechanism to repair DNA double strand breaks originating from ionising radiation in 
yeast. 
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1.2.4 DNA ligase I 
1.2.4.1 Introduction 
By the mid-seventies, two distinct DNA ligases had been detected in mammalian cell 
extracts, only one of which, namely DNA ligase I, was induced upon cell 
proliferation. This enzyme is the major ligase activity in proliferating cells 
(Soderhall, 1975, Soderhall and Lindahi, 1975). The protein was first purified to 
apparent homogeneity from calf thymus (Teraoka and Tsukada, 1982; Tomkinson et 
al., 1990). 
A partial cDNA sequence of human DNA ligase I was obtained by screening a 
human cDNA library by hybridisation with oligonucleotides derived from a peptide 
sequence of bovine DNA ligase I. Subsequently, a full-length human cDNA was 
obtained by functional complementation of a Saccharomyces cerevisiae cdc9 
temperature-sensitive DNA ligase mutant (Barnes et al., 1990, see also next section). 
To date, DNA ligase I homologues from human, mouse, X laevis, A. thaliana, S. 
pombe and S. cerevisiae have been cloned and sequenced (Barnes et al., 1990, Savini 
et al., 1994, Lepetit et al., 1996, Taylor et al., 1998b, Barker et al., 1987, Barker et 
al., 1985). The size of these enzymes ranges from 180 kDa for  laevis, 102 kDa for 
human down to 85 kDa for the budding yeast homologue. Figure 1.9 shows a 
sequence alignment of DNA ligase I homologues. 
Figure 1.9 (following page): Sequence alignment of DNA ligase I proteins from humans (HsLigl), 
mouse (MmLigI), Xenopus laevis (XlLigI), Arabidopsis thaliana (AthLigl), Schizosaccharomyces 
pombe (SpCdcl7) and Saccharomyces cerevisiae (ScCdc9). The alignment was performed with 
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1.2.4.2 DNA ligase I in DNA replication 
Several lines of evidence strongly imply a role for DNA ligase I in DNA replication. 
The budding yeast and fission yeast temperature-sensitive mutants cdc9 and cdcl 7, 
respectively, that are deficient in DNA ligase I, arrest in early S-phase and 
accumulate low molecular weight DNA (Johnston and Nasmyth, 1978; Nasmyth, 
1977; see also next section). Similarly, the human cell line 46BR, which contains 
two point mutations in different alleles of the LIGJ gene, displays an abnormal 
joining of Okazaki fragments (Barnes etal., 1992; Prigent et al., 1994). Human DNA 
ligase I can complement the Saccharomyces cerevisiae cdc9 mutant (Barnes et al., 
1990) and the defect in the joining of Okazaki fragments can be complemented by 
the addition of human DNA ligase I but not by DNA ligase III or T4 ligase 
(Mackenney et al., 1997). Furthermore, in reconstitution of complete SV40 
replication with purified replication factors, only mammalian DNA ligase I functions 
in the replication system whereas DNA ligase III cannot substitute and T4 ligase only 
functions inefficiently (Waga et al., 1994). In summary, DNA ligase I is the enzyme 
responsible for the joining of Okazaki fragments that are generated during the DNA 
replication of the lagging strand. 
The DNA ligase I gene is essential for cell viability. Both yeast temperature-sensitive 
mutants that are deficient in DNA ligase I are lethal at the restrictive temperature 
(Nasmyth, 1977; Johnston and Nasmyth, 1978) and gene knockout experiments with 
mouse embryonic stem cells - where both LIGJ alleles had been inactivated - 
showed that the cells were only viable if a human DNA ligase I cDNA was 
ectopically expressed (Petrini et al., 1995). However, a seemingly contrary report 
described that mouse embryos in which the last three exons had been deleted from 
both copies of the LIGJ gene developed to midterm (Bentley et at., 1996). It is 
possible that other ligases were partly substituting for DNA ligase I and/or low levels 
of undetectable ligase I protein was present. 
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12.4.3 Role of the N-terminal domain for DNA replication 
Most studies with DNA ligase I have been carried out with the human enzyme. 
Human ligase I is composed of 919 amino acids with a molecular weight of 102 kDa, 
running on a SDS-gel at an apparent molecular weight of 125 kDa (Barnes et al., 
1990). It comprises a large C-terminal portion (amino acids 217-919) which can be 
sub-divided into the conserved non-catalytic domain and the T7-11ke catalytic core 
domains, and a small N-terminal domain (amino acids 1-216) which is hydrophilic 
and very sensitive to proteolysis. The N-terminal domain is not required for catalytic 
activity (Tomkinson et al., 1990) but is indispensable for in vivo function. Mouse 
embryonic stem cells with a DNA ligase I null mutation are rescued by a full-length 
human DNA ligase I cDNA but not by an N-terminally truncated version (Petrini et 
al., 1995). Interestingly, a human cDNA clone lacking the first 633 nucleotides, 
which corresponds roughly to the N-terminal domain, was able to complement the 
yeast cdc9-7 mutant (Barnes etal., 1990). 
Studies with extracts of SV40-transformed 46BR cells, which displayed aberrant in 
vitro DNA replication, elucidated that full length DNA ligase I was 10-fold more 
efficient in complementation experiments than the catalytic domain on its own. This 
implies that the N-terminal part of DNA ligase I is required for efficient lagging 
strand replication (Mackenney etal., 1997). 
Several studies have been performed concerning the intracellular localisation of 
DNA ligase I throughout the cell cycle (Lasko et al., 1990a, Li et al., 1994, 
Montecucco etal., 1995, Cardoso etal., 1997). It has been found that in non-S-phase 
nuclei DNA ligase I is distributed throughout the whole nucleus excluding the 
nucleolus (Lasko et al., 1990a). In mitosis, DNA ligase I is excluded from the 
condensed chromosomes and after re-formation of the nuclear envelope it is rapidly 
imported into the nucleus (Cardoso et al., 1997). In S-phase nuclei DNA ligase I 
specifically localises at sub-nuclear sites of DNA synthesis (Montecucco et al., 
1995). Montecucco and co-workers identified a 13-amino acid stretch within the N-
terminal domain of (human) DNA ligase I (amino acids 119-131) that serves as a 
nuclear localisation signal (NLS). They also found that the N-terminal amino acids 
preceding the NLS are necessary for the association of DNA ligase I with replication 
factories (Montecucco et al., 1995). In a later report, Cardoso et al. (1997) came to 
the conclusion that a bipartite sequence consisting of aa 1-28 and aa 111-179 were 
necessary and sufficient to direct DNA ligase I to sites of ongoing replication. The 
entire catalytic domain was completely dispensable for localisation to replication 
foci. DNA ligase I co-localised with PCNA and methyltransferase, which had 
previously been shown to be present at sites of DNA synthesis (Leonhardt et al., 
1992). Subsequently Montecucco and co-workers (1998) refined the mapping of the 
so-called replication factory targeting sequence (RFTS). The first 20 amino acids are 
necessary and sufficient for sub-nuclear targeting to replication foci in vivo. 
DNA ligase I interacts with PCNA, a protein central to DNA replication, other DNA 
metabolic events and cell cycle progression (see section 1.1.3). Human PCNA was 
recovered as a protein specifically retained by a DNA ligase I affinity column and 
this interaction is mediated by the N-terminal 118 amino acids of DNA ligase I 
(Levin et al., 1997). Intriguingly, in a later report it was shown that the first twenty 
amino acids of human DNA ligase I are sufficient for interaction with PCNA in 
GST-pull-down-assays - the same residues that are responsible for sub-nuclear 
targeting (Montecucco et al., 1998) and that are conserved in various PCNA binding 
proteins (Warbrick, 1998, see section 1.1.3.4). Mutations of the conserved 
phenylalanine residues within the PCNA-binding motif abolish both targeting to 
replication foci as well as PCNA binding (Montecucco et al., 1998). It is therefore 
tempting to speculate that DNA ligase I could be recruited to sites of DNA 
replication via an interaction with PCNA. 
DNA ligase I and p21, which both contain the PCNA binding motif, inhibit in vitro 
PCNA-dependent DNA synthesis by poi ö (Levin et al., 1997, Mossi et al., 1998) 
which suggests that the former molecules compete with pol 6 for binding to PCNA. 
Moreover, human DNA ligase I where the adjacent phenylalanine residues of the 
PCNA binding motif had been mutated, results in deficient joining of Okazaki 
fragments in 46BR.1G1 cell extracts whereas the wild type enzyme corrects the 
replication defect under those conditions (Levin et al., 2000). Consistently, PCNA 
has been reported to increase ligation efficiency on a linear substrate and on a 
circular substrate in the presence of RF-C (as clamp-loader) (Tom et al., 2001). 
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Taking into account the fact that DNA ligase I binds to PCNA via its N-terminal 
domain which is highly susceptible to proteolysis, it is understandable that the 
identification of this interaction is very much dependent on the experimental 
procedures. Loor et al. (1997), for example, failed to identify this interaction 
probably because of proteolytic degradation of the N-terminus of DNA ligase I. 
In summary, evidence suggests that the observed interaction between DNA ligase I 
and PCNA is functionally relevant. However, the physiological significance of this 
association is still not answered conclusively. 
The N-terminal portion of the protein also seems to be the target for post-
translational modification; specific phosphorylation of serine residues by casein 
kinase II (CKII) within the N-domain modulates catalytic activity in vitro. Human 
ligase I expressed in E.coli is inactive. However, catalytic activity can be restored by 
preincubation with CKII (Prigent et al., 1992). A residue in the N-terminal domain of 
human DNA ligase I, Ser66, which is part of a strong CKII consensus site, is 
phosphorylated in a cell-cycle dependent manner with it being phosphorylated in G2 
and mitosis, becoming dephosphorylated in early G1 and the amount of 
phosphorylated form increasing during S-phase (Rossi et al., 1999). Also, Cdk2-
cyclin A is complexed with PCNA from HeLa nuclear extracts, this ternary complex 
could phosphorylate ligase I and PCNA seems to exert a stimulating effect on this 
activity (Koundrioukoff et al., 2000). 
1.2.4.4 DNA ligase I in DNA repair 
In addition to its role in DNA replication, DNA ligase I also plays a role in DNA 
repair. The human 46BR cell line and the budding and fission yeast mutants are 
hypersensitive to a variety of DNA damaging agents such as IJY light, alkylating 
agents and ionising radiation. Complementation of cdc9 with human DNA ligase I 
cDNA corrects this phenotype (Barnes et al., 1992; Johnston and Nasmyth, 1978; 
Nasmyth, 1977). However, it has been reported that the ligation activity in this case 
can be substituted for by ligase III or T4 ligase (Kubota et al., 1996). 
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DNA ligase I is required for the final step in several DNA repair pathways. 
Nucleotide excision repair (NER) has been reconstituted with recombinant human 
proteins: in addition to a set of proteins specific for recognition and removal of the 
damaged site, the replication proteins DNA polymerase ö or c, PCNA, RF-C and 
DNA ligase I were required for completion of DNA repair (Araujo etal., 2000). 
DNA ligase I has been found to interact with pot J3, a DNA polymerase functioning 
in BER pathways. The two proteins were present in a complex capable of carrying 
out BER and co-immunoprecipitated from bovine testes nuclear extract (Prasad et 
al., 1996). Subsequently, the interaction site within DNA ligase I was determined to 
lie in the N-terminal domain (Dimitriadis et al., 1998). The precise residues required 
for the interaction are not known but mutations in the PCNA binding motif of human 
DNA ligase I did not affect PCNA binding suggesting that pot f3 and PCNA bind to 
distinct regions within the N-terminal domain. A functional PCNA binding motif is 
required in long-patch BER assays indicating that DNA ligase also acts in 
conjunction with PCNA in DNA repair pathways (Levin et al., 2000) 
1.2.4.5 Yeast DNA ligase I homologues 
In a screen for temperature-sensitive mutants defective in cell cycle progression in S. 
poinbe, mutants probably defective in the structural gene for DNA ligase, termed 
cdcl7, were isolated (Nasmyth, 1977) (see also section 1.3). The cells grew normally 
at 25°C but, in contrast to wild type cells, were unable to form colonies at 35°C. 
Instead, the cells arrested in S-phase with a highly elongated phenotype (cdc 
phenotype). The mutants displayed four different phenotypes: 
1) A lethality at the restrictive temperature (cdc) that is caused by a defect at the end 
of S phase - the cells underwent bulk DNA synthesis but the DNA was defective. 2) 
The mutants showed an abnormally high sensitivity to UV radiation, 3) a deficient 
joining of nascent DNA strands and 4) an abnormally low level of DNA ligase 
activity. Three different mutant alleles of the cdcl 7 gene, arisen from independent 
mutageneses, have been isolated - cdcl 7-K42, which is the best-characterised allele, 
cdcl7-M75 and cdcl7-L]6. In 1979, Nasmyth described the partial purification of 
Cdc17 and a new method of assaying DNA ligase. He showed that the cdc 
phenotype and the deficiency in DNA ligase activity in cdcl 7-K42 is due to a single 
mutation resulting in a thermolabile DNA ligase. Around the same time the 
Saccharomyces cerevisiae cell cycle mutant cdc9 has been identified which showed 
similar properties to the cdcl 7 mutants (Johnston and Nasmyth, 1978). 
In the following years, both the Saccharomyces cerevisiae and Schizosaccharomyces 
pombe DNA ligase genes, CDC9 and cdcl7, respectively - homologues of 
mammalian DNA ligase I - were cloned by complementation of the S. pombe cdcl 7 
temperature-sensitive DNA ligase I mutant (Barker and Johnston, 1983; Johnston et 
al., 1986) and subsequently sequenced (Barker et al., 1985; Barker et al., 1987). 
S. pombe Cdcl7 consists of 768 amino acids with a molecular weight of 86,581 Da 
and the S. cerevisiae counterpart comprises 755 amino acids and has a molecular 
weight of 84,828 Da. In contrast to CDC9, which does not have introns (Barker et 
al., 1985), cdcl7 contains two small introns of 40 and 63 nucleotides, respectively, 
close to the 5' end (Barker et al., 1987, see Appendix 1). The lack of introns in 
CDC9 probably explains why CDC9 is able to cross-complement cdcl 7 mutations 
(Barker and Johnston, 1983) whilst the reverse complementation is not successful 
(Johnston et al., 1986). 
The yeast ligases contain the six boxes of homology common to DNA ligases and the 
active lysine residue of budding and fission yeast is at position 419 and 416, 
respectively. Like the human enzyme, the budding yeast homologue is an 
asymmetric monomer and has an N-terminal domain which is readily susceptible to 
endogenous and chemical proteolysis (Tomkinson et al., 1990; Tomkinson et at., 
1992). 
A striking difference between Cdcl7 and Cdc9p is their mode of expression 
throughout the cell cycle. The cdcl 7 transcript is present at constant levels whilst the 
CDC9 m-RNA is periodically transcribed peaking at the GuS boundary, and this 
also correlates with their specific activity of DNA ligation (White et at., 1986). Since 
both enzymes fulfil the same function it could be considered surprising that they are 
expressed in such a different way, however, this may simply reflect the fact that the 
two yeasts differ substantially in the organisation of their cell cycles and that periodic 
expression in budding yeast does not serve any particular purpose. 
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Very recently another DNA ligase protein apart from Cdcl7 and Lig4 was reported 
to be encoded by the S. pombe genome. This gene, termed lpp1 (for ligase 
Qaralogue protein, Stuart MacNeill, personal communication) encodes a ligase most 
closely related to DNA ligase I homologues. Its catalytic domains share around 40% 
sequence identity (-60% homology) with Cdcl7 and human DNA ligase I and its 
conserved non-catalytic domain is -30% identical (50% homologous) with those of 
DNA ligase I proteins. The gene is not essential for viability and possible functions 
are currently under investigation (Stuart MacNeill, personal communication). 
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1.3 Introduction to the fission yeast S. pombe 
1.3.1 Overview 
The fission yeast Schizosaccharornyces pombe is a unicellular ascomycete fungus. S. 
pombe cells are rod-shaped, grow by apical extension and divide by medial fission. It 
is only distantly related to the budding yeast Saccharornyces cerevisiae and recent 
phylogenetic analyses suggest that they are only as related to each other as either of 
them is to animals (Sipiczki, 2000, Heckman et al., 2001). Phylogenetically, S. 
pombe is classified as an Archiascomycete. Its genome size is 13.8 Mb, and the DNA 
is contained on three ci'romosomes of 5.7, 4.6 and 3.5 Mb. Sequencing of the 
genome is now complete and data can be accessed via the Sanger Centre website 
under http://www.sanger.ac.uk/Projects/S_pombe/.  
S. pombe is an excellent model system for studying gene function and its haploid and 
diploid states of existence (see below) allow easy genetic manipulation. 
1.3.2 S. pombe life cycle 
When S. pombe cells are provided with an abundance of nutrients, they enter the 
mitotic cell cycle, which is described in more detail in the next section. When 
deprived of nutrients several developmental fates are possible. Essentially, S. pombe 
cells are of two mating-types, termed h and h. If the culture only contains cells of 
one mating-type, they will exit the mitotic cell cycle and accumulate in stationery 
phase. If both mating-types are present, cells of opposite mating-type conjugate and 
form a zygote, which then undergoes meiosis and sporulation. A zygotic ascus is 
generated containing four spores, which lie dormant until the nutritional conditions 
improve. Then spores will germinate and the mitotic cell cycle is re-entered. 
However, if diploid zygotes are re-supplied with nutrients, prior to the initiation of 
meiosis, they enter the mitotic cell-cycle. The growth mode of diploid cells is similar 
to that of haploid cells except that the former are longer (20-25 tm versus 12-15 tm 
at cell division) and wider (4-5 JIm versus 3-4 im at cell division) than the latter. In 
the laboratory, the generation time of S. pombe varies between two to four hours, 
Ell 
depending on the media (complex or minimal) and growth temperature. Figure 1.10 
illustrates the life cycle of S. pombe cells. 
1.3.3 S. pombe cell cycle 
The mode of growth of fission yeast cells by length extension allows the stage of a 
cell within the cell cycle to be determined by measuring its cell length (Mitchison, 
1957). S. pombe possesses a typically eukaryotic cell cycle with distinct G1 , S, G2 
and M phases. M, G1 and S phase each occupy --10% of one cell cycle and G2 
accounts for the remaining 70%. In rapidly growing cells, G1 and S phase are 
completed soon after mitosis but before cell division is complete. Thus, the smallest, 
new-born cells are in G2 (see Figure 1.1 1). 
There are two major control points in the mitotic cell cycle of S. pombe: in late G1  
before the initiation of S phase and in late G2 before the initiation of mitosis. The 
point in G1 when cells become committed to the mitotic cell cycle is termed START 
(Hartwell et al., 1974, Nurse and Bissett, 1981). Passage of START and entry into S 
phase are dependent on prior completion of mitosis and cells reaching a certain cell 
size (Nurse, 1975, Nurse and Thuriaux, 1977). The control point in late G2 
determines the time of entry into mitosis. Passage of this G2/M control point require 
that the cells reach a critical size as well as completion of S phase and repair of any 
DNA damage that may have occurred. The presence of these checkpoints ensure that 
mitosis is not initiated until the faithful duplication of the genome and that DNA 
synthesis does not begin until mitosis is complete (control of the S. pombe cell cycle 
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Figure 1.10: Life cycle of the fission yeast S. pombe. Top left: haploid mitotic cell cycle, centre and 
lower left: haploid cells mating to form a diploid zygote, followed by meiosis and sporulation resulting 
in a zygotic ascus. Lower right: re-entry of diploid cells into the mitotic cell cycle. Illustration kindly 
provided by Stuart MacNeill. 
Figure 1.11: Schematic representation of the S.pombe cell cycle (picture taken from Alfa et al., 1993). 
The relative duration of the cell cycle phases and morphological changes are indicated. 
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1.3.4 cdc mutants and S phase genes 
Many conditional-lethal (i.e. temperature-sensitive or cold-sensitive) S. pombe 
mutants defective in cell cycle progression have been isolated in genetic screens. Cell 
cycle arrest in S. pombe typically leads to cell elongation where cells continue to 
grow but are unable to divide, due to checkpoint activation. Therefore, mutants can 
be identified by being highly elongated, termed the cdc (cell division cycle) 
phenotype. Twenty-five so-called cdc genes have been identified in the original 
screens for cell cycle defective mutants, which can be classified according to their 
arrest point. They include genes required for entry into the cell cycle, for DNA 
replication, for entry into mitosis and for septation (Nurse et al., 1976, Nasmyth and 
Nurse, 1981). Eleven of the originally identified cdc mutants were shown to encode 
genes whose functions are required for S phase (reviewed in MacNeill and Nurse, 
1997), among them cdcl 7, which is the subject of this work. Those genes are listed 
in Table 1.3 a). Table 1.3 b) gives an overview of additional genes whose products 
have subsequently been shown to be important during S phase in S. pombe. Finally, 
Figure 1.12 illustrates proteins involved in the S. pombe S phase. 
Table 1.3 a): S. pombe cdc genes, identified in the original screens for mutants defective in cell cycle 
progression (Nurse et al., 1976, Nasmyth and Nurse, 1981), which have been shown to function in S 
phase. Different designations of the samegene are separated by a forward slash, and different gene 
products making up subunits of a functional complex are separated by commata. 
gene names description 
cdc] DNA polymerase 6 B-subunit 
cdc6/pol3 DNA polymerase 6 catalytic subunit 
cdc 17 DNA ligase 
cdc18 regulator of S phase onset; Cdc6 homologue 
cdcl 9/ndal/mcrn2 Mcm2 
cdc20 DNA polymerase c catalytic subunit 
cdc2l/mcm4 Mcm4 
cdc22 large subunit of ribonucleotide reductase 
cdc23 McmlO 
cdc24 required for completion of DNA replication; function unknown 
cdc27 DNA polymerase 6 C-subunit 
MI 
Table 1.3 b): Further S. pombe S phase genes 
gene names description 
cdml DNA polymerase 6 D-subunit 
cdtl regulator of S phase onset 
dna2 Dna2 endonuclease/helicase 
hskl, dfpl homologue of Cdc7 protein kinase 
mc,n3, mcm5/nda4, further MCM subunits (in addition to mcm2/cdc19 and mcm4/cdc2l) 
mcm6/mis5, mcm7 
orpl/cdc3O/orcl, orp2, ORC subunits 
orp3, orp4, orp5, orp6 
pcnl PCNA homologue 
polJ/cdc29/swi7 DNA polymerase a catalytic subunit 
rad2 FEN I homologue 
rad4/cut5 required for initiation of DNA replication and replication checkpoint 
rfcl, rfc2, rfc3, rfc4, rfc5 RF-C subunits 
rpal/radl 1, rpa2, rpa3 RPA subunits 
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Figure 1.12: Schematic representation of S. pombe proteins involved in S phase. 
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1.4 Protein targeting to mitochondria 
During the course of this work it became clear that S. pombe DNA ligase I, the 
subject of this study, is targeted to mitochondria - in addition to its nuclear 
localisation. The following section gives a brief introduction to mitochondria and 
subsequently an overview is given of mechanisms whereby targeting to mitochondria 
can be achieved. 
1.4.1 Introduction 
Mitochondria are organelles surrounded by a phospholipid bilayer membrane and are 
the sites of oxidative phosphorylation, whereby most of the ATP in eukaryotic cells 
is produced. They can be subdivided into the outer and inner membrane, the 
intermembrane space and the matrix. Mitochondria have their own circular DNA 
molecules, ranging in size from 16.6 kb for human mitochondrial (mt) DNA, 19.4 
kb for the genome of S. pombe mitochondria to 78 kb for S. cerevisiae mtDNA. The 
genomes encode between 8 and 13 proteins, the large and small subunits of rRNA 
that make up mitochondrial ribosomes, and between 22 and 25 tRNAs. All 
mitochondrially synthesised proteins are involved in electron transport or ATP 
synthesis. The genetic code used in mammalian and fungal mitochondria differs in 
most of the cases from the universal translation code; however, the standard code is 
used for protein-encoding genes in S. pombe mitochondria (Paquin et al., 1997). 
Many proteins which are localised in mitochondria, such as DNA and RNA 
polymerases, metabolic enzymes and most proteins involved in oxidative 
phosphorylation, are encoded by nuclear genes and transcribed on cytosolic 
ribosomes. This raises the question as to how proteins are targeted to mitochondria. 
The following section gives an overview of common mechanisms that have evolved 
to ensure that proteins are targeted to mitochondria and other cellular destinations. 
16. 
1.4.2 Targeting mechanisms 
Nascent proteins, which are translated on cytosolic ribosomes, are usually targeted to 
organelles by uptake-targeting sequences specific for the respective location. For 
example, proteins destined for the endoplasmatic reticulum (ER) generally harbour 
an N-terminal signal sequence with a hydrophobic core whereas peroxisomal 
proteins have C-terminal tripeptides of the Ser-Lys-Leu motif. Nuclear localisation 
signals (NLS) are usually internal and consist of highly positively charged mono- or 
bipartite sequences. Mitochondrial targeting signals (MTS) are N-terminal sequences 
which form amphiphilic a-helices: one side of the helix being predominantly 
hydrophobic, whereas the other side is positively charged (von Heijne, 1986, Roise 
and Schatz, 1988). Apart from these common physico-chemical properties, no 
sequence similarities have been identified in mitochondrial presequences of different 
proteins. They are, however, capable of directing non-mitochondrial proteins into the 
organelle. The N-terminal MTS targets the so-called preprotein to mitochondria 
where it is recognised by the protein import machineries located in the mitochondrial 
membranes. These translocases are termed TOM and TIM (for translocase of the 
outer membrane and translocase of the inner membrane, respectively) and transport 
the target protein in energy-driven processes into the mitochondrial matrix. The 
detailed mechanisms of protein transport into mitochondria lie outside the scope of 
this introduction and are reviewed in Neupert, 1997 and Pfarmer et al., 1997. If the 
protein functions in mitochondrial compartments other than the matrix, further 
sorting processes come into play. In the matrix the targeting sequence of the 
translocated preprotein is cleaved off by a mitochondrial processing peptidase (MPP) 
and matrix chaperones aid folding of the protein into its active configuration. 
How can multi-compartmentalised proteins that are encoded by a single gene contain 
more than one targeting information? The most common method by which isoforms 
of a particular protein localise to mitochondria as well as to another compartment, 
are produced, is to have two (or more) in-frame translation initiation sites in the 5' 
region of the gene. The region between the two start codons typically encodes an 
amphiphilic a-helix which serves as a mitochondrial targeting sequence. Two major 
pathways can be identified either of which leads to the presence of (generally) two 
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proteins, encoded by the same gene, being found in different sub-cellular 
compartments. Firstly, alternative transcription initiation from different promoters 
may produce two mRNAs, which differ at their 5' ends. The long transcript contains 
both AUG codons and default translation from the upstream AUG codon yields the 
mitochondrial preprotein. Translation from the short mRNA begins at the second 
AUG and results in the non-mitochondrial form. The relative abundance of the 
isoforms in this case are at least partly determined through the transcript levels. 
Alternatively, only a single transcript may be produced, but alternative translation 
initiation from in-frame AUG codons produce proteins with different N-termini. 
Parameters which can influence the choice of initiation codon include the secondary 
structure of the mRNA (Bairn and Sherman, 1988) and the sequence context 
surrounding the start codons (Kozak, 1996). Irrespective of the strategy adopted, the 
longer protein usually contains the MTS and will therefore be targeted to 
mitochondria, whereas the shorter protein will remain in the cytosol unless it 
harbours additional sorting signals. Combinations of the above described 
mechanisms may yield more complex sub-cellular distributions. 
One example of proteins which are targeted to their destinations in the above 
described manner is the gene products of S. pombe uve1. Fission yeast uve1 
encodes a UV-damage endonuclease (UVDE), which functions in the UVDE-
dependent repair pathway (UVER). S. pombe and Neurospora crassa both utilise this 
type of DNA repair system - closely related to BER (base-excision-repair) - for the 
removal of UV-induced DNA damage (Bowman et al., 1994). The uve] nucleotide 
sequence possesses three in-frame start codons at positions 1, 56 and 64 and the N-
terminal 20 amino acids show characteristic MTS features. Translation initiation 
from the upstream AUG generates a protein which localises to mitochondria and 
usage of the second and/or third start codon yields nuclear UVDE. Repair kinetics of 
a UV-induced DNA damage (CPD, cyclobutane pyrimidine dimers) at a nuclear and 
mitochondrial locus indicate that UVER functions both in the nucleus and in 
mitochondria (Yasuhira and Yasui, 2000). 
Higher eukaryotes have developed further strategies to allow production of multi-
compartmentalised proteins from a single gene. For example, the products of the 
human UNG gene are mitochondrial and nuclear uracil-DNA-glycosylase, designated 
UNG1 and 1.JNG2, respectively. They are generated by a combination of alternative 
transcription initiation and alternative splicing (Nilsen et al., 1997) and differ in their 
N-terminal residues. The N-terniinus of UNG1 contains an MTS whereas N-terminal 
amino acids of IJNG2 are part of a complex NLS (Otterlei et al., 1998). Uracil-DNA-
glycosylase initiates the first step in base-excision repair. 
(Further examples of targeting mechanisms of a particular gene product to multiple 
cellular compartments are reviewed in Danpure, 1995.) 
1.5 Aim of this work 
This study initially set out to examine the functions of the non-catalytic domains of 
the S. pombe DNA ligase I protein Cdcl7. In particular, to investigate by 
complementation analyses, whether the presence of the non-catalytic domains of 
Cdc 17 were required for cell viability (Chapter 2). Previous work had shown that the 
N-terminal domain of Cdc17 was able to bind the S. pombe PCNA homologue Pcnl. 
Experiments that examine the relevance of this interaction for in vivo function of the 
ligase protein are described (Chapter 4). Prompted by recent publications and 
personal observations, the ability of cdcl 7 to encode a mitochondrial DNA ligase 
was also investigated (Chapter 3). 
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2 Genetics and structure-function analyses of cdc17 
21 Introduction 
As discussed in Chapter 1, in common with other DNA ligase I proteins, the S. 
pombe protein Cdc17 consists of three distinct domains. The C-terminal catalytic 
domains (Core) is highly conserved across all ATP-dependent ligases. The conserved 
non-catalytic domain (CNCD) is common to archaeal and eukaryotic DNA ligases 
and has no attributed function as yet. An N-terminal extension (NT) - unique to 
eukaryotic DNA ligase I homologues - shares little sequence similarity between 
species except a p21-like PCNA binding motif, which will be the subject of a later 
chapter (see Chapter 4). 
There have been several reports on the effect of deleting the non-catalytic domains of 
DNA ligase proteins on their catalytic activity in vitro (Sekiguchi and Shuman, 1997 
and see below). Clearly, the N-terminal domain is dispensable for catalytic activity in 
case of the human and budding yeast DNA ligase I proteins (Tomkinson et al., 1990, 
Tomkinson et al., 1992). In the absence of the conserved non-catalytic domain 
ligation activity was still detectable in in vitro assays albeit to a lower extent 
(Sekiguchi and Shuman, 1997). In human cells, the N-terminal domain was found to 
contain an NLS and a replication factory targeting sequence (RFTS) (Montecucco et 
al., 1995 and 1998). However, the question whether this domain is essential for DNA 
ligase function has not been answered conclusively yet. 
In this chapter the contribution of the non-catalytic domains of Cdc 17, namely the 
conserved non-catalytic domain and the N-terminal domain, to the in vivo function of 
Cdc 17 is investigated. Truncated versions of Cdc 17 are tested for their ability to 
rescue temperature-sensitive cdcl 7 strains and subsequently a cdcl 7 deletion strain, 
which was constructed as part of this work. 
In preparation for these functional complementation experiments the temperature-
sensitive strains cdcl7-K42, cdcl7-L16 and cdcl7-M75, which were isolated as 
conditional lethal mutants defective in cell cycle progression at the restrictive 
temperature (Nasmyth, 1977), were characterised and their lesion sites determined. 
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2.2 Analysis of temperature-sensitive cdc17 strains 
2.2.1 Sequence characterisation of cdcl7ts  alleles 
As a first step towards identifying domains within the Cdc 17 protein that are required 
for cellular functions the lesion sites in the thermolabile proteins were determined. 
For this purpose, genomic DNA from the temperature-sensitive strains cdcl 7-K42, 
cdc17-L16 and cdcl7-M75 was prepared and used as a template for PCR-
amplification with primers flanking the cdc17 locus. The alleles were cloned and 
sequenced (see Materials and Methods, section 6.10.2 for details). 
In each case a single deviation from the wild-type DNA sequence was detected 
resulting in a single amino acid change. The results of the sequence analysis are 
presented in Table 2. 1. 
Table 2.1: Sequence analysis of mutant cdcl 7 alleles 
allele K42 L16 M75 
nucleotide 2216 3074 3371 
wild-type sequence GAA CCG CCT 
Glu298 Pro584 Pro679 
mutant sequence AAA TCG TCT 
Lys298 Ser584 Ser679 
The numbering of nucleotides and amino acids is as in Appendix 1 and Appendix 2, 
respectively, and the relative positions of the mutations within the Cdc17 protein is 
depicted in Figure 2.1. 
cdcl 7-K42 carries a mutation within the conserved non-catalytic domain (CNCD) 
and the mutated sites of the ligase proteins of cdcl 7-L16 and cdcl 7-M75 lie within 
the catalytic domains. The positions of the lesions within Cdc17 are discussed in 
detail in section 2.6. 
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Cdcl7 
125 	 390 	 768 
I IIIIIaIV V 	VI 
cc/c17-K42 	cdc17-L16 	cc/c17-M75 
E298K P5845 P6795 
Figure 2.1: Positions of the mutation sites within the Cdc17 protein of the temperature-sensitive 
cdcl 7 alleles. NT: N-terminal domain, CNCD: conserved non-catalytic domain, Core: catalytic 
domains. The roman numerals I - VI indicate the conserved motifs present in ATP-dependent DNA 
ligases. The numbers refer to amino acid positions. 
52 
2.2.2 Physiological characterisation 
In addition to identifying the positions of the mutations, the growth properties of the 
temperature-sensitive strains at the permissive and restrictive temperature was 
compared. The cells were grown up overnight in YE at 25°C, split, diluted into fresh 
YE to an 0D600 of - 0.05 and grown at 25°C or 36°C. OD and cell number were 
monitored over a 10 hour period. The growth curves are shown in Figure 2.2. 
In order to assess the functionality of the mutant proteins at permissive, intermediate 
and restrictive temperatures, cell length was measured after growth for 6 hours in YE 
at the respective temperatures (see Table 2.2). 
Table 2.2: Cell lengths of cdc17" strains at permissive, intermediate and restrictive temperatures 
strain 	 25°C 	 32°C 	 36°C 
cdcl7-K42 	(14.1 ± 1.7) Jim 	(23.5 ± 4.8) tm 	(28.9 ± 4.7) gm 
cdcl7-L16 	(13.1 ± 1.0) gm 	(21.9±4.6)tm 	(29.8 ±4.8) tm 
cdcl7-M75 	(13.9± 1.2)j.tm 	(14.7±1.3)Jim 	(25.6±5.1)tm 
Strains cdcl7-K42 and cdc17-L16 behave similarly. Although their cell mass 
increases to a similar extent at the permissive and restrictive temperature, cell 
number reached a plateau after around nine hours at 36°C, indicating a loss of 
viability. Consequently, the cells became highly elongated. 
In contrast, with cdcl 7-M75 the cell number increases similarly at the permissive and 
restrictive temperature over the examined time and the cdc phenotype manifests itself 
in a marked rise in optical density. Also, cell elongation in cdcl 7-M75 is not as 
pronounced as in the other two strains. In summary, cdcl 7-M75 shows a more subtle 
and less tight temperature-sensitive phenotype at 36°C. 
Figure 2.2 (following page): Semi-logarithmic growth curves of a) cdcl7-K42, b) cdc17-L16 and c) 
cdc17-M75. Solid lines represent cell number (left graph) and dashed lines represent 0D600 (right 
graph). Growth properties at 25°C is indicated in pink and at 36°C in blue. 
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2.3 Cdc17 deletion strain 
2.3.1 Introduction 
In the previous section three temperature-sensitive cdcl 7 strains were characterised. 
The extent of cell cycle inhibition at the restrictive temperature differed significantly 
among the strains. This indicates that those conditional lethal mutations are unlikely 
to be true null alleles and may retain some residual activity. In order to create a 
background that is completely depleted for the Cdc 17 protein an S. pombe strain 
deleted for cdcl 7 was engineered. 
2.3.2 Construction 
Since previous work (Nasmyth, 1977) has shown that cdcl7 is an essential gene, the 
deletion of cdcl 7 was performed in a diploid strain. The complete gene was replaced 
with the kanMX6 cassette, conferring resistance to the antibiotic G418. This gene 
deletion was carried out using the PCR-mediated gene targeting method described by 
Bähler et al., 1998. Briefly, the kanMX6 gene was PCR-amplified from the plasmid 
pFA6a-kanMX6 with primers that terminate in short stretches of homology (79 bp) 
to the genomic sequences immediately upstream and downstream of the cdcl 7 
coding sequence. 15 tg DNA was transformed into a diploid strain of genotype leul-
32/leu 1-32 ura4-D 1 8/ura4-D1 8 his 7-3 66/h is 7-366 ade6-M21 O/ade6-M2 16 hih + and 
integrants were selected on G418 containing plates. Four stable transformants were 
recovered. In order to verify that the kanMX6 module had integrated correctly at the 
cdcl 7 locus, the transformants were screened by PCR. Genomic DNA from the four 
transformants and the corresponding wild-type strain was used as a template in PCR 
reactions with different combinations of primers. A schematic diagram of the 
construction of the cdcl 77cdc1 7A: :kanMX6 diploid and the relative positions of the 
primers used for PCR are shown in Figure 2.3 a). Figure 2.3 b) shows a picture of an 
agarose gel with the PCR reaction products using genomic DNA of the four 
transformants and the wild-type strain as the template. For details see Materials and 
Methods, section 6.6.10. 
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Figure 2.3: Replacement of one cdc17 allele with the kanMX6 cassette in a diploid strain, a) 
Schematic presentation of the PCR-based gene targeting method. The PCR-amplified kanMX6 module 
with 5' and 3' ends homologous to sequences upstream and downstream of cdc17 (indicated as thick 
lines) was introduced into a diploid strain (see text for genotype). Homologous recombination events 
should yield a heterozygous deletion diploid, as depicted in the lower half. The numbered arrows 
indicate primers which were used to amplify the region from the wild-type and putative deletion 
diploids using genomic DNA as a template. b) Agarose gel showing PCR reactions, where regions of 
genomic DNA from four putative heterozygous deletion diploids (named 14) and the corresponding 
wild-type was amplified with the indicated oligonucleotides (listed in Materials and Methods). In 
transformants 2 and 4 correct integration events had occurred. 
2.3.3 Genetic analysis 
Transformant 4 was used for further analyses. The heterozygous diploid of genotype 
cdcl 7+  /cdcl 7. :kanMX6 leul-32/leul-32 ura4-Dl8Iura4-D1 8 his 7-366/his 7-366 
ade6-M210/ade6-M216 h7h was sporulated and 39 tetrads were dissected. Only in 
10 cases did two colonies arise from the four isolated spores. In the other cases either 
only one spore resulted in a colony (20 out of 39) or all the four spores failed to 
produce a colony (9 out of 39). The reason for this is unclear. However, all the spores 
that were able to form colonies were G418-sensitive and adenine auxotrophs, i.e. 
haploids containing wild-type cdcl 7. Random spore analysis was also carried out 
and 96 meiotic products were Al found to be G418-sensitive. Taken together the 
results from the spore germination experiments, no haploids deleted for cdcl 7 could 
be recovered. This finding confirms the observation that cdcl7 is an essential gene - 
in agreement with Nasmyth, 1977. 
2.4 Functional analyses 
2.4.1 Introduction 
In order to investigate Cdcl7 function in several genetic backgrounds cdcl 7 was 
cloned into the S. pombe expression vectors of the pREPX-series. pREP3X, 
pREP41X and pREP81X contain the thiamine regulatable nmt promoter with 
decreasing promoter strengths allowing expression levels which differ over five 
orders of magnitude (Maundrell, 1990, Maundrell, 1993, Basi et al., 1993). The 
properties of the pREPX vectors are described in Materials and Methods, section 
6.3.2). The full length cdcl7 gene was cloned into the BamHI site of the pREPX 
vectors. 
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2.4.2 Expression of cdc17 in a wild-type background 
In order to determine if high levels of Cdcl7 exert any effect on wild-type cells 
cdc17 was expressed at a variety of different levels: pREP3X, pREP3X-cdcl7, 
pREP4 1 X-cdc 17 and pREP8 1 X-cdc 17 were transformed into the wild-type strain 
Sp5 (leu), grown to mid-log phase in EMM in the presence (promoter OFF) and 
absence (promoter ON) of thiamine and their cell lengths were measured. Table 2.3 
gives an overview of the results. 
Table 2.3: Cell lengths of wild-type strain Sp5 transformed with pREP3X, pREP3X-cdcl7, 
pREP41X-cdc17 and pREP81X-cdc17 
plasmid 	 promoter OFF 	promoter ON 
pREP3X 	 (13.9 ± 1.6) pm 
pREP3X-cdcl7 	(14.1 ± 1.2) gm 	(22.3 ± 7.4) .tm 
pREP41X-cdc17 	(15.1 ± 1.4) gm 	(15.1 ± 3.3) im 
pREP81X-cdcl7 	(14.7 ± 1.6) im 	(14.6 ± 1.7) tm 
The highest possible expression of cdcl 7, i.e. from pREP3X in the absence of 
thiamine (promoter ON), leads to an elongation of wild-type cells of 60% compared 
to control cells. Elongated S. pombe cells are symptomatic of a delay in cell cycle 
progression (see section 1.3) which, in this case, are a consequence of gross 
overproduction of Cdcl7. An approximate ten-fold reduction in cdcl 7 expression 
levels (expressed from the induced nmt4l promoter) results in a cell length similar to 
wild-type. However, the increased standard deviation implies that a small proportion 
of cells are slightly elongated. This possibly reflects variations in plasmid copy 
number. It can be concluded that endogenous Cdcl7 is produced to a lower extent 
than expression from pREP41X in the absence of thiamine (promoter ON). 
Expression of cdcl7 from the low strength nmt8l promoter does not exert any visible 
effect in wild-type cells. 
2.4.3 Rescue of cdcl7 mutant strains with cdclr 
In order to estimate the minimal requirement for levels of functional Cdc 17 protein 
in S. pombe cells, cdcl 7 mutant strains were tested for rescue by various expression 
levels of cdcl 7. pREP8 1 X-cdc 17 was transformed into the temperature-sensitive 
strains cdcl7-K42 and cdcl7-M75, grown to mid-log phase in the presence of 
thiamine, i.e. lowest possible expression level, and the cell lengths were determined. 
Table 2.4 summarises the measured cell lengths. Expression levels of cdcl7 from the 
repressed nmt8l promoter are insufficient to rescue the cdc phenotype of cdcl 7-K42, 
since the cells are somewhat elongated at the restrictive temperature. In contrast, 
cdcl 7-M75 can be rescued under the same conditions. In keeping with the 
observation that cdcl7-M75 is only mildly temperature-sensitive (see section 2.2.2), 
this may suggest that residual Cdcl7-M75 activity contributes to the observed 
rescue. 
Table 2.4: Cell lengths of the indicated temperature-sensitive cdc17 strains transformed with 
pREP8 1 X-cdc 17, grown at the permissive temperature of 25°C or the restrictive temperature of 36°C 




cdcl 7-K42IpREP8 1 X-cdc 17 
	
(15.0 ± 1.5) tm 
	
(18.5 ± 6.8) jim 
cdcl 7-M75/pREP8 1 X-cdc 17 
	
(15.4 ± 2.3) .irn 
	
(14.5 ± 3.2) pm 
Additionally, meiotic products of cdcl 7t/cdcl 7: :kanMX6 transformed with either 
pREP41X-cdcl7 or pREP81X-cdcl7, which were G418-resistant and therefore 
deleted for cdcl 7, were grown up in the presence (promoter OFF) or absence 
(promoter ON) of thiamine at 32 °C and their cell lengths, which are shown in Table 
2.5, were determined. 
Table 2.5: Cell lengths of haploid cdcI7A transformed with pREP4IX-cdc17 or pREP8IX-cdcl7 
promoter OFF 	promoter ON 
cdc17AIpREP41X-cdcl7 	(15.3 ± 1.4) jim 	(14.7 ± 3.0) jim 
cdc17zVpREP8lX-cdcl7 	 (18.8 ± 5.3) gm 	(15.9 ± 1.8) jim 
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As observed for cdcl 7-K42, expression of cdcl 7 from the repressed nmt8l promoter 
is not enough to fully rescue cdcl 7A, whereas an approximate ten-fold increase in 
expression level (i.e. expression from pREP41X, promoter OFF) does complement 
cdcl 7z. 
Taken together, the above data indicate that the level of Cdc 17 protein expressed 
from the repressed nmt8l promoter is insufficient to fully rescue either cdcl7-K42 at 
36°C or cdcl 7A. 
2.4.4 Detection of Odd 7 protein in a wild-type background 
Since cell lengths measurements indicate that neither cdcl 7 expression from the 
induced nmtl promoter nor from the repressed nmt8 l promoter reflect endogenous 
levels of Cdcl7 protein it was reasoned that expression from nmt4l yields Cdcl7 
quantities comparable to those found in wild-type cells. To confirm this, protein 
extracts were prepared from wild-type Sp5 cells transformed with either pREP41X or 
pREP41X-cdc17. Cells were grown in the absence and presence of thiamine and total 
protein was extracted from an equivalent amount of cells. Protein samples were run 
on an SDS polyacrylamide gel, transferred to a PVDF membrane and probed with 
anti-Cdcl7-peptide antibody. Figure 2.4 shows a Western blot of the various cell 
extracts expressing Cdcl7. 
Wild-type cells expressing Cdcl7 from the repressed nmt4l promoter produce 
approximately 1.5 - 2 x the amount of Cdcl7 compared to wild-type levels (Figure 
2.4, lane 6 versus lane 5). Expression from the induced nmt4l promoter leads to an 
100 - 200-fold overproduction of the protein (compare lanes 3 and 4 to lane 6). 
Supported by functional genetic analyses, it can be concluded that expression of 
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Figure 2.4: Serial dilutions of the protein extract from wild-type (Sp5) cells expressing Cdcl7 in the 
absence of thiamine were made (lanes 1-4) in lx SIDS sample buffer and separated on an SIDS 
polyacrylamide gel alongside protein extracts from Sp5/pREP41X (i.e. containing wild-type levels of 
CdcI7) and Sp5IpREP41X-cdcl7 grown in thiamine (lanes 5-6). The gel was blotted onto a PVDF 
membrane and probed with anti-Cdcl7-peptide antibody used at a 1:5 dilution. Cdcl7 protein was 
detected with the ECL system using the anti-rabbit secondary antibody at a 1:2000 dilution, lane M 
denotes a marker protein at 83 kDa. 
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2.5 Functional complementation experiments 
2.5.1 Introduction 
In order to determine which parts of the Cdc 17 protein perform essential functions in 
vivo, several truncated constructs were engineered and tested for their ability to 
rescue temperature-sensitive strains as well as a deletion strain. The cdcl 7 constructs 
were cloned into pREP41X since experiments described in the previous section have 
shown that production of Cdcl7 from the repressed nmt4l promoter reflects 
endogenous protein levels. The following section gives an overview of the constructs 
used before the results of the functional complementation experiments of the 
temperature-sensitive strains (section 2.5.3) and the deletion strain (section 2.5.4) are 
presented. 
2.5.2 Cdcl7 constructs 
Several truncated or mutated forms of cdc] 7 were constructed as described in 
Materials and Methods, section 6.3.3. cdcl 7 genes encoding proteins lacking either 
the N-terminal domain or the N-terminal domain plus the conserved non-catalytic 
domain were cloned 3' to the nmt promoter into the BamHJ-site of pREP41X. Full 
length cdcl 7 served as a positive control and a construct with a mutation in the active 
site residue constituted a negative control. A description of the constructs used is 
given in Table 2.6 and Figure 2.5. 
In order to confirm that the mutant Cdcl7 proteins are expressed under the nmt 
promoter the pREP41X constructs were transformed into the wild-type Sp5 strain. 
Re-isolated transformants were grown up in EMM to mid-log phase and protein 
extracts from an equivalent amount of cells were prepared. The protein samples were 
separated on an SDS polyacrylamide gel and probed with anti-Cdcl7-peptide 
antibody (1:200 dilution). A Western blot of wild-type cells expressing the various 
Cdcl7 constructs is shown in Figure 2.6. 
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Table 2.6: pREP41X vectors, containing various mutant versions of cdc17, used for functional 
complementation experiments 
Plasmid name 	 Description of encoded protein 
pREP41X-cdc17 	full length protein (amino acids 1-768) 
pREP41X-cdcl7-NA125 	Cdcl7 lacking the N-terminal domain, but retaining 
conserved non-catalytic domain and catalytic core 
(amino acids 126-768) 
pREP41X-cdcl7-NA390 	Catalytic core only of Cdcl7 (amino acids 391-768) 
pREP41X-cdcl7-K416A Full length Cdcl7 with a point mutation changing the 
active site residue lysine 416 to an alanine (negative 
control) 
pREP41X 






Figure 2.5: Schematic presentations of Cdcl7 proteins, expressed from pREP41X, which are used in 
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Figure 2.6: Protein extracts of wild-type Sp5 cells transformed with pREP-constructs were separated 
on an SDS polyacrylamide gel, which was blotted onto a PVDF membrane and probed with anti-
Cdc 1 7-peptide antibody used at a 1:200 dilution. This antibody is directed against the C-terminal 20 
amino acids (aa 749-768) of Cdcl7. Protein was detected with the ECL system using the anti-rabbit 
secondary antibody at a 1:5000 dilution. Lanes 1-6 contain an equivalent amount of protein extracts 
from the following cells: lane 1: Sp5IpREP41X, lane 2: Sp5/pREP41X-cdcl7-K416A, lane 3: 
Sp5/pREP4 I X-cdc 1 7-NA390, lane 4: Sp5/pREP4 I X-cdc 1 7-Nix 125, lane 5: Sp5IpREP4 1 X-cdc 17, 
lane 6: Sp5/pREP3X-cdc17-N390. 
Full length Cdc17, the inactive ligase Cdcl7-K416A and the Cdc17-NA125 protein, 
truncated for the N-terminal domain, are expressed to a similar extent (see lanes 5, 2 
and 4) and are, as shown in section 3.4, 100 - 200-fold overproduced relative to 
endogenous Cdcl7. In contrast, the level of Cdcl7-NA390 protein is much lower 
than those of the above mentioned proteins (lane 3 versus lanes 2, 4 and 5). Even 
expression under the control of the strong nmtl promoter resulted in only marginallly 
increased Cdcl7-NA390-levels (lane 6) indicating that the latter protein may not be 
very stable. However, Cdcl7-A390 is present to a higher degree than wild-type levels 
of the Cdcl7 protein, which are not detectable under the conditions used (lane 1). 
2.5.3 Rescue of cdcl7ts strains 
2.5.3.1 Cdc17 proteins 
The temperature-sensitive strains cdcl 7-K42 and cdcl 7-L16 were transformed with 
pREP41X harbouring various versions of cdc17 (see Table 2.6 and Figure 2.5), 
plated onto EMM containing thiamine and incubated at 25°C until colonies appeared. 
(The growth characteristics and cell lengths of cdcl 7-M75 at different temperatures 
(see section 2.2.2) imply that its temperature-sensitive phenotype is less tight than 
that of the other two strains. For this reason, cdcl 7-M75 was not used for the 
complementation experiments.) Well-isolated transformants from each combination 
of ts strain and plasmid were grown up to mid-log phase in EMM with and without 
thiamine. Cell number was determined and 1000 cells per plate were plated twice 
onto EMM with and without thiamine. Plates were incubated at 25°C and 36°C for 
five days. 
Irrespective of the plasmids present in the two ts strains the cells were viable at the 
permissive temperature of 25°C. Consequently, the cdcl 7 constructs do not exert any 
dominant negative phenotype at this temperature. However, at the restrictive 
temperature of 36°C the ability of the different Cdc17 proteins to rescue varies 
considerably among the alleles. The results of the rescue experiments are 
summarised in Table 2.7. 
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Table 2.7: Ability of mutant Cdcl7 proteins to rescue the temperature-sensitive strains cdc] 7-K42 
and cdcl7-L16 at 36°C. Growth was scored subjectively on a scale of +++, which indicates excellent 
rescue similar to wild type, to --- for no rescue. The number of colonies as well as their phenotype, 
judged by microscopical examination (see footnotes), were taken into consideration. 
Strain 	 cdcl 7-K42 	 cdcl 7-L16 
Promoter 	 OFF 	ON 	OFF 	ON 
pREP41X-cdc17 	 +++ 	+++ 	+++ 	+++ 
pREP41X-cdcl7-NA125 	2 
pREP4IX-cdcl7-NA390 	--- 	 --- 
pREP41X-cdcl7-K416A 	--- 	 --- 
pREP41X 	 --- 	 --- 
cells are slightly elongated 	2 microcolonies ofl6-5OO small, round, swollen cells 
On the plates incubated at the restrictive temperature there was a wide range of 
colony sizes present. This probably reflects a variation of expression levels in 
individual cells. The full length Cdcl7 protein was able to rescue both ts alleles 
irrespective of the promoter being induced or repressed. The major difference 
between cdci7-K42 and cdci7-L16 is their capacity to be rescued by Cdcl7-NA 125. 
Whereas Cdcl7 lacking the N-terminal domain rescues cdci 7-Li 6 quite well at low 
levels it cannot rescue cdci 7-K42. Overproduction of Cdcl7-NA125 partly restores 
viability of cdc17-K42 and leads to full complementation of cdcl7-L16. 
Interestingly, microscopic examination of cdcl 7-K42 expressing low levels of 
Cdcl7-NA125 revealed microcolonies of :!~500 cells, which were small, round and 
swollen. This phenotype is atypical of cells with defects in S phase suggesting that 
Cdcl7 may carry out other non- S-phase-sp ecific-functions, which are defective in 
cdcl 7-K42 but not in cdci 7-Li 6. 
A Cdcl7 protein consisting only of the catalytic domains, Cdcl7-NA390, was unable 
to rescue either temperature-sensitive strain. Since immunoblotting analyses showed 
that this protein is expressed at much lower levels, its inability to complement the ts 
strains may be the result of insufficient protein present in the cell. In order to clarify 
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if higher levels of the core-protein Cdcl7-NA390 rescued cdc17 ts strains the 
corresponding gene portion was cloned under the control of the stronger nmtl 
promoter. Plasmid pREP3X-cdcl7-NA390 was transformed into Sp5 cells and total 
protein extract was prepared from mid-log phase cells. The extracts were separated 
on an SDS polyacrylamide gel and a Western blot (see section 2.5.2, Figure 2.6, lane 
6) illustrates the relative amount of protein compared to expression under the nmt4l 
promoter. Expression of cdcl 7-NA390 from nmtl is several fold higher than from 
nmt4l. pREP3X-cdcl7-NA390 was transformed into cdc17-K42 and cdc17-L16. 
Isolated transformants were streaked out on EMM alongside various controls and 
incubated at 25°C and 36.5°C. 
Figure 2.7 shows pictures of the plates after incubation for 3 days at the respective 
temperatures. Production ofCdcl7-NA390 at the highest possible level was unable to 
rescue either cdcl7-K42 or cdc17-L16. Considering that this level is still 
approximately 10 x below wild-type-level it is not possible to conclude that the core 
Cdc17 protein would be able to rescue at comparable levels. It was noted, however, 
that ts strains transformed with pREP3X-cdcl7-NA390 and grown in the absence of 
thiamine (i.e. promoter ON) at the permissive temperature showed a pronounced 
increase in generation time. Thus, overproduction of the catalytic domains of Cdc 17 
results in a slight dominant negative phenotype. This growth inhibition is not due to a 
cell-cycle delay since the cells are not elongated. 
The rescue experiments of cdcl 7-K42 and cdcl 7-L16 by truncated Cdc17 proteins 
demonstrate that the C-terminal catalytic domains alone are not sufficient to 
functionally complement strains temperature-sensitive for Cdcl7. Consequently, the 
conserved non-catalytic domain of Cdcl7 appears to perform essential functions. 
However, the importance of the N-terminal domain for Cdc 17 function cannot be 
conclusively assessed, since a protein lacking this domain was unable to rescue 
cdcl 7-K42, but did complement cdcl 7-L16. Clearly, the presence of the respective ts 
proteins in the mutant cells at the restrictive temperature contributes to the varying 
ability of truncated ligase proteins to restore function. 
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25°C 	 36°C 
cdc!7-K42 
cd'c17-L16 
Figure 2.7: The temperature sensitive-strains cdcl7-K42 and cdcl7-L16 were transformed with the 
pREP-plasmids indicated in the top panel. Well-isolated transformants were streaked out on EMM 
and incubated at 25°C and 36°C for 3 days. 
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2.5.3.2 Other DNA ligase proteins 
In addition to Cdcl7 truncations other DNA ligase proteins were also tested for their 
ability to complement cdcl 7" strains. The catalytic core domains of the putative S. 
pombe DNA ligase Lppl as well as the DNA ligase of the archaeon Sulfolobus 
sulfataricus, expressed from pREP3X and pREP41X, were examined regarding their 
ability to sustain growth of cdcl 7-K42 and cdcl 7-L16 (plasmids were provided by 
Stuart MacNeil!). However, no rescuing activity could be detected. 
In order to investigate if possible Lpp 1 functions could partially overlap with those 
of Cdcl7 the effect of absence of ippl on cdc17 strains was examined. A haploid 
strain deleted for ippi (provided by Stuart MacNeil!) was crossed to cdcl 7-K42, 
cdcl7-L16 and cdcl7-M75, the resulting diploids were sporulated and the meiotic 
products inspected. In each case lppIA cdcl 7' double mutants were recovered with a 
percentage between 23-30%. This indicates that ippi appears to function, if at all, 
independently of cdcl 7. 
2.5.4 Rescue of cdc17z\ 
2.5.4.1 Introduction 
Functional complementation experiments of cdcl 71c  strains by an N-terminal Cdc 17 
truncation, described in the previous section, could not provide an unambiguous 
answer to the role of the N-terminal domain for in vivo function, possibly due to the 
varying contribution of the different thermolabile proteins. In order to examine the 
ability of truncated Cdcl7 proteins per se to sustain growth of cells, rescue 
experiments were performed in a cdcl 7A strain. 
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2.5.4.2 Experimental Strategy - Plasmid Shuffle System 
A common strategy to test essential protein functions in a deletion strain would be to 
introduce the expression constructs in a heterozygous deletion diploid and examine 
the cells carrying the deletion allele following sporulation. The kanMX6 gene 
replacing one cdcl 7 allele in the constructed cdcl 7A strain, and which confers 
resistance to the antibiotic 0418, was found to be unsuitable as a selectable marker in 
minimal media, since wild-type cells (which do not have a copy of kanMX6) were 
able to grow on EMM plates containing G418. 
Instead of selecting for cdcl 7A cells carrying the expression constructs in succession, 
it was decided to use a plasmid shuffle system. As a basis for the plasmid shuffle, a 
haploid cdcl 7A strain was constructed which is kept alive by a wild-type copy of the 
gene on the pUR19 plasmid, carrying the ura4 gene which complements the uracil 
auxotrophy of the strain (genotype: cdcl 7A::kanMX6 leuI-32 ura4-D18 his 7-366 
ade6-M2JX pUR19-.cdcl7). The various pREP41X-cdcl7 constructs (1eu) were 
introduced into this strain, thereby complementing its leucine auxotrophy. Cells 
carrying both plasmids were plated out on 5-FOA (5-fluoroorotic acid), which selects 
against ura cells. Therefore, the arising colonies should only contain pREP41X 
plasmids and the ability of truncated or mutated cdcl 7 versions to rescue the deletion 
can be assessed. Details of the experimental procedure are described in Materials and 
Methods, section 6.6.11. 
2.5.4.3 Complementation experiments of cdc17z 
The pREP41X-vectors carrying mutant cdc17 versions listed in Table 2.6 were 
transformed into cdc I 7AIpUR 1 9-cdc 17 (ura) and plated on media selecting for both 
plasmids either with or without thiamine. After isolation of transformants cells were 
grown up in EMM with and without thiamine to mid-log phase. Cell number was 
determined and 1000 cells were plated onto EMM with supplements, uracil, 5-FOA 
and either with or without thiamine. Plates were incubated at 32 °C for seven days. 
The results of the rescue experiments are summarised below and in Table 2.8. Figure 
2.8 shows photographs of most of the plates. 
We 
Table 2.8: Rescue of cdcl 7A by mutated Cdc 17 proteins. The experiment was carried out as described 
in the previous section and Materials and Methods. + indicates excellent rescue and - denotes no 
rescue 
Promoter 	 OFF (+ thiamine) 	ON (- thiamine) 
pREP41X-cdc17 	 + 	 + 
pREP41X-cdcl7-NA125 	 -- 	 + 
pREP41X-cdcl7-NA390 	 -- 	 -- 
pREP41X-cdcl7-K416A 	 -- 	 -- 
pREP41X 	 -- 
The full length Cdc17 protein is able to rescue cdcJ7A irrespective of the promoter 
being turned off or on, resulting in endogenous protein levels or 100 - 200-fold 
overproduction, respectively (Figure 2.8 a)). Cdcl7-NA125, the protein truncated for 
the N-terminal domain, is capable of complementing cdcl 7 deletion cells, but only 
when overexpressed (promoter ON). Expression of the Cdcl7-NA125-truncation at 
levels comparable to those of the full length enzyme in wild-type cells (promoter 
OFF) does not give rise to any viable colonies, indicating that the N-terminal domain 
does perform important functions in vivo (Figure 2.8 b)). The Cdcl7-NA390 protein, 
consisting only of the C-terminal catalytic domains, is not able to rescue under either 
condition (Figure 2.8 c)). Considering that, when the nmt promoter is induced, only a 
fraction of the amount of full length or N-terminally truncated protein is produced 
(see Figure 2.6), it cannot be completely ruled out that levels corresponding to full-
length or the N-terminally truncated Cdcl7-NA125 protein in the induced state were 
able to rescue. As expected, cdcl7A cells are inviable in the absence of any Cdc17 





C) 	 pREP41X-cdc17-Nt390 
d) 	 pREP41X 
Figure 2.8: Rescue of cdcl 7A by the indicated cdcl 7 constructs. Experimental details are described in 
the previous sections and Materials and Methods, section 6.6.11. Plates on the left side contain 
thiamine, which represses expression from the nint promoter and plates on the right lack thiamine 
which induces expression of cdcl 7 constructs under the nmt promoter. 
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26 Discussion 
In the previous sections strains temperature-sensitive for cdcl 7 have been 
characterised and examined for rescue with truncated CdcI7 proteins. 
In rescue experiments, the cdcl 7-K42 strain behaves most like the deletion strain, in 
that it is not complemented by a Cdcl7 protein deleted for the N-terminal domain, 
Cdcl7-NA125, when produced at levels comparable to wild-type. cdcl7-K42 carries 
a mutation within the conserved non-catalytic domain (CNCD). The negatively 
charged glutamic acid residue 298 is replaced with a positively charged lysine 
residue. Alignment of DNA ligase I homologues shows that G1u298 constitutes an 
invariant residue (see Figure 2.9 left) in a highly conserved area between eukaryotic 
and archaeal proteins. This degree of conservation suggests that essential functions 
are intrinsic to this domain. The mutated site of the ligase protein of cdcl7-L16 lies 
within the catalytic domains. Pro584, which is conserved between yeast (see Figure 
2.9, bottom) and is situated between conserved motifs IV and V, is replaced by a 
serine residue. Unlike cdcl 7-K42 and cdcl 7A, cdcl 7-L16 could be complemented by 
Cdcl7-NA125, expressed at levels similar to wild-type. 
The above described lesions could manifest itself in several, possibly different, ways. 
Firstly, the protein levels after incubation at the restrictive temperature could vary 
due to differences in enzyme stability. Preliminary immunoblotting analyses of 
protein extracts from all three temperature-sensitive strains could not detect any 
significant decrease in mutant Cdcl7 levels after growth for six hours at the 
restrictive temperature (data not shown). It can, however, not be ruled out that the 
enzyme stability does decrease, since the protein amounts were just above detection 
levels. 
Secondly, cdcl7-K42 and cdc17-L16, which were employed for the rescue 
experiments, possibly show a varying degree of residual ligase activity: whereas 
Cdcl7-L16 activity may just be below the threshold required for normal cell cycle 
progression and can therefore be complemented by low levels of a protein with intact 
catalytic domains, the thermolabile Cdcl7-K42 activity may be much lower and 
therefore cannot be rescued. Since the N-terminal domain of Cdcl7 does perform 
important functions, as judged by its presence being necessary for rescue of cdcl 7A 
73 
at low levels comparable to endogenous conditions, the N-terminal domain of 
Cdcl7-K42, carrying out possible targeting functions, could direct the protein to sites 
of nicked DNA, but through the mutation in the conserved non-catalytic domain the 
enzyme is rendered deficient to complete its task. Thus, Cdc17-K42 may compete 
with the truncated Cdcl7-Nl25. 
The mutation in cdcl 7-L16 is situated between motifs IV and V, which are common 
to nucleotidyltransferases. The T7 crystal structure reveals that those residues are 
situated at the base of the cleft between the two catalytic domains and an optimal 
structural configuration is likely to be crucial for efficient catalytic mechanism 
and/or affinity for DNA, factors which may be reduced in this mutant. 
In contrast, the altered residue in cdcl 7-M75, Pro679, which is converted to a serine, 
is unique to the fission yeast protein and falls within an amino acid stretch of 
comparably little sequence homology (see Figure 2.9, right). Consistent with this, the 
temperature-sensitivity of cdcl 7-M75 can be considered mild: no significant 
difference in growth behaviour of cdcl 7-M75, grown for 10 hours at either the 
permissive or restrictive temperature, was seen. Instead, the observed cell elongation 
correlated with an increase in cell mass. Ligation assays with crude extracts or 
partially purified enzyme of cdcl 7-M75 failed to detect any thermolability of the 
mutant protein in vitro (Nasmyth, 1979). It seems that the mutation in the cdcl 7-M75 
allele gives rise to only a slightly deficient protein, possibly due to minor structural 
changes which reduce enzyme kinetics. 
Figure 2.9 (see following page): The mutation sites of the three temperature-sensitive alleles of cdcl7 
within the protein are indicated. Sequence alignment of proteins from several species around the 
lesion sites of cdcl7-K42, cdcl7-L16 and cdcl7-M75 are shown. Species names are as follows: Sp: 
Schizosaccharomyces pombe, Sc: Saccharomyces cerevisiae, Hs: Homo sapiens, XI: Xenopus laevis, 
Da: Desulfolobus ambivalens (archaeon). The altered amino acids of the corresponding mutant 
proteins are shown above the alignment. Invariant residues are marked with "*", highly conserved 
residues with ":" and conserved residues with ""'. The sequence alignment was performed using 
ClustaIX. 
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2.7 Summary 
In this chapter the mutation sites of the three existing temperature-sensitive alleles of 
cdc17 have been determined. cdcl7-K42 and cdc17-L16 have been tested for 
functional complementation by Cdc 17 proteins deleted for the N-terminal domain or 
only consisting of the catalytic domains. Additionally, a strain deleted for cdcl 7 was 
constructed and tested for rescue by truncated proteins. cdcl7-K42, which bears a 
point mutation in the middle conserved non-catalytic domain, as well as cdcl 7A was 
not complemented by an N-terminally truncated Cdc 17 protein, when expressed at 
levels similar to wild-type. In contrast, this protein was able to rescue cdc17-L16, 
harbouring a mutation in the C-terminal catalytic core. Moderate overexpression 
rescued all three strains. The catalytic core of Cdc 17 was unable to rescue either 
strain irrespective of the expression level. By genetic and biochemical methods it 
was established that endogenous levels of Cdc 17 are comparable to expression from 
the repressed nmt promoter in pREP4 lx. 
It is concluded that the conserved non-catalytic domain of Cdc 17 performs essential 
functions and that the N-terminal domain contributes to proper functioning of the 
enzyme in vivo. 
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3. Nuclear and mitochondrial forms of Cdc17 
31 Introduction 
The N-terminal domain of DNA ligase I is poorly conserved from species to species, 
raising the question of how it contributes to DNA ligase function. Although the N-
terminal domain of human DNA ligase I is dispensable for catalytic activity in vitro 
(Tomkinson et al., 1990), it is required for in vivo function (Petrini et al., 1995). 
Studies on human DNA ligase I have identified a nuclear localisation signal (NLS) 
within its N-terminal domain (Montecucco et al., 1995). Moreover, a p21Clike 
PCNA binding site has been discovered in the extreme N-terminus of several 
eukaryotic DNA ligase I proteins, the investigation of which will be the subject of 
Chapter 4. 
In recent years several reports have been published on the presence of DNA ligase 
proteins in mitochondria (see Chapter 1, section 1.2.3). In vertebrates such as 
Xenopus and humans, the DNA ligase III protein has been shown to function in 
mitochondria (Pinz and Bogenhagen, 1998, Lakshmipathy and Campbell 1999 and 
2001) in addition to its roles in nuclear repair pathways and meiotic recombination 
(Mackey et al., 1996, Nash et al., 1997). 
While this work was in progress, the DNA ligase I homologue of S. cerevisiae Cdc9, 
previously shown to be involved in nuclear DNA replication and repair pathways 
(see Chapter 1), was found to be present in the mitochondria also (Willer et al., 1999, 
Donahue et al., 2001). Localisation of Cdc9p to the different cellular compartments 
is regulated through the use of alternative translational start codons (Willer et al., 
1999). By mutational analyses Wilier et al. showed that translation from the 
upstream AUG codon produced two mitochondrially-associated forms: a precursor 
and its cleavage product, the mature mitochondrial protein. Translation from a 
downstream start codon produced the major nuclear form of Cdc9. Mitochondrial 
protein extracts containing Cdc9 were able to seal nicks in double stranded DNA in 
vitro whereas extracts from a strain with a conditional lethal allele of CDC9 were 
incapable of doing so (Donahue et al., 2001). A functionally important role of 
77 
mitochondrial Cdc9 protein in vivo is indicated by the observations that a cdc9t8 
strain showed a reduced mitochondrial DNA content and had diminished capacity to 
repair DNA double-strand breaks, which were introduced by the inducible expression 
of mitochondrially targeted EcoRI (Donahue etal., 2001). 
In order to investigate whether cdcl 7 might also encode a mitochondrial protein, 
possible sub-cellular targeting functions of the N-terminal domain of Cdc17 were 
examined. Fusion proteins between the N-terminal 175 amino acids of Cdc17 and 
GFP were created and tested for their localisation. In this chapter evidence is 
presented that the N-terminal domain of Cdc 17 is sufficient to target GFP to the 
nucleus and mitochondria. Amino acid residues that are essential for localisation to 
either compartment were identified through mutational analyses. In addition, the 
ability of mutated Cdc 17 proteins with impaired targeting to nucleus or mitochondria 
are examined for the ability to rescue Cdc 17 deficient strains. 
3.2 Localisation studies 
3.2.1 The N-terminal domain of Cdc17 targets GFP to nucleus 
and mitochondria 
In order to establish if the N-terminal domain of Cdc 17 could target the protein to the 
mitochondria, localisation studies using GFP-fusion proteins were performed. 
A portion of the cdcl 7 gene encoding the N-terminal domain and the first 50 amino 
acids of the CNCD was cloned into pREP3X-GFP in order to express a fusion 
protein consisting of GFP C-terminal to the first 175 amino acids of Cdc17 (see 
section 6.3.2.3). The resulting plasmid pREP3X-cdcl7[1-175]-GFP was transformed 
into wild-type S. pombe cells (S p5)  and grown in EMM until mid-log phase in the 
absence of thiamine. Cells were harvested and examined by fluorescence microscopy 
(details see Materials and Methods, section 6.7.1 and section 3.2.5.1). 
Figure 3.1 a) shows typical fluorescence patterns of cells expressing Cdcl7[1-175]-
GFP: bright staining throughout the whole nucleus was seen (sometimes the 
exclusion of fluorescence signals from the nucleolus is visible). Furthermore, other 
cellular structures exhibit fluorescence as well: extended tubules and string-like 
structures throughout the cytoplasm are visible. This staining pattern is similar to 
previously published images of S. pombe mitochondria (Robinow and Hyams, 1989, 
Yaffe et al., 1996, Pelloquin et al., 1999). To gain further evidence that the extra-
nuclear fluorescence is due to localisation of the fusion protein to mitochondria, cells 
expressing the Cdc I 7-GFP-fusion were incubated with the mitochondrion-specific 
dye MitoTracker® Red (Molecular Probes) and the cells were viewed in the green 
and red channels for detection of GFP-fusion protein and MitoTracker respectively. 
Figure 3.1 b) shows double-labelling of a cell expressing the fusion with 
MitoTracker. Good colocalisation between extra-nuclear GFP fluorescence and the 
MitoTracker signal is apparent. In Figure 3.1 c) images of cells expressing GFP 
alone as a control are shown. Fluorescence is distributed throughout the whole cell 
including the nucleus. 
In Summary, the N-terminal domain of Cdcl7 (amino acids 1-175) is capable of 
targeting the heterologous GFP protein to both the nucleus and mitochondria. 
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a) 
b) 	 green 	red 	merge 
121111 
Figure 3.1: Images of S. pombe Sp5 cells expressing Cdcl7[1-175]-GFP, a) and b), and GFP alone, 
c), from the induced nmtl promoter. Scale bar in panel a) represents 10[Lm. In panel b) a cell 
expressing the GFP-fusion (left) is stained with the mitochondrion-specific dye MitoTracker® Red 
(middle). In the merged image on the right localisation of the GFP-fusion to mitochondria is indicated 
in yellow. Details of cell preparation and fluorescence microscopy are given in Materials and 
Methods, section 6.7.1. 
3.2.2 Nuclear targeting 
In order to investigate which residues within the N-terminal domain of Cdc 17 are 
responsible for nuclear targeting, GFP-fusions of N-terminally-truncated versions of 
Cdcl7[1-175] were examined for their localisation. pREP3X-GFP-vectors encoding 
the N-terminal domain of Cdc 17 lacking the first 31,65,96 and 125 amino acids (see 
Materials and Methods) were expressed in S. pombe Sp5 cells and the distribution of 
GFP fluorescence determined. Cdcl7[32-175]-GFP was capable of localising 
specifically to the nucleus whereas truncation of a further 34 amino acids (Cdc 17[66-
175]-GFP)resulted in non-specific fluorescence throughout the cell. Images of cells 
displaying typical fluorescence patterns for the different fusion proteins are shown in 
Figure 3.2 b) and c). It should be noted that the slightly increased fluorescence 
visible in the nucleus of cells expressing Cdcl7[66-175]-GFP is unlikely to be 
specific since cells expressing only GFP exhibit a very similar fluorescence pattern 
(compare to Figure 3.1 c)). Cdcl7[97-175]-GFP and Cdcl7[125-175]-GFP also 
localised throughout the whole cell (data not shown). In conclusion, loss of amino 
acids 32-65 prevents the N-terminal portion of Cdcl7 targeting GFP specifically to 
the nucleus. 
On the other hand, amino acids 32-65 fused to GFP were deficient in specific nuclear 
localisation and displayed the same distribution as GFP alone (data not shown). 
Therefore, amino acids 32-65 are necessary but not sufficient for nuclear localisation. 
Examination of the amino acid sequence of the N-terminus of Cdc 17 does not reveal 
any strong candidates for a classical nuclear localisation signal (NLS) (Nigg, 1997). 
However, residues 62-64 constitute a short stretch of basic amino acids, which is an 
integral part of an NLS. To test the role of these in nuclear targeting, a mutant was 
generated which was composed of the full length N-terminal domain where amino 
acids 62KRK64 were changed to 62AAA64. This GFP-fusion, Cdcl7[1-175]ANLS-
GFP, was expressed in S .pombe Sp5 from pREP3X. Figure 3.2 d) represents 
characteristic distribution of the fusion-protein. Cdcl7[1-175]ANLS is unable to 
direct GFP specifically to the nucleus; green fluorescence is dispersed throughout the 
cell. The latter finding demonstrates that amino acids 62-64 of the N-terminus of 




C) 	 -cdcl7[66-175]-GFP 
d) 	 -cdc17[1-175]ANL5-GFP 
Figure 3.2: Images of S. pombe Sp5 cells transformed with pREP3X-vectors carrying the indicated 
inserts. Scale bar represents 10 rim. Cells were grown and prepared for fluorescence microscopy as 
described in Materials and Methods, section 6.7.1. 
3.2.3 Mitochondrial targeting sequence of Cdc17 
Amino acids 1-175 of Cdcl7 are capable of targeting GFP to the nucleus and 
mitochondria (see section 3.2.1). Dissection of the N-terminal portion has elucidated 
amino acid residues that are essential for nuclear localisation (see previous section). 
What residues are essential for targeting to mitochondria? The fluorescence pattern 
of Cdcl7[32-175]-GFP (see previous section, Figure 3.2 b)), which is exclusively 
nuclear, indicates that residues 1-31 are important for mitochondrial localisation. 
The usage of alternative in-frame start codons for translation initiation to produce 
proteins which are each destined for a different cellular compartment is a common 
mechanism to generate multi-compartmentalised proteins from a single gene 
(reviewed in Danpure, 1995). Translation from the first methionine typically 
produces a mitochondrial precursor which is targeted to the mitochondria where it is 
processed to a mature mitochondrial protein. The amino acids encoded between the 
first and a second AUG codon often take the characteristic conformation of an 
amphiphilic cc-helix, where one side of the helix predominantly contains positively 
charged residues while the opposite side is hydrophobic and uncharged (von Heijne, 
1986). This characteristic presequence aids targeting to mitochondria, is recognised 
by the mitochondrial protein import machinery and is cleaved upon translocation 
through the mitochondrial membrane (Pfanner, 2000). 
The extreme N-terminus of Cdcl7 contains two in-frame methionine start codons at 
amino acid positions 1 and 20 (Figure 3.3 a)). Examination of the sequence between 
the two methionines revealed its potential to encode an amphipathic helix typical for 
mitochondrial targeting equences (MTS). Figure 3.3 b) gives a schematic 
representation of the structure of the first 19 residues of Cdc17. 
Scanning of the Cdc17 sequence using computer programmes aimed at identifying 
N-terminal sorting signals (Claros et al., 1997) underlined the potential of Cdcl7 to 
be imported into mitochondria. The PSORT II server (http://psort.nibb.ac.jp/)  
predicts the potential of a protein to be mitochondrial according to the method of 
Nakai and Kanehisa, 1992, which looks at the amino acid composition of the first 20 
residues. It predicts that Cdc17 has properties which could enable it to be imported 
into mitochondria. The Mitoprot 111.0 programme, which specifically examines the 
potential of proteins to be targeted to mitochondria and/or chioroplasts (e-mail 
server: mitoprot@wotan.ens.fr), also predicts Cdcl7 to be mitochondrial. In addition 
to the amino acid composition, this discriminant analysis takes into account several 
other parameters including the calculation of the maximal hydrophobicity of 7 
neighbouring residues (this is the size of an a-helix thought to interact with 
membranes) on the maximal a-segment using four different scales of hydrophobicity 
(Claros and Vincens, 1996). The output of the calculations is the probability (0<P<1) 
of the protein to be imported into mitochondria given as DIM (discriminant function 
for mitochondrial proteins). Cdcl7 has a value of 0.54, which is only slightly above 
the threshold (0.5) when proteins are considered to have properties to be imported 
into mitochondria. The other S. pombe DNA ligase proteins Lig4 and Lpp 1 are 
unlikely to be targeted to mitochondria with DIM values of 0.06 and 0.05, 
respectively. Interestingly, the Arabidopsis thaliana DNA ligase I protein is found 
highly probable to be imported into mitochondria and/or chloroplasts with a value of 
0.99. The S. pombe DNA replication proteins Po13 (DFM=0.06), Rad2 (DFM=0.05) 
and Dna2 (DFM=0.07) are unlikely to be targeted to mitochondria. In contrast, S. 
pombe proteins known to be imported into mitochondria showed high prediction 
values, e.g. the Holliday junction resolvase Ydc2 (Doe et al., 2000) with a 
probability of 0.81 and the UV-damage endonuclease Uvel (Yasuhira and Yasui, 
2000) with a predicted probability of 0.98. 
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Figure 3.3: Putative mitochondrial targeting sequence ofCdcl7. a) amino acid sequence of the first 
30 amino acids of Cdcl7. The first and second methionine is indexed 1 and 2, respectively. b) (X-
helical projection (http://marqusee9.berkeley.edulkaellhelical.htm) of the first 18 residues of Cdcl7. 
Hydrophobic residues are shaded. 
3.2.4 Targeting to mitochondria 
The N-terminus of Cdc 17 clearly has properties that allow targeting to mitochondria. 
If there were to be two forms of Cdc 17 produced, one starting at the first methionine 
and harbouring the MTS (mitochondrial targeting sequence) and another one 
beginning at the second methionine at position 20 and therefore lacking the MTS, it 
can be reasoned that the latter form should constitute the nuclear version of Cdcl7. 
In order to test this hypothesis, mutant forms of the N-terminal domain of Cdcl7 
fused to GFP were engineered and examined for their sub-cellular localisation. 
The GFP-fusion of the N-terminus of Cdcl7 starting at the second methionine and 
therefore lacking the putative MTS, Cdcl7[20-175]-GFP, was produced from the 
induced nmtl promoter in S. pombe Sp5 cells. Microscopic examination under the 
fluorescence microscope revealed solely nuclear localisation (Figure 3.4 b), left 
panel). The thread-like structures which represent mitochondria and are stained with 
MitoTracker Red (Figure 3.4 b), middle panel) are clearly absent in the green and 
merged image (the absence of yellow colour indicates that the fusion protein does not 
localise to mitochondria). 
A second construct, consisting of the complete N-terminal domain and the beginning 
of the CNCD (amino acids 1-175) but where the second AUG - believed to be the 
translation initiation site for nuclear Cdcl7 - is replaced with a GCG codon 
(Cdc 17 [1-1 75]M2OA-GFP), was found to localise predominantly to mitochondria. 
The majority of cells displayed the staining pattern as seen in Figure 3.4 c). The 
fusion protein is still targeted to mitochondria as double labelling with MitoTracker 
Red clearly shows (Figure 3.4 c), right panel). However, nuclear staining is greatly 
diminished in most cases. Comparison of fluorescence intensity of cells expressing 
Cdcl7[1-175]M20A-GFP, where the second methionine residue of the N-terminal 
domain of Cdc 17 at position 20 is replaced by an alanine residue, to those expressing 
GFP-fusions of the wild-type, Cdcl7[1-175], or the exclusively nuclear-targeted N-
terminal domain, Cdcl7[20-175], shows a drastic reduction in nuclear localisation: 
approximately 20% did not show any nuclear fluorescence and 80% displayed weak 
nuclear signals, which in intensity at most equalled mitochondrial fluorescence, 
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whereas in the former cases mitochondrial fluorescence sometimes was barely 
visible due to very bright nuclear fluorescence. 
It was reasoned that the presence of the NLS, at least partly consisting of amino acids 
62 KRK 64 (see section 3.2.2), in cells expressing Cdcl7[1-175]M2OA-GFP possibly 
allowed a small proportion of GFP-fusion-molecules to enter the nucleus despite the 
lack of the second start codon. To test this hypothesis, a third construct was 
engineered, in which the residues which had previously been identified as being 
essential for nuclear targeting, 62KRK64, were replaced with alanines in addition to 
the mutation of the second methionine. The fluorescence distribution of the resulting 
construct, Cdcl7[1-175]M20AANLS-GFP is presented in Figure 3.4 d). If 
nucleotides encoding an integral part of the NLS, amino acids 62 KRK 64, are 
altered in addition to the second translation initiation start codon, the N-terminal 
domain of Cdc 17 targets GFP to mitochondria only. 
Figure 3.4 (following page): Images of Sp5 cells expressing pREP3X-plasmids carrying the indicated 
inserts and stained with MitoTracker® Red (for details see Materials and Methods, section 6.7.1). The 
left panels show the intracellular distribution of the Cdcl7-GFP-fusion and the middle panels 
represent mitochondria. The right panels show a merged image with the GFP-fusion in green, 
mitochondria in red and colocalisation of the GFP-fusion to mitochondria in yellow. The scale bar in 
panel c) represents 10 im. 
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3.2.5 Further analyses of sub-cellular localisation 
In the previous sections it was shown that the full-length N-terminal domain of 
Cdc17 (amino acids 1-175) directs GFP to the nucleus and mitochondria. Mutational 
analyses revealed residues important for targeting to the nucleus and mitochondria. 
In Appendix 4 a summary of engineered GFP-fusion proteins and their respective 
sub-cellular locations is given. Several additional experiments regarding the sub-
cellular targeting functions of Cdcl7 were carried out. These are described below. 
3.2.5.1 Cdcl7-GFP localisation at reduced expression levels 
Most of the fusion proteins described in the previous sections were also expressed in 
S. porn be 5p5 cells under the control of the weaker nmt promoter in pREP4 1X 
(promoter ON). The fluorescence distribution was indistinguishable from that seen 
with the pREP3X-constructs, albeit much weaker. Therefore, pictures were taken 
from cells expressing Cdcl7[NT]-GFP from pREP3X. When Sp5 cells transformed 
with pREP3X-GFP-fusion vectors were grown in the presence of thiamine, i.e. 
promoter repressed, no fluorescence signals were detectable with the equipment 
used. 
As was described in Chapter 2, it was observed that overexpression of cdcl 7 from 
pREP3X (promoter ON) resulted in a cdc phenotype. In order to avoid any toxic 
effects on the cells due to overproduction of protein, the cells were kept in the 
presence of thiamine (promoter OFF) and only exposed to inducing conditions for a 
minimum amount of time (12-16 h) before viewing. 
3.2.5.2 Cdcl7-GFP and replication foci 
In an experiment aimed at investigating whether the N-terminus of Cdcl7 - fused to 
GFP - formed foci within the nucleus, which would be indicative of sites of ongoing 
DNA replication, as has been described for human DNA ligase I (Cardoso et al., 
1997, Montecucco et al., 1998, Leonhardt et al., 2000), a time-course experiment 
was performed. Sp5 cells transformed with pREP3X-cdcl7[1-175]-GFP, grown in 
minimal medium containing thiamine, were shifted to thiamine-free medium and 
viewed at hourly intervals. However, no foci formation was detected. Instead, the 
fluorescence pattern went from no fluorescence after 9 hours incubation without 
thiamine to faint staining throughout the whole nucleus after 10 hours to intense 
nuclear staining thereafter. It cannot be concluded whether additional parts of the 
Cdc 17 protein are required for sub-nuclear targeting of GFP or if it is simply that the 
resolution of the microscope and/or camera used was not sensitive enough. 
3.2.5.3 Immunofluorescence studies 
Affirmation that the respective full-length Cdc17 proteins localise in a similar 
fashion to Cdc 17 [1-175] -GFP-fusion-constructs came from preliminary 
immunofluorescence experiments. SpS cells transformed with pREP41X-cdcl7, - 
cdcl7-NA3I or -cdcl7-M20A, grown in the absence of thiamine, were 
formaldehyde-fixed and spheroplasts were incubated with affinity-purified anti-
Cdc 1 7-peptide antibody (used at a 1:100 dilution) and stained with the secondary 
antibodies Alexa 488 or Cy3. Cells expressing full-length Cdc17 gave rise to nuclear 
and cytoplasmic signals. The cytoplasmic fluorescence was absent in Sp5/pREP41X-
cdcl7-A31 cells and no nuclear staining was apparent in cells expressing Cdcl7-
M20A. Figure 3.5 shows pictures of cells expressing the above described constructs. 
No signals were detected when the cells were grown in the presence of thiamine 
(promoter OFF) (data not shown). 
a) 
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Figure 3.5: Immunofluorescence images of S. pombe Sp5 cells transformed with pREP4 1X-cdcl 7-
constructs (as indicated on the left), grown in the absence of thiamine. Formaldehyde-fixed cells were 
incubated with affmity-purified @-Cdc 1 7-peptide antibody (1:100 dilution) and subsequently in a) 
Cy3 (1:2000 dilution) or b) Alexa 488 (1:500 dilution) secondary antibody. Scale bar in b), right 
panel represents 10 Rm. Details are described in Materials and Methods. 
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3.3 Detection of presumptive nuclear and mitochondrial 
Cdc17 proteins 
Manipulations of the extreme N-terminus of Cdc 17 result in altered targeting of GFP 
to the nucleus and/or mitochondria (see previous sections). In order to examine 
whether the presumptive nuclear (amino acid 20-768) and mitochondrial (amino acid 
1-768 for the precursor form) forms of Cdc17 could be visualised by Western 
blotting, wild-type Sp5 cells harbouring pREP41X-cdcl7, pREP41X-cdcl7-NA19, 
pREP41X-cdcl7-M20A and empty pREP41X vector were grown up to mid-
logarithmic phase in the absence of thiamine and protein extracts were prepared from 
an equivalent amount of cells. The extracts were separated on an SDS-
polyacrylamide gel and the Cdc17 proteins were Western blotted with affinity-
purified anti-Cdc I 7-peptide antibody. The results are presented in Figure 3.6. 
The full-length protein as well as the presumed nuclear Cdc 17 protein starting from 
the second methionine at position 20, Cdcl7-NA19, were produced to very high 
levels, i.e. 100-200 x the amount of endogenous Cdc 17 protein (see section 2.4.4). In 
contrast, cdcl 7 encoding the full-length protein with an alanine replacing the second 
methionine at position 20, Cdcl7-M20A, was expressed at very low levels (Figure 
3.6, compare lanes 1 and 3 to lane 2). This is consistent with the notion that the 
predominant (nuclear) form of Cdcl7 is translated from the second AUG codon. 
Detection of Cdc l7-M2OA gave rise to two distinct bands (Figure 3.6 b), lane 2) and 
it is tempting to speculate that they represent the mitochondrial precursor and the 
mature mitochondrial form. The Cdc 17- and Cdc l7-NA19-proteins yield a number of 
different bands of similar molecular weight, the major one of which is of 
intermediate size to the protein bands visible in lane 2 and may well represent the 
nuclear form of Cdc 17. Protein bands of slightly higher and lower molecular weight 
are seen with the full-length Cdc 17 protein which are absent in Cdc l7-NA19. These 
may correspond to the mitochondrial precursor and the mitochondrial form of Cdc 17. 
Endogenous Cdc 17 protein was not detectable under these conditions (see Figure 3.6, 
lane 4), which means that the visible protein species are solely the result of 
expression from pREP41X. 
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Similar results were obtained when protein extracts, prepared from Sp5 cells 
expressing the corresponding GFP-fusion proteins, were immunoblotted with anti-
GFP antibody (data not shown). This confirms that the different expression profiles 
are most likely the result of alterations in the N-terminal domain of Cdcl7. 
Although an unambiguous assignment of protein bands to distinct nuclear and 
mitochondrial species is not possible, the immunoblotting analyses in Figure 3.6 (and 
data not shown), together with the localisation studies (section 3.2), are consistent 
with the conclusions that nuclear Cdcl7 is translated from the second methionine and 
that the mitochondrial precursor form of Cdcl7 starts from the upstream first 
methionine and subsequently is processed to the mature mitochondrial protein (see 
also sections 3.5 and 5.5). 
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Figure 3.6: Western blotting analysis of protein extracts prepared from Sp5 cells transformed with 
pREP41X vectors containing the indicated cdc17 constructs. The cells were grown in the absence of 
thiamine to mid-log phase and Western blotting was carried out as described in Materials and 
Methods. Cdc 17 proteins were detected with anti-Cdc I 7-peptide antibody (1:200 dilution). a) short 
exposure, b) long exposure. 
3.4 Rescue of cdc17 deficient strains with N-terminally 
truncated Cdc17 proteins 
3.4.1 Introduction 
In the first chapter evidence was presented that Cdcl7 lacking the N-terminal 
domain, if expressed to levels resembling wild-type, was unable to support growth of 
either the temperature-sensitive strain cdcl 7-K42 or a cdcl 7 null strain (section 2.5). 
Taking into account the results presented in the previous sections of this chapter, a 
likely explanation for this inability to complement cdcl 7 deficient strains is the loss 
of intracellular sorting signals which lie within the N-terminal domain. In order to 
elucidate the functional relevance of the identified targeting signals, plasmids coding 
for Cdc 17, Cdc 17-NA 19 (nuclear) and Cdc 1 7-M20A (predominantly mitochondrial) 
were tested for functional complementation of cdcl 7-K42, cdcl 7-L16 and cdcl 7A. In 
addition, the deletion strain was tested for rescue by additional N-terminally nested 
deletions. 
3.4.2 Rescue of cdcl7ts  strains 
The functional complementation experiments of cdcl strains were carried out as 
described in section 2.5.3 and Materials and Methods. Briefly, the ts strains 
transformed with the appropriate pREP41X plasmids were grown at 25°C and 1000 
cells were spread on thiamine-containing selective media. The plates were incubated 
at 25°C and 36.5°C for 5 days. Incubation at 25°C in all cases resulted in excellent 
viability confirming that expression of the proteins did not exert any dominant 
negative phenotype. Figure 3.7 shows the results of the rescue experiments at 
36.5°C. At the restrictive temperature, rescue of the temperature-sensitive strains by 
the predominantly mitochondrial Cdc 1 7-M2OA protein was quite similar for both 
temperature-sensitive alleles. Both strains were rescued reasonably well: the number 
of colony forming units was reduced by roughly 25% compared to rescue by the 
wild-type protein. The colonies formed varied considerably in size, a phenomenon 
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commonly seen when the rescued ts strains are incubated at the restrictive 
temperature and which likely reflects a variation in expression levels. Microscopic 
examination revealed that cells were elongated but while the cells were only 
moderately elongated in cdc17-L16, cdcl7-K42 cells showed a highly elongated 
phenotype. 
The situation was entirely different for functional complementation by the Cdcl7-
NA19 protein. cdc17-L16 was rescued to a level similar to wild-type. On the other 
hand, Cdcl7-NA19 was unable to complement cdci7-K42 at all. Microscopic 
examination showed the presence of microcolonies of round and swollen cells 
similar to those seen in cdc17-K42/pREP41X-NA125 (see Chapter 2, section 2.5.3). 
The experiments were also carried out where the proteins were moderately 
overproduced, i.e. induction of nmt4i promoter through the absence of thiamine. In 
all but one case, rescue comparable to wild-type level was noted. Elevated levels of 
Cdcl7-NA19, however, still failed to complement cdc17-K42. 
In summary, a drastic difference is observed in the ability of the putative nuclear 
Cdcl7-NA19 protein to functionally complement cdci 7-K42 and cdci 7-Li 6. 
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Figure 3.7: Ability of Cdcl7 proteins to rescue the temperature-sensitive strains cdcl7-K42 and cdcl7-L16. The ts strains, transformed with 
pREP41X-vectors carrying the indicated cdc17 constructs, were grown at 25°C and 1000 cells were plated onto EMM plates containing thiamine. 
Plates were incubated at 25°C and 36°C for 5 days. Rescue was scored from +±+ (equivalent to wild-type) to - (no rescue). Predominant phenotype is 
indicated as wild-type-like (small cell), slightly elongated (medium cell) and cdc phenotype (large cell). 1: microcolonies of round and swollen cells. 
3.4.2 Rescue of cdcl7A 
The functional complementation experiments of cdcl 7A using the plasmid shuffle 
approach were carried out as described in section 2.5.4 and Materials and Methods. 
Briefly, haploid cdc17A cells, kept alive by pUR19-cdcl7 (ura), were transformed 
with pREP41X (1eu) vectors harbouring different cdcl 7 constructs (see Figure 3.8). 
1000 cells containing both plasmids were plated out on EMM lacking leucine and 
containing thiamine and 5-FOA, and incubated at 32°C. Cells in arising colonies 
should only hold Cdc17 proteins expressed from pREP41X. The results are 
summarised in Figure 3.8. 
After incubation for 4 days, only cdcl7A cells expressing wild-type Cdcl7 were able 
to grow. Neither expression of the predominantly mitochondrial Cdcl7-M20A 
protein nor any of the N-terminal truncations yielded viable colonies (see Figure 
3.8). Incubation for 7 days resulted in poor growth of deletion cells expressing a 
Cdc17 truncation lacking the N-terminal 65 amino acids (Cdcl7-NA65), whereas no 
colonies were seen on any of the other plates (data not shown). If the plates were 
incubated for a further 3 days (total incubation time of 10 days) tiny colonies (<0.5 
mm in diameter) appeared on the plates. Microscopic examination of these colonies 
revealed that, in most of the cases, cells were elongated to varying degrees compared 
to cdcl 7A rescued by the wild-type protein. The notable exception were cdcl 7A cells 
producing Cdcl7-NA19, the protein starting from the second methionine - which is 
believed to constitute the nuclear form of Cdcl7. In this case no cell elongation was 
visible (see Figure 3.8, right panel); this will be investigated further in the following 
chapter. The abortive microcolonies predominantly consisted of a small number of 
round and swollen cells, similar to those observed with cdcl 7-K42 expressing 
Cdcl7-NA125 (see section 2.5.3). Overproduction of all the N-terminally altered 
cdc17 constructs to approximately 100-200 x the endogenous level functionally 
complemented cdcl 7A (data not shown). 
The results presented show that loss of the first 19 amino acids of Cdc 17 prevents the 
full rescue of a cdcl 7z\ strain. The data support the conclusion that mitochondrial 
DNA ligase function is essential for proliferation. 
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Figure 3.8: Rescue of cdc17Ex by N-terminally mutated Cdcl7 proteins. The experiment was carried out as described in section 2.5.4 and Materials 
and Methods, section 6.6.11. Cdc 17 proteins were expressed in the presence of thiamine (promoter OFF). Rescue was scored from ++-H- (equivalent 
to wild-type) to - (no rescue). Predominant phenotype is indicated as wild-type-like (small cell), slightly elongated, elongated or highly elongated 
(large cell). 
3.5 Discussion 
This chapter provides evidence that the N-terminal 175 amino acids of the S. pombe 
DNA ligase I protein Cdcl7 directs the heterologous GFP protein to the nucleus and 
mitochondria (section 3.2.1). Moreover, targeting signals to the respective organelles 
are contained within the first 65 amino acids of Cdcl7 (section 3.2.2 and 3.2.3). 
Alternative usage of the in-frame methionine codons of Cdcl7 in the extreme 5' 
region seems to be responsible for the dual localisation of the enzyme since lack of 
the sequence preceding the second methionine prevents mitochondrial targeting and 
modification of the second methionine drastically reduces nuclear localisation. 
Possible mechanisms whereby targeting to different cellular compartments may be 
achieved is discussed in section 5.5. 
Preliminary immunofluorescence experiments have been carried out in order to 
ascertain whether the full-length proteins localise in a similar fashion to the N-
terminal domain of Cdcl7 (Figure 3.5). Generally, the localisation of full-length 
Cdc 17 proteins with alterations in their N-termini correspond to that of the Cdc 17 [1-
175]-GFP-fusions, i.e. expression of Cdcl7 starting from the second methionine 
results in greatly reduced fluorescence of extra-nuclear structures and Cdc 17 with a 
mutation in the second methionine does not yield nuclear fluorescence. It is, 
however, striking that nuclear fluorescence apparently concentrates on the nuclear 
periphery. It is not clear whether this represents true localisation to the nuclear rim or 
is an artefact, for example due to the primary antibody insufficiently penetrating the 
nucleus. To date, no reports on studies with yeasts are known, which describe the 
localisation of DNA replication foci or proteins to the nuclear periphery. For 
example, a recently developed technique to label sites of ongoing DNA replication 
by BrdU in yeast nuclei demonstrated that replication foci were distributed 
throughout the nucleus (Lengronne et al., 2001). Also, in S. pombe, MCM subunits 
were found dispersed in the nucleus (Pasion and Forsburg, 1999). However, since, in 
the presented immunofluorescence experiments, expression of Cdcl7 proteins with 
different N-termini produce different localisation patterns, the results are considered 
significant. 
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Investigation of residues required for nuclear targeting revealed that amino acids 62 
KRK 64 are necessary for targeting function. They are however, not sufficient since 
amino acids 32-65 alone are incapable of specific nuclear sorting. Previous studies 
on conserved features of nuclear localisation signals have identified two classes: the 
first one is the basic-type NLS composed of a few basic residues that are either 
monopartite of the consensus (KIR)4..6 or bipartite with the consensus motif (KIR)2 
X 0.12  (KIR)3 (Nigg, 1997). Other types of NLS which show no obvious resemblance 
to the classical NLS and are heterogeneous in nature have been determined 
experimentally. In a screen for novel NLS, clusters of 2-3 arginine or lysine residues 
that were too close or too far apart to be classified as the bipartite basic NLS were 
identified (Christophe etal., 2000). With respect to Cdcl7, close inspection of the N-
terminal sequence of Cdcl7 revealed another small cluster of basic residues: 97 
KKQK 100. Possibly, this serves as the second part of the NLS of S. pombe Cdcl7. 
In order to visualise differences in the presumed nuclear and mitochondrial forms of 
Cdc 17, protein extracts of cells producing the distinct forms were detected with anti-
Cdcl7 antibody. Immunoblotting analyses of wild-type Sp5 cell extracts moderately 
overexpressing Cdcl7 identified various Cdcl7 species. Expression of the N-
terminally truncated protein Cdc 17-AN 19 yielded product levels similar to that of the 
wild-type gene and also resulted in a smear of several indistinct bands. It cannot be 
concluded if the proteins detected are caused by physiological or artefactual 
degradation, possibly due to overproduction, or if they reflect post-translational 
modifications. Attempts were made to separate cell extracts into a mitochondrial 
fraction and a post-mitochondrial supernatant and detect the respective associated 
Cdc17 proteins. However, the lack of an antibody to an S. pombe mitochondrial 
protein suitable for immunoblotting, greatly hindered this task since the successful 
separation of sub-cellular fractions could not be monitored. 
Complementation of the cdcl 7tS  strains cdci 7-K42 and cdcl 7-Li 6 with Cdcl7 
NA19, which is the presumed nuclear form of the enzyme, elucidated further 
differences in the nature of the temperature-sensitive Cdcl7 proteins (already 
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discussed in section 2.6). The inability of Cdcl7-NM9 to rescue cdcl7-K42 may 
reflect the possibility that thermolabile Cdcl7-K42 is also defective in a function 
required for mitochondrial DNA ligase activity. Therefore, additional production of 
nuclear Cdcl7 cannot compensate for the requirement of mitochondrial Cdcl7 
function. Whenever cdcl 7-K42 or cdcl 7A was complemented with low levels of 
Cdcl7 proteins deleted for the N-terminal 19 to 125 amino acids (which lack the 
mitochondrial targeting sequence), the majority of cells were unable to produce 
colonies and microscopic examination showed accumulation of 16-<500 round and 
swollen cells. The remainder display an extremely slow growth phenotype. These 
phenotypes are presumably a consequence of defective Cdcl7 function in 
mitochondria. 
3.6 Summary 
This chapter presents evidence that the N-terminal 175 amino acids of Cdcl7 target 
the heterologous GFP protein to the nucleus and mitochondria. The full-length 
Cdcl7 protein also localises to both cellular compartments. The N-terminal 19 amino 
acids are essential for targeting GFP to mitochondria since their deletion abolishes 
localisation to this organelle but still allows targeting to the nucleus. The major 
nuclear form of Cdcl7 is probably translated from the second in-frame AUG codon 
encoding for a methionine at position 20, mutation of which results in greatly 
reduced nuclear localisation. Furthermore, residues essential for sorting to the 
nucleus were also identified. Immunoblotting analyses showed that proteins 
localising to the nucleus produce a major species which is of intermediate size to two 
protein species, which are present at >10-fold lower levels and are being produced as 
the result of expression of a cdcl 7 gene where the second AUG codon had been 
mutated. Cdcl7 function is required in both organelles since a cdcl 7 deletion strain 
cannot be fully complemented by expression of the presumed nuclear or 
mitochondrial Cdcl7 proteins. 
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4. Role of PCNA binding motif for in vivo function of 
Cdcl7 
4.1 Introduction 
The S. pombe DNA ligase I homologue Cdcl7 contains a PCNA binding site at its 
N-terminus: amino acids 24 to 31 (24 QSDISNFF 31) constitute an evolutionarily 
conserved PCNA binding motif which has first been identified in the mammalian cell 
cycle and DNA replication inhibitor p2lC 	(Xiong et al., 1993, Warbrick et al., 
1995) (see Introduction, section 1.1.5). Preliminary experiments have confirmed that 
the N-terminal 175 amino acids of Cdcl7 are able to bind the S. pombe PCNA 
homologue Pen 1: Cdcl7[1-175]-GST bound to recombinant His-tagged Pen  in pull-
down experiments (Stuart MacNeill, personal communication). Most proteins 
containing such a motif, which have been tested for their ability to interact with 
PCNA in vitro, have been found to do so. However, several studies that were aimed 
at investigating the functional relevance of the interaction of PCNA with the target 
protein in vivo have given rise to varying results. The PCNA binding motif in the C-
subunit Cdc27 of S. pombe DNA polymerase 6 has been shown to be essential for 
function of the protein in vivo (Reynolds et al., 2000). Indeed, a very recent report 
suggested that the p21-like PCNA binding motif present in the human homologue of 
pol 6 C-subunit p66 constitutes the major PCNA binding site required for PCNA-
dependent stimulation of Pot 6 in DNA replication (Ducoux et al., 2001). On the 
other hand, the canonical motif is also present in the N-terminus of large subunit 
Rfcl of the five-subunit clamp loader RF-C. An N-terminal deletion including the 
motif of S. cerevisiae Rfc 1 however apparently did not affect the replication function 
of RF-C (Gomes et al., 2000) and a similar result was obtained with an N-terminal 
deletion in the human Rfcl homologue in in vitro assays (Uhlmann etal., 1997). 
In the previous chapter evidence was presented that cdcl 7 encodes nuclear and 
mitochondrial forms of DNA ligase I. The extreme N-terminus appears to be 
responsible for targeting the enzyme to mitochondria. It was hypothesised that a 
mitochondrial targeting sequence at its N-terminus directs Cdcl7 to the 
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mitochondrial import machinery where the presequence is cleaved off upon 
translocation through the mitochondrial membranes to yield the mature 
mitochondrial protein. Predictions of the cleavage site range from position 21 (using 
the MitoProt programme) to position 33 (PSORT). Mitochondrial Cdc17 appears to 
perform important functions as judged by the inability of a truncated Cdcl7 protein, 
Cdcl7-NA19 to support normal growth of a cdc17A deletion strain (see Chapter 3, 
section 3.4). 
In this chapter an attempt is undertaken at investigating the relevance of the PCNA 
binding motif and therefore, by implication, the importance of binding to PCNA for 
in vivo function of nuclear DNA ligase I in S. pombe. Taken into consideration that 
the PCNA binding motif and the mitochondrial presequence cleavage site are 
potentially overlapping it becomes clear that a straightforward approach is 
inadequate for this task, as any manipulation of the motif may affect the 
mitochondrial targeting function. Evidence is presented that it is possible to separate 
the two functions of Cdc17 by expressing distinct nuclear and mitochondrial forms. 
This strategy is used to manipulate only the nuclear Cdc 17 protein with the aim of 
elucidating the significance of the PCNA binding motif for in vivo function. Firstly, 
further physiological analyses are presented which point toward a functionally 
important role of the motif. 
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4.2 Genetic analyses 
Inhibition of cell cycle progression, e.g. due to defects in DNA replication, is 
reflected by elongation of S. pombe cells. In Chapter 2 it was shown that 
overexpression of Cdcl7 caused wild-type cells to elongate by about 60% (22.3 im 
for cells overexpressing cdc17 compared to 13.9 j.im for control cells, see section 
2.4). In order to determine if the presence of the PCNA binding motif contributes to 
the cell cycle delay seen under these circumstances, a cdc17 construct which is 
deleted for sequences encoding the N-terminal 31 amino acids including the p2l '  
like PCNA binding motif (24 QSDISNFF 31) was cloned 3' to the nmtl promoter 
and overexpressed in S. pombe Sp5 cells. In the absence of the PCNA binding motif 
the cell elongation was significantly reduced: cells divided at a cell length of (17.6 ± 
4.7) JIm which corresponds to an increase of only 27% relative to cells transformed 
with empty vector. 
Additional indications that overproduction of proteins containing the PCNA binding 
motif causes deleterious effects on cell cycle progression came from three other 
observations. Firstly, Sp5 cells grossly overproducing Cdcl7-NA19, which possesses 
the motif and is believed to constitute the nuclear form of Cdcl7, divided at an 
increased cell length of (21.4 ± 6.3) [tm. Secondly, cells expressing the N-terminal 
domain plus the conserved non-catalytic domain of Cdc17 at high levels (i.e. Sp5 
cells transformed with pREP3X-cdcl7-CA379, grown in the absence of thiamine) 
were highly elongated with a cell size at division of (21.1 ± 6.2) tm, which is 
comparable to the cell size seen with cells overproducing the full length protein 
((22.3 ± 7.4) gm). Thirdly, in order to confirm that cell cycle delay is caused directly 
by high levels of a protein carrying the PCNA binding motif, which is likely to 
sequester the PCNA molecules in the cell, another construct was generated. 
Sequences encoding amino acids 1-31 of Cdcl7, which include the mitochondrial 
targeting sequence and the motif, were replaced with sequences encoding the 
p21Cll)like PCNA binding motif of the S. pombe DNA replication protein Rfcl (1 
MSNSDIRSFF 10). This construct was cloned into pREP41X, resulting in 
pREP41X-cdcl7-NA31-rfcl[1-l0], and introduced into 5p5 cells. Transformants 
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were grown in the presence (promoter OFF) and absence (promoter ON) of thiamine 
and cell length was determined. Overproduction of this construct resulted in a cell 
elongation of approximately 40% compared to low-level-expression (20.7 .im versus 
14.9 }lm). Note that the moderate overproduction of Cdcl7 with the PCNA binding 
motif of Rfcl has a much more drastic effect on cell cycle progression than 
expression of the full-length wild-type Cdc 17 protein. Western blotting confirmed 
that both constructs were expressed to comparable levels (data not shown). Table 4.1 
summarises the cell length measurements and Figure 4.1 gives an overview of the 
results. 
Table 4.1: Cell lengths of S. pombe Sp5 cells carrying the indicated plasmids. Cells were grown to 
mid-log phase either in the presence (promoter OFF) or absence (promoter ON) of thiamine and cell 
length was determined. 
plasmid promoter OFF promoter ON 
pREP3X-cdcl7-NA3 1 --- (17.6 ± 4.7) tm 
pREP3X-cdcl7-NA19 --- (21.4 ± 6.3) im 
pREP3X-cdcl7-CA379 --- (21.1 ± 6.2) tm 
compare: pREP3X-cdcl7 --- (22.3 ± 7.4) [tin 
pREP41X-cdcl7-NA31-rfcl[1-10] (14.9 ± 1.3) .tm (20.7 ± 7.0) im 
compare: pREP41X-cdcl7 (15.1 ± 1.4) j.tm (15.1 ± 3.3) .tm 
pREP41X (15.0±1.6)jim (14.7±1.8)tm 
In the previous chapter results were presented regarding the ability of N-terminal 
truncated Cdc 17 proteins to rescue a cdcl 7 deletion strain. Under normal conditions 
no rescue was observed with proteins truncated for the first 19 and 31 residues 
respectively, most likely due to defect of the mitochondrial function of Cdc 17, which 
could be the cause of severely compromised growth. However, much prolonged 
incubation resulted in the appearance of tiny colonies. Microscopic examination of 
these revealed that cdcl 7A cells expressing a Cdc 17 protein which lacks the first 19 
residues, but still possesses the PCNA-binding motif, were of a size equivalent to 
wild-type whereas cdcl 7A cells expressing Cdc 17 lacking the PCNA binding motif, 
Cdc 1 7-NA3 1, were highly elongated. The above data point toward an important role 
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of the PCNA binding motif for in vivo function, suggesting that nuclear function of 
Cdcl7 depends on an interaction with PCNA. 
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Figure 4.1: Summary of cell length measurements. S. pombe Sp5 cells, transformed with the indicated 
plasmids were grown to mid-log phase in the absence of thiamine and cell length at division was 
measured. Different degrees of cell elongation are shown. Thick arrows denote expression from the 
induced nmtl promoter and thin arrows indicate expression from the induced nmt4l promoter. See text 
for details. 
4.3 Separate expression of nuclear and mitochondrial Cdc17 
4.3.1 Introduction 
Evidence presented in the previous section indicates that the PCNA binding motif of 
Cdc17 may carry out essential functions. It would be of great interest to find out if 
the in vivo function of nuclear Cdc 17 was dependent on an interaction with PCNA. 
Since the motif potentially overlaps with the mitochondrial presequence, its 
manipulation for the purpose of investigating its function is likely to impair 
mitochondrial Cdc17 function. Studies on the intracellular targeting of GFP by 
different versions of the N-terminal domain of Cdc 17 revealed that some constructs 
localised exclusively to the nucleus whereas others were predominantly targeted to 
mitochondria (see Chapter 3, Figure 3.4). If it was possible to simultaneously 
produce Cdcl7 proteins that are targeted to one cellular compartment only, i.e. the 
nucleus or mitochondria, then the dual requirement for functions of Cdc 17 should be 
satisfied. This would then allow the manipulation of the PCNA binding motif in the 
nuclear protein without perturbing mitochondrial DNA ligase function. In order to 
determine if separate expression of genes encoding nuclear and mitochondrial Cdc 17 
proteins can successfully substitute for expression of the wild-type gene a strategy 
for co-expression of the respective proteins in cdcl 7A was devised. 
4.3.2 Experimental strategy 
A plasmid shuffle system was described in Chapter 2 which was used to investigate 
the ability of truncated or mutated Cdc 17 proteins to rescue the deletion strain 
(section 2.5). Based on this approach a method for the simultaneous expression of the 
nuclear protein Cdc 1 7-NA 19 and the predominantly or exclusively mitochondrial 
protein Cdcl7-M20A and Cdcl7-M20AANLS, respectively, was designed. A 
prerequisite for this double plasmid shuffle approach is the observation that moderate 
overexpression of N-terminally altered Cdc 17 proteins are able to sustain growth of a 
strain deleted for cdcl 7 (see Chapter 3, section 3.4). In contrast, expression of either 
Cdcl7-NA19, Cdcl7-M20A or Cdcl7-M20AANLS at levels similar to wild-type, 
was unable to rescue the cdcl 7 deletion strain (see previous Chapter, section 3.4 and 
Figure 3.8 and data not shown). 
The experimental strategy of choice is outlined in Figure 4.2 a) and details are 
described in Materials and Methods. Briefly, the leu ura haploid strain 
cdcl7::kanMX6 leul-32 ura4-D18 his7-366 ade6-M21?, in which the only cdc17 
allele is replaced with the kanMX6 marker, is maintained by a wild-type cdcl 7 copy 
expressed from pUR19 (ura). The plasmid pREP41X-cdcl7-NA19 encoding nuclear 
Cdc 17 is introduced into that strain and plated out on media selecting for both 
plasmids. A well-isolated transformant was then grown up in liquid culture and 
plated onto minimal medium selecting for the pREP41X plasmid (leu) and 
containing the drug 5-FOA, which selects against ura cells. At this stage the media 
lacks thiamine which allows the production of elevated levels of Cdcl7-NA19. After 
confirmation that the strain is ura, i.e. that pUR19-cdcl7 is lost, the pREP42 (ura) 
vector carrying cdcl 7-M2OA or cdcl 7-M2OAziNLS, encoding for mitochondrial 
Cdcl7, was transformed in. In a last step, cdcl7A cells harbouring pREP4IX-cdc17-
NA19 and pREP42X-cdc17-M20A (or -M20AANLS) was grown up and 1000 cells 
were plated on selective media containing thiamine (i.e. promoter OFF). 
After incubation for five days at 32°C >900 colonies were visible. Microscopic 
examination of the cells confirmed that the cell morphology was similar to wild-type 
cells with a cell length of (14.4 ± 3.3) j.im (see Figures 4.2 b), right panel and Figure 
4.3, left panel). As a positive control pREP41X-cdcl7 was introduced instead of 
pREP41X-cdcl7-NA19. The colony number was comparable, the only difference 
being a more uniform colony size range. Negative controls included empty 
pREP41X vector in the first plasmid shuffle (i.e. lack of nuclear Cdcl7), which did 
not produce any viable colonies, and the introduction of empty pREP42X in the 
second shuffle (i.e. lack of mitochondrial Cdcl7), which also resulted in no colonies 
under these experimental conditions. The reason why Cdcl7-M20A and Cdcl7-
M20AANLS were both used as mitochondrial proteins will be commented on at a 
later stage. At this point it is only worth noting that both can serve as a source of 
mitochondrial Cdc 17. 
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Figure 4.2 b) summarises the result together with previous results. The ability of the 
simultaneous expression of Cdcl7-NA19 and Cdcl7-M20A or Cdcl7-M20AANLS 
to restore viability of cdcl7A shows that nuclear and mitochondrial Cdcl7 functions 
can be separated. 
From now on the designations outlined in Table 4.2 will be used in order to facilitate 
comprehensibility. 
Table 4.2: Designations used throughout the remainder of this chapter. 
designation 	 explanation 
cdcl 7A 	 cdcl 7::kanMX6 leul-32 ura4-D18 his 7-366 ade6-M21? 
low expression 	 expression from pREP41X in the presence of thiamine, 
yields approximately endogenous Cdcl7 levels 
overexpression 	 expression from pREP41X in the absence of thiamine, 
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Figure 4.2: a) Schematic representation of the double plasmid shuffle approach used to separately 
express nuclear and mitochondrial Cdcl7. b) Co-expression of nuclear and mitochondrial Cdcl7 
sustains viability of cdclTh cells. nuci = nuclear (encoding Cdcl7-NM9), mito = mitochondrial 
(encoding Cdcl7-M2OA or Cdcl7-M2OAiNLS) 
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4.3.3 Effect of removing the PCNA binding motif from nuclear 
Cdcl7 
In a next step, the strategy described above was used to assess the importance of the 
presence of the PCNA binding motif. A vector encoding nuclear Cdc 17 lacking the 
PCNA binding motif was introduced into cdc17A!pUR19-cdcl7 and the double 
plasmid shuffle was performed, as outlined in Figure 4.2 a) and described in the 
previous section. Expression of nuclear Cdcl7 possessing the motif served as a 
positive control. Initially, Cdc17-M20A was used as the mitochondrially targeted 
protein. 1000 cells, expressing nuclear Cdc17 with or without the motif as well as 
Cdcl7-M20A, grown in the absence of thiamine, were plated out on selective media 
containing thiamine and incubated for five days. The results are summarised in 
Figure 4.3. Loss of the PCNA binding motif in the nuclear Cdcl7 protein caused a 
drastic decrease in cell viability as judged by the number of colony forming units 
(see photographs in Figure 4.3). Additionally, cells were highly elongated compared 
to the control (32.2 tm versus 14.4 .tm). Note that the size of the existing colonies 
varied considerably. 
The conclusion from this experiment is that the presence of the PCNA binding motif 
is important for nuclear DNA ligase I function. It was speculated that those 15% of 
cells that were able to form colonies could do so because a fraction of the 
mitochondrial protein Cdcl7-M20A, which retains the PCNA binding motif as part 
of the putative mitochondrial presequence, was somehow capable of performing 
nuclear Cdc17 function. Consistent with this assumption would be the observation 
that - in the intracellular localisation studies - Cdcl7[1-175]-M20A-GFP showed 
some nuclear fluorescence (see Chapter 3, Figure 3.4 c)). In order to investigate this 
possibility, it was decided to employ the Cdcl7-M20AANLS protein as 
mitochondrial Cdcl7. The corresponding N-terminal domain had targeted GFP 
exclusively to mitochondria (see Chapter 3, Figure 3.4 d)). Also it had been shown 
that Cdcl7-M20AANLS was able to rescue cdc17A when co-expressed with Cdcl7-
NA19 (see previous section, legend to Figure 4.2). 
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motif ' ' ' motif 
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mitochondrial Cdc17 	................................................ 
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> 95% viability 	 - 15% viability 
9 	± 3.3) pm 	K2(322 ± 9.2) pm 
Figure 4.3: Result of the double plasmid shuffle experiment, explained in the text. Nuclear proteins 
are Cdcl7-NA19 (with motif) and Cdcl7-NA31 (without motif) and the depicted mitochondrial 
protein is Cdcl7-M20A. cdc]7A cells containing both plasmids were plated out on selective media 
containing thiamine and incubated at 32°C for five days. 
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Using the double plasmid shuffle approach the ability of nuclear Cdc17 lacking the 
PCNA binding motif and Cdcl7-M20AANLS to sustain growth of cdc17t was 
investigated. However, no significant difference was detected relative to the use of 
Cdcl7-M20A as the mitochondrial protein: the experiment was carried out several 
times and the number of colonies that arose lay between 10% and 30% compared to 
the control (Cdcl7-NA19 as nuclear protein). Again, the rescued cells were 
considerably elongated compared to control cells (see Figure 4.4 top panels). 
It is possible that the survival of a proportion of cdcl 7A cells expressing nuclear 
Cdc 17 lacking the PCNA binding motif and a mitochondrial form may be due to 
high levels of these proteins being present in the cells (bearing in mind that 
overexpression of those proteins rescues the deletion strain). In order to investigate 
this possibility colonies from the selective plates containing thiamine were re-
streaked on thiamine or grown up in liquid culture before plating out on thiamine a 
second time. However, it was found that cells were able to grow when re-streaked on 
thiamine. Similarly, cell material taken from medium- to large-diameter colonies did 
grow in liquid culture containing thiamine, although 4-5 times slower than 
cdc17A cells expressing nuclear Cdc17 possessing the motif alongside mitochondrial 
DNA ligase. When an equivalent number of cells were plated out on thiamine a 
second time, viability of cdc17A cells harbouring nuclear Cdc17 without the PCNA 
binding motif was only slightly reduced compared to control cells ( 80% versus 
>95%). Additionally, microscopic inspection revealed only marginally elongated 
cells. The findings of the follow-up experiments are illustrated in Figure 4.4. 
In conclusion, if nuclear Cdc17 lacking the PCNA binding motif, co-expressed with 
a mitochondrial Cdcl7, is subjected to conditions allowing only limited production 
of proteins, cell viability is reduced by 70-90%. Cell elongation implies that the 
DNA replication checkpoint machinery is called into action indicating that DNA 
replication is defective in these cells. However, prolonged growth under those 
conditions results in improved cell viability, with the viable cells dividing at a 
reduced cell size compared to initial plating on thiamine-containing media. 
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Figure 4.4: Summary of the results of the conducted double plasmid shuffle experiments. Nuclear 
proteins are Cdc 1 7-NA 19 (with motif) and Cdc 1 7-NA3 1 (without motif) and the mitochondrial protein 
is either Cdc l7-M2OA or Cdc l7-M2OAANLS. See text for details. 
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4.3.4 Outlook 
The most likely explanation of the observed behaviour of cdcl 7A cells expressing 
nuclear Cdcl7 lacking the PCNA binding motif and a mitochondrial form, described 
in the previous section, is that cells with elevated Cdcl7 levels are selected for. In 
order to test whether prolonged growth in thiamine-containing media causes 
increased Cdcl7 levels, which would reflect such selective pressures, protein extracts 
were prepared from cdcl 7z\ cells of equally sized colonies which differ in the time-
span they have been cultured on thiamine-containing media (see Figure 4.4). 
Preliminary immunoblotting analyses of these extracts with anti-Cdcl7-antibody 
were performed. However, the resultant Western blots were difficult to interpret: 
many degradation products were detected and, in cells expressing more than one 
form of Cdc 17, it was impossible to determine which protein species originated from 
which expression construct (data not shown). However, no significant increase in 
protein levels with respect to prolonged growth on thiamine was seen. It is worth 
noting, that the overall detected protein level was at least two-fold higher in cells 
expressing nuclear Cdc17 lacking the motif to those expressing nuclear Cdc17 with 
the motif suggesting that protein levels are a crucial factor in these experiments. In 
order to circumvent the issue of expression from multi-copy plasmids, it would be 
critical that nuclear Cdcl7 was expressed from the chromosomal cdc17 copy. 
Furthermore, to distinguish between nuclear and mitochondrial forms, differential 
tagging could be useful. Several attempts have been undertaken to C-terminally-tag 
chromosomal cdcl 7 employing the PCR-mediated gene targeting method (Bähler et 
al., 1998), but the tagged protein either could not be detected (GFP-tag, data not 
shown) or the presence of the tag impaired the growth properties of the strain 
(13myc-tag, data not shown). 
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4.4 Discussion 
4.4.1 Overexpression of proteins with a PCNA binding motif 
In section 4.2 the impact of high levels of Cdc17 proteins containing the PCNA 
binding motif on cell cycle progression was investigated. Expressing full-length 
Cdc17 or the presumed nuclear Cdcl7-NA19 from the derepressed nmtl promoter 
(highest possible expression) caused SpS cells to elongate considerably, whereas 
gross overproduction of Cdc 17 lacking the PCNA binding motif, Cdc 1 7-NA3 1, only 
showed a minor cell cycle delay. These results fit in with previous studies 
overexpressing proteins containing p21° '-like PCNA binding motifs in S. pombe. 
Heterologous expression of human p21 from the derepressed nmt4l promoter in S. 
pombe caused an inhibition of cell cycle progress (Tournier et al., 1996). In contrast, 
expression of a p21 protein with a mutation in the PCNA binding motif that is 
defective in PCNA binding abolished cell cycle inhibitory effects suggesting that the 
cell cycle delay was due to binding to PCNA (Tournier et al., 1996). The authors 
also demonstrated that the degree of cell cycle inhibition correlated with p21 
expression levels (Tournier et al., 1996). Similarly, a C-terminal portion of Cdc27 
including the PCNA binding site was found to cause significant cell elongation 
whereas a similar fragment lacking the motif did not (Reynolds et al., 2000). 
Interestingly, there are differences in the extent of cell cycle inhibition due to 
overexpression of motif-containing proteins which suggests that additional factors 
influence the ability of those proteins to bind to PCNA. The expression of a Cdc17 
protein where amino acids 1-31 were replaced with the PCNA binding motif of S. 
pombe Rfc 1 (amino acids 1-10) from the derepressed nmt4l promoter was sufficient 
to exert a pronounced cdc phenotype. On the contrary, cdcl 7 expressed from the 
same promoter resulted in only a very minor cell cycle delay. It is unclear where the 
difference in cell cycle inhibitory effects originates from. As far as can be assessed 
from Western blotting analyses the two proteins are expressed to similar levels (data 
not shown). Comparison of the PCNA binding site regions reveals subtle differences 
in their amino acid composition, which may account for their differing binding 
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affinities to PCNA. Figure 4.6 shows an alignment of the respective PCNA binding 
motifs. 
SpCdc1720 MS T R Q S DI S N F F 
SpRfcl 1 	 M S N S D I R S F F 
Figure 4.5: An alignment of PCNA binding motifs present in the Cdcl7 protein which have been 
overproduced in S. pombe. The boxed residues are the conserved features of the motif. See text for 
details. 
4.4.2 Co-expression of nuclear and mitochondrial Cdc17 in 
cdc I 7A 
Experiments described in chapter 2 led to the conclusion that production of Cdc 17 
from the repressed nmt4l promoter most closely reflected endogenous levels of the 
DNA ligase I protein. Studies presented in Chapter 3 elucidated that Cdc 17 proteins 
are present in the nucleus and in mitochondria and identified forms of Cdc17 which 
are likely to be associated with only one cellular compartment. Functional 
complementation experiments using cdcl7A revealed that Cdcl7 function is required 
in both cellular compartments. The simultaneous expression of nuclear and 
mitochondrial Cdc 17 resulted in rescue of a cdcl 7 deletion strain. This was taken as 
an indication that nuclear and mitochondrial functions can be separated and that the 
expression of separate proteins ensures proper DNA ligase I activities. 
The expression in cdcl 7A of a Cdcl7 protein truncated for the first 31 amino acids - 
including the PCNA binding motif - alongside a mitochondrially targeted protein 
(from the repressed nmt promoter in pREP41X and pREP42X, respectively) resulted 
initially in a significant decrease in cell viability. The colonies that arose were few in 
number and varied considerably in size. The degree of cell elongation was roughly 
inversely proportional to the colony size. Whereas cells taken from medium to large 
colonies could be re-cultivated in the presence of thiamine, cell material from small 
colonies was unable to propagate any further. This suggests that the intracellular 
Cdcl7 protein levels may play a crucial role for the survival of cdc17A cells. If 
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nuclear Cdc 17 levels (lacking the motif) pass a threshold, then reasonably sized 
colonies can be formed, although the cells are delayed in cell cycle progression. 
However, if this threshold is not reached then small colonies are formed which 
eventually cease to grow. 
Several parameters concerning the experimental strategy do not allow an 
unambiguous conclusion as to whether the PCNA binding motif is required for 
nuclear Cdc17 function. It is clearly not absolutely essential since experiments 
presented in Chapter 2 showed that 100 - 200-fold overproduction of a protein 
lacking the N-terminal 125 amino acids rescued cdcl 7/s. This implies that high levels 
of Cdc 17, truncated for the N-terminal domain can bypass the requirement for sub-
cellular targeting signals and the presence of the PCNA binding motif. In conclusion, 
protein levels play a crucial role in assessing the importance of PCNA binding to 
Cdcl7. Expressing proteins from multi-copy plasmids consequently results in 
considerable variation of intracellular mRNA and protein levels. Efforts aimed at 
providing uniform expression levels through expression from the chromosome have 
proven unsuccessful since it was impossible to tag chromosomal cdcl 7 Despite the 
described obstacles, it should be stressed, that expression of nuclear Cdc17 lacking 
the PCNA binding motif (alongside mitochondrial Cdc 17) in a cdcl 7/s strain, when 
produced at levels similar to those in wild-type cells, results in greatly reduced cell 
viability, compared to Cdc17 harbouring the motif. This, together with the 
overexpression studies, strongly suggests that the DNA ligase I - PCNA interaction 
serves a vital role in S. pombe. 
4.5 Summary 
The PCNA binding motif, which is present in the N-terminal domain of Cdcl7, 
serves important functions in S. pombe. Overexpression of Cdc17 proteins 
harbouring its own motif or that of Rfc 1 in wild-type cells causes a considerable cell 
cycle delay. Nuclear Cdcl7, co-expressed with mitochondrial Cdc17, is able to 
rescue cdcl 7/s. The absence of the PCNA binding motif from nuclear Cdc 17 causes 
a severe reduction in cell viability. 
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5. Discussion 
5.1 Summary of results 
This section summarises the results that have been presented in this work. 
The lesion sites in the cdcl 7 temperature-sensitive mutants, that were part of the 
original cdc mutant collection, were determined. In each case a single nucleotide 
change resulted in a single amino acid change. In cdcl 7-K42, amino acid G1u298 is 
replaced by a lysine residue, in cdcl7-L]6 Pro584 is converted to a serine and cdcl7-
M75 harbours a mutation resulting in a Pro679 to serine change. 
In a wild-type S. pombe strain, Cdcl7 protein levels are comparable to those 
generated by expression of cdcl 7 from the repressed promoter in pREP4 1X. 
Lack of the N-terminal 125 amino acids of Cdcl7 fails to complement a cdcl 7 
deletion strain when expressed at levels similar to wild-type, whereas at a 100 - 200-
fold overproduction rescue does occur. In contrast, expression of cdcl 7 constructs 
encoding only the catalytic domains do not rescue cdcl 7A irrespective of the 
expression level. 
The N-terminal domain of Cdcl7 (amino acids 1-175) localises GFP to the nucleus 
and mitochondria. Removal of the first 19 amino acids abolishes mitochondrial 
targeting and alteration of amino acid Met20 to an alanine residue dramatically 
reduces nuclear localisation. Residues 62 Lys-Arg-Lys 64 are crucial residues for the 
nuclear localisation signal. 
Nuclear and mitochondrial Cdcl7 functions are both essential for S. pombe cells, 
since cdcl 7A is not complemented by proteins which are defective in localisation to 
either cellular compartment. It is possible to separate nuclear and mitochondrial 
functions of Cdcl7, as judged by functional complementation of cdcl 7z\ by their co-
expression. Lack of the PCNA binding motif from nuclear Cdcl7 drastically reduces 
cell viability when expressed, together with mitochondrial Cdcl7, at levels 




In the following three sections published work that is related to this thesis is 
discussed and, where appropriate, compared to the results presented here. Section 5.3 
concentrates on complementation studies of various DNA ligase proteins in different 
organisms. In section 5.4, mitochondrial DNA ligase functions are addressed as well 
as possible mechanisms for the dual targeting. Section 5.5 deals specifically with the 
interaction between DNA ligase I and PCNA and what purpose it may serve and in 
section 5.6 a brief summary of what is known about possible other DNA ligase I-
interacting-proteins is given. 
5.3 Structure-function analyses 
Functional complementation experiments carried out in this work were aimed at 
clarifying the functions of the non-catalytic domains in DNA ligase I homologues. 
DNA ligases all have versions of the catalytic domains in common, which make up 
the complete ATP-dependent enzyme of bacteriophages and are considered to be the 
minimal architecture necessary for carrying out the ligation reaction. 
In the literature, several (cross-)complementing experiments have been described. 
For example, mutational analyses have been performed on human DNA ligase I 
cDNA expressing N-terminally truncated ligase proteins in a conditional-lethal 
NADtdependent DNA ligase mutant of E. coli. Human DNA ligase I lacking the N-
terminal 249 amino acids was capable of rescuing the temperature-sensitive 
phenotype whereas truncation of a further 35 amino acids could not complement. It 
has to be noted however that the former protein was expressed to a higher degree 
than the latter (Kodama et al., 1991). This suggests that those 35 amino acids may 
contribute to the stability of the enzyme (see below). 
Other studies have shown, that a human DNA ligase I truncation lacking the N-
terminal 231 amino acids was unable to complement mouse embryonic stem cells 
with a lethal DNA ligase I null mutation. Even isolates where the truncation was 
expressed several fold higher than the wild-type gene in murine cells, also failed to 
rescue. In contrast, the same construct was able to complement the temperature- 
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dependent lethality of the S. cerevisiae ligase mutant cdc9-7 (Petrini et al., 1995). 
There are several possibilities as to why the N-terminal truncation does not rescue 
murine knock-out cells. 
Firstly, it is conceivable that the quantity of truncated protein is not high enough for 
complementation of murine DNA ligase I knockout cells. Consistent with this, an N-
terminal truncation of the S. pombe DNA ligase I homologue Cdcl7, when expressed 
at levels similar to wild-type, is unable to rescue a deletion strain. However, 100 - 
200-fold overexpression of this construct is able to support growth, indicating that 
high levels of truncated DNA ligase I protein can bypass the requirement for the N-
terminal domain (Chapter 2, see also discussion section 5.5). The requirements to 
rescue a ligase-deficient yeast strain may be less demanding. For example, the level 
of the ectopically expressed truncation (under the control of the strong ADHJ 
promoter) in yeast relative to wild-type Cdc9p is not known, but is likely to be high. 
Although the activity of the truncated human DNA ligase I protein was sufficient to 
permit growth of cdc9-7, the ligase activity in this case was less than 20% compared 
to wild-type Cdc9p (Petrini et al., 1995), supporting the conclusion that full rescue 
cannot be achieved by an N-terminal truncation. 
Secondly, N-terminally truncated DNA ligase I proteins may lack species-specific 
interaction sites for regulatory and/or replication proteins which are essential for 
proper functioning at approximately endogenous levels. The N-terminus, for 
example, binds to PCNA, an interaction which will be discussed in section 5.5 in 
more detail. 
As yet, no function has been assigned to the conserved non-catalytic domain 
(CNCD). Several lines of evidence suggest that the CNCD contributes to an 
increased stability of the enzyme. Human DNA ligase I starting at residue 285 
expressed in E. coli was produced to a much lower extent than truncated proteins 
starting at amino acid 220 or 250 (Kodama et al., 1991). Experiments presented in 
this work show that the catalytic core without the CNCD can only be produced to a 
maximum of 25% compared to the wild-type protein according to immunoblotting 
analyses (section 2.5). 
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Human DNA ligase III and IV are both found as heterodimers in interaction with 
proteins that stabilise the ligase (XRCC 1 and XRCC4, respectively). Strains deficient 
for these accessory proteins display reduced levels of the respective ligases. These 
associations occur through the C-terminal extensions of the ligases, which contain 
putative protein-interacting domains. In the case of DNA ligase IV, the association 
with an XRCC4 homologue is conserved in yeast. DNA ligase I does not contain any 
C-terminal modules but instead it has an extended middle domain (in addition to the 
proteolytically sensitive N-terminal domain discussed above), which is conserved 
between cellular replicative DNA ligase homologues. It is conceivable that this 
middle domain serves to stabilise the ligase, possibly via an interaction with an (as 
yet) unidentified protein partner. Perhaps this partner may even be ligase itself since 
biophysical experiments suggested that DNA ligase I is able to trimerise (Dimitriadis 
et al., 1998). However, this association was dependent on salt concentration and 
temperature and the fact that a homo-oligomerisation has not been described 
elsewhere raises the question as to whether or not this is biologically significant. 
The CNCD may also well be the target of interaction sites of DNA replication/repair 
proteins which anchor the protein in the rep lisome/repairosome. Alternatively - or 
additionally - this domain may be responsible for increasing the efficiency of 
ligation. A recent publication described the finding that the eukaryotic single-
stranded binding protein RPA was able to stimulate in vitro DNA ligase I activity by 
specifically increasing the rate of catalysis (Ranalli et al., 2001). Since T4 DNA 
ligase (which lacks a CNCD) was not affected, the stimulation may well be mediated 
via the middle domain. Whether this has any functional implications for the in vivo 
situation remains to be determined. 
In addition to the complementation of a temperature-sensitive E. coli ligase mutant 
by an N-terminally truncated version of human DNA ligase I (see above), other 
reports also describe the complementation of ligase-deficient strains with enzymes 
which are only distantly related on an evolutionary basis. For instance, Salmonella 
typhimurium with a disrupted NADt.ligase could be apparently fully complemented 
by the ATP-dependent T4 DNA ligase (Park et al., 1989). It appears that an NAD- 
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ligase function can be substituted for by their ATP-dependent counterparts, probably 
when present at high levels. 
Rather surprisingly, there is a recent report which describes the apparently full 
complementation of S. cerevisiae cdc9A and cdc9A lig4A strains by expression of the 
ATP-dependent Chiorella virus ligase (only consisting of the catalytic core domains) 
or by the NADtligase of E. coli (Sriskanda et al., 1999). It should be noted, 
however, that while wild-type CDC9 was expressed under its own promoter the 
heterologous ligases were expressed under the control of the strong TPIJ promoter 
from CEN plasmids. Triosephosphate-isomerase is a key enzyme in glycolysis, the 
first step in the major energy metabolic pathway, with a highly active promoter. 
Thus, it is possible that proteins are expressed at very high levels from this promoter. 
Further, the researchers found that high levels (expressed from the TPIJ promoter) of 
Cdc9 proteins with deletions of the 178-343 N-terminal amino acid residues could 
not rescue cdc9A  or cdc9A lig4A supporting the proposal that the middle domain may 
increase enzyme stability. Consistent with this finding, experiments with the fission 
yeast DNA ligase I homologue demonstrated that a Cdc 17 protein deleted for the N-
terminal 390 amino acids and only consisting of the catalytic domains was unable to 
rescue a deletion strain even at high levels of expression (Chapter 2). It appears that 
while high levels of the distantly related Chiorella virus ligase can rescue a deletion 
strain, the homologous portion of the endogenous enzyme cannot. In this regard it 
may be interesting to establish if the additional motifs present in the C-terminal 
portion of NAD-ligases, namely a zinc finger, HhH motif and BRCT domain 
(Doherty and Suh, 2000), are required for rescue of eukaryotic species devoid of an 
ATP-ligase. 
It should be stressed that complementation with heterologous DNA ligase proteins 
requires their gross overproduction, which does not reflect physiological conditions. 
It is proposed that the conserved non-catalytic domain serves to stabilise the enzyme 
and that factors intrinsic to this domain may additionally increase the overall 
efficiency of the enzyme. With regard to the rescue of an S. pombe strain deleted for 
cdcl 7, the presence of the CNCD was required under all tested conditions. Hence, 
the conserved non-catalytic domain performs essential functions in vivo. 
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The N-terminal domain of the S. pombe DNA ligase I protein Cdcl7 performs 
important functions in vivo, which will be discussed in greater detail in the following 
two sections, but overexpression of the rest of the enzyme can circumvent its 
requirement. 
5.4 DNA ligase in mitochondria 
5.4.1 Function in DNA repair 
In this work it has been shown that the S. pombe DNA ligase I homologue Cdcl7 is 
localised in the mitochondria as well as the nucleus. Previous work demonstrated the 
presence of a mitochondrial DNA ligase in Xenopus and humans. In these cases the 
ligase proteins originate from the LIG3 gene, the nuclear product of which is thought 
to be involved in the final step of base-excision repair (BER). Recently, in S. 
cerevisiae the existence of a mitochondrial Cdc9 protein was reported. Cdc9p is a 
DNA ligase I homologue and constitutes the replicative ligase function during 
chromosomal DNA replication in budding yeast. S. cerevisiae and S. pombe genomes 
do not have genes encoding DNA ligase III homologues. 
In the past few years, several other components known to be involved in the nuclear 
BER pathway have been identified in human mitochondria, that is an AP 
endonuclease encoded by APE2 and an UNG encoded uracil-glycosylase (see 
Introduction). Pinz and Bogenhagen, 1998, demonstrated that Xenopus mitochondria 
possess all the factors necessary to perform BER, including the mitochondrial DNA 
polymerase pot y  and a ligase (for a recent review on mitochondrial BER see 
Bogenhagen etal., 2001). The existence of the BER-like UVER pathway in S. pombe 
indicates that DNA repair of some types of lesions, namely those that can be 
generated endogenously through reactive oxygen species, is conserved in 
mitochondria from yeast to man. 
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5.4.2 Function in DNA replication 
Although great advances have recently been made on DNA repair in mitochondria, 
much less is known about replication of mitochondrial DNA. Early work suggested 
that mammalian mtDNA is replicated by a strand-asymmetric mechanism, where 
leading strand (heavy- or H-strand) synthesis is initiated from its origin and once the 
lagging strand (light- or L-strand) origin is displaced, synthesis of the latter strand 
begins in the opposite direction (Clayton, 1982, reviewed in Clayton, 1996). Recent 
analyses of mammalian mtDNA replication intermediates by 2D-gel-electrophoresis 
identified replication products which most likely arise from coupled leading- and 
lagging-strand synthesis, in addition to products presumed to derive from the strand-
asynchronous-mode of DNA replication (Holt et al., 2000). Application of the same 
technique to the analysis of S. pombe mtDNA replication yielded products which 
prompted the authors to suggest a rolling-circle-type model of DNA replication (Han 
and Stachow, 1994). Irrespective of the precise mechanism, the fact that human and 
yeast mtDNA generally seem to adopt the conformation of covalently closed circles, 
dictates the necessity for the participation of a DNA ligase during mtDNA 
replication. 
Expression of mitochondrial genes serves an essential function in most organisms 
and a prerequisite of this is an intact mitochondrial genome. Since a lack of 
mitochondrial Cdc9 in S. cerevisiae or diminished levels of mitochondrial DNA 
ligase III in human HT1080 cells has been shown to result in a reduction of mtDNA 
content, it can be concluded that the respective ligase proteins perform vital functions 
in mtDNA replication (Donahue et al., 2001, Lakshmipathy and Campbell, 2001). 
Experiments presented in this thesis underscore the importance of mitochondrial 
DNA ligase function: the absence of mitochondrial Cdc17 in S. pombe rendered cells 
inviable. In this regard it is worth noting that S. pombe is considered a petite-negative 
yeast. This is in contrast to the petite-positive S. cerevisiae. Budding yeast is able to 
tolerate large deletions in or the complete absence of mitochondrial DNA (p or p°  
strains, respectively), the result of which is the formation of small (= petite) colonies 
when grown on non-fermentable media. In other words, the survival of S. pombe 
cells depends on the expression of mitochondrial genes. 
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Since the ligase I genes in yeasts and ligase III genes in Xenopus and humans appear 
to encode the only mitochondrial ligase, the respective ligase proteins seem to unify 
mitochondrial DNA replication and repair functions. 
5.4.3 Dual localisation of Cdc17 
S. pombe cdcl 7 belongs to a class of genes which encode isozymes that are found in 
the nucleus as well as in mitochondria. Characteristic for genes encoding such 
proteins is the presence of two (or more) in-frame translation-initiation codons in 
their 5' region. In section 1.4 it was described that the usage of alternative start 
codons yielding proteins that possess or lack a mitochondrial targeting sequence 
(MTS) can occur either at the transcriptional or the translational level. Figure 5.1 
gives an outline of how cdcl 7 may encode nuclear and mitochondrial versions of 
DNA ligase. 
When cdcl 7 was originally characterised, S 1 -nuclease-mapping revealed the 
existence of a major and minor transcription initiation start site as judged by the 
relative abundance of two mRNA species (Barker et al., 1987). The predicted 5' 
termini of the transcripts would correlate with translation of a predominantly nuclear 
Cdc17 protein from the major transcript (cdc171-mRNA), where translation starts 
at the second AUG codon of the initially identified ORF (which represents the first 
accessible in this message), and the production of a less copious mitochondrial 
version from the minor transcript (cdcl7m jto-mRNA). This presents an elegant 
solution to the different requirements of ligase activity according to the varying 
quantity of DNA present in the organelles: considering that the copy number of the 
mitochondrial genome (19 kb) per cell is several hundred at most (Bostock, 1969) 
the overall DNA content in mitochondria is on average 10% of the nuclear genome. 
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Figure 5.1: Model of how the cdcl7 gene can give rise to two proteins targeted to mitochondria and 
the nucleus. Note that either two transcripts can be produced which each are translated or alternative 
translation initiation from one mRNA is used (see Chapter 1). MPP stands for mitochondrial 
processing peptidase which cleaves off the presequence after the mitochondrial import machinery has 
recognised the N-terminal signal peptide. The precise location of the MPP cleavage site is not known. 
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The only targeting information known to be present in the presumptive nuclear 
Cdcl7 protein is the nuclear localisation signal (NLS), which is partly represented by 
amino acids 64 KRK 66 (Chapter 3). The mitochondrial Cdc17 protein precursor, 
however, harbours the upstream MTS in addition to the NLS. What mechanisms 
ensure the mitochondrial targeting of this translated protein in preference to its 
nuclear localisation? One possible explanation takes the kinetics of translation and 
translocation inside a cell into consideration. If a translationally active mRNA, 
encoding a mitochondrial precursor, happens to be in proximity to the mitochondrial 
import machinery, it is likely that subsequent preprotein molecules are imported co-
translationally. In keeping with this model, electron microscopy studies have shown 
that translationally active ribosomes accumulate on the surface of yeast mitochondria 
(reviewed in Lithgow, 2000). Alternative or additional possibilities include that 
translation initiation from cdc17 10-mRNA starts at both the upstream and 
downstream start codon and/or that a proportion of Cdc 17 proteins harbouring the 
MTS also localises to the nucleus. The latter suggestion would account for the 
observation that a GFP-fusion of the N-terminus of Cdcl7, in which the second start 
methionine was replaced by an alanine, showed weak nuclear fluorescence. 
However, this observation could also be due to high levels of cdc 1 7mjto-mRNA, 
expressed from pREP3X, leading to the mitochondrial protein import machineries 
working to capacity. Attempts to perform experiments to identify which forms of 
Cdc17 localised to which compartment were hampered by the fact that C-terminal 
tagging of cdcl 7 impaired growth. Also, sub-cellular fractionation could not be 
monitored satisfactorily. 
5.5 DNA ligase I - PCNA interaction 
DNA ligase I and its homologous proteins harbour a p21° -like PCNA binding 
motif in the extreme N-terminus. The N-terminal domain of the S. pombe DNA 
ligase I protein Cdcl7 binds the fission yeast PCNA-homologue Pcnl in vitro and as 
part of this work it was shown that rescue of cdc17A with a nuclear Cdcl7 protein 
that is lacking the motif dramatically reduced cell viability, when expressed at 
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physiological levels. Surviving cells displayed a cdc phenotype indicative of defects 
in S phase. 
Although previous studies have already shown that the presence of the conserved 
motif in human DNA ligase I is necessary for localisation to sub-nuclear foci 
(Montecucco et al., 1998), the work presented here further supports the conclusion 
that the association between ligase and PCNA is, under physiological conditions, 
required for S. pombe cell survival. This requirement can however be bypassed by 
high levels of N-terminally truncated ligase protein. This observation is in 
accordance with several published reports. The in vitro SV40 DNA replication 
system has been used to test the ability of human 46BR.1G1 cell extracts, which 
possess a mutationally altered DNA ligase I, to perform complete DNA synthesis. 
Although 4613R.1G1 cells have normal ligase protein levels, they only display 5% of 
wild-type DNA joining activity. Consistent with this, DNA synthesis by these cell 
extracts was incomplete, leaving behind Okazaki fragments that were not ligated 
together. Addition of DNA ligase I corrected this defect. An equivalent amount of 
enzyme lacking the N-terminal domain could not correct aberrant DNA replication, 
whereas addition of a ten-fold excess of this truncation supported efficient DNA 
synthesis (Prigent et al., 1994, Mackenney et al., 1997). Furthermore, the same DNA 
replication system (in vitro SV40 DNA replication by 46BR. 1 G 1 cell extracts) was 
used by Levin et al., 2000. They showed that the full-length DNA ligase I, where the 
adjacent phenylalanine residues of the PCNA binding motif had been replaced by 
alanines, did not complement the replication defect when an equivalent amount of 
wild-type protein corrected the deficiency. Again, addition of a ten-fold excess of the 
mutant DNA ligase I protein resulted in completely ligated DNA replication products 
(Levin et al., 2000). Although the above described experiments were carried out in 
vitro, experiments in this work suggest that approximately physiological amounts of 
nuclear S. pombe DNA ligase I without the motif were insufficient to restore normal 
DNA replication in vivo since a deletion strain could not be functionally 
complemented. 
What is the precise function of DNA ligase I binding to PCNA? The results of 
several studies argue against the possibility that PCNA directly stimulates catalytic 
activity of DNA ligase I. Preincubation of DNA substrates containing a single nick 
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with PCNA did not have a significant effect on DNA joining upon addition of DNA 
ligase I (Levin et al., 1997). Although Tom et al., 2001 did find a stimulation of 
ligase acitivity, they showed that it was coupled to PCNA being bound on the nick-
containing-DNA. Furthermore, the fact that PCNA incubated with T4 DNA ligase 
did not show any stimulatory effect on ligation activity most probably rules out a 
direct influence on catalytic activity. It is more likely that the presence of PCNA on 
DNA increases the rate of DNA ligase I-binding to the substrate via an interaction 
with PCNA. This would explain that, at physiological levels of DNA ligase I, the 
PCNA-interaction-site is required to target DNA ligase I to nicks, whereas high 
levels of DNA ligase protein can circumvent the "substrate-targeting-sequence", 
because statistically it is very probable that a ligase molecule will be close to its 
action site. This explanation is consistent with the findings presented in this work 
and described above, and also with the observation that the PCNA binding motif is 
necessary for specific localisation to sub-nuclear replication foci (Montecucco et al., 
1998). 
56 Other DNA ligase I interacting proteins 
In the literature physical interactions of DNA ligase I with two proteins apart from 
PCNA have been described so far. Interestingly, both proteins are not thought to be 
involved in DNA replication, but are rather components of DNA repair pathways. 
These proteins are DNA polymerase 3, a polymerase functioning in base-excision 
repair (Prasad et al., 1996) and Mre 11, which is implicated in double-strand break 
repair, specifically meiotic recombination and non-homologous-end-joining (Petrini 
et al., 1995b). The latter finding is rather surprising since specifically DNA ligase IV 
homologues have been implied in functioning in double-strand repair pathways. 
Therefore, so far it appears as if DNA ligase I only interacts with the DNA 
replication protein PCNA (which is also involved in DNA repair pathways). In the 
original report describing an interaction between DNA ligase I and PCNA, PCNA 
was discovered as a protein from Hela cell nuclear extracts specifically retained on a 
DNA ligase I affinity resin (Levin et al., 1997). Similarly, Mre 11 was discovered as 
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an interactor in a two-hybrid-screen. To date, no other interacting proteins have been 
published although screens have been carried out. This could partly be due to the fact 
that the N-terminal domain of DNA ligase I proteins is highly sensitive to proteolytic 
degradation. Since attempts to C-terminal tag the S. pombe DNA ligase I gene 
cdcl 7 has proven unsuccessful (data not shown), Cdcl7-associating proteins could 
not be identified by co-immunoprecipitation. In this lab, work is underway to 
produce the middle conserved non-catalytic domain of Cdcl7, which will 
subsequently be tested for interactors (Leonora Ciufo, personal communication). 
A correlation between DNA ligase I and other proteins involved in Okazaki fragment 
processing - other than PCNA - has so far only come from the detection of genetic 
interactions. In this regard, overexpression of cdcl 7 rescues the temperature-
sensitive lethality of dna2 temperature-sensitive mutants. Also, cdcl 7-K42 is 
synthetically lethal with dna2 mutants, which has also been shown to be the case for 
the respective budding yeast proteins (Kang et al., 2000, Ireland et al., 2000). 
As part of this work, cdcl 7 has been tested specifically for interactions with several 
DNA replication proteins using a two-hybrid assay. However, no interactions were 
observed between Cdcl7 and itself, Rad2, Dna2, Cdc24, Cdcl and Cdc27 using the 
overlay assay. Moreover, a two-hybrid screen was carried out using the conserved 
non-catalytic and catalytic domains of the budding yeast DNA ligase I homologue 
Cdc9 as a bait against a S. cerevisiae cDNA library. Again, no obviously meaningful 
interactors were recovered. 
5.7 Conclusions 
The S. pombe cdcl 7 gene, which encodes the DNA ligase I homologue, is essential 
for cell viability (Nasmyth, 1977 and this work). In addition to the C-terminal 
catalytic domains, the middle conserved non-catalytic domain is necessary for 
functional complementation of a cdcl 7 deletion strain. The latter domain appears to 
be required for increased stability of the enzyme. The presence of the N-terminal 
domain of Cdcl7 is important for complementing cdcl7 deficient strains at 
physiological levels. Intrinsic to this domain are sub-cellular localisation signals 
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signals, namely nuclear and mitochondrial targeting sequences, as well as a PCNA 
binding motif, which serves as targeting the ligase to nicked DNA. 
No genetical or physical interactions with other DNA replication proteins were 
found; this does, however, not rule out their existence. It would be highly interesting 
to identify possible interactors of DNA ligase I at the replication fork, which may 
give further insights into the precise mechanism of the abundant process of Okazaki 
fragment maturation during DNA replication. In this regard, it would also be 
worthwhile to determine any DNA ligase-associated proteins in mitochondria, in 
order to aid understanding of mitochondrial DNA replication and repair. 
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6. Materials and Methods 
6.1 General 
Many of the standard molecular biological and biochemical methods were carried out 
on the basis of the protocols described in Sambrook etal., 1989. 
6.1.1 Chemicals 
Chemicals were purchased from Amersham, BDH, Fisher, Fluka or Sigma unless 
otherwise stated. 
6.1.2 Enzymes 
Restriction enzymes, DNA polymerases and other enzymes used in this work were 
purchased from Gibco BRL, NEB, Promega, Roche and Sigma unless otherwise 
stated. 
6.1.3 Commonly used reagents 
CPS 	 50 mM citrate-phosphate buffer, pH 5.6, 1.2 M 
sorbitol, 0.1 % (vlv) -mercaptoethanol, 40 mM 
EDTA 
DNA loading buffer (6x) 	0.25% bromophenol blue, 0.25% xylene cyanol FF, 
40% sucrose 
LiAc (I Ox) 	 1 M lithium acetate, pH 7.5 (dii. acetic acid) 
PBS (lOx) 	 115 g/l Na2HPO4, 29.6 g/l NaH2PO4, 58.4 g/l NaCl 
PBST 	 lx PBS, 0.1% (v/v) Tween-20 
Protein gel running buffer 	3 g/l Tris, 14.4 g/l glycine, 1 g/l SDS 
SDS sample buffer (2x) 	100mM Tris-HC1, pH 6.8, 200mM DTT (added 
fresh immediately before use), 4% (w/v) SDS, 
0.2% (w/v) bromophenoi blue 
1K11 
1M sodium phosphate buffer, 
pH 7.0 
TAE (50x) 
TE (I Ox), pH 7.5 




57.7 mi/I 1M Na2HPO4, 42.3 mi/l 1M NaH2PO4 
242 gIl Tris, 57.1 mi/i glacial acetic acid, 100 mi/I 
0.5 M EDTA (pH 8.0) 
100 mM Tris-HC1, 10 mM EDTA, pH 7.5 
100 mM Tris-HC1, 10 mM EDTA, pH 8.0 
14.4 g/i giycine, 3 g/i This, 20% methanol 
10% PEG 3000, 10 mM MgC12, 10 mM MgSO4 
5% DMSO in LB 
TSB +20 mM glucose 
6.2 Oligonucleotides 
Oiigonucleotides were routinely ordered from Amersham Pharmacia or MWG 
Biotech. Stock solutions were 100 tM and working concentrations were 10 iM for 
PCR amplification and 1.6 jtM for sequencing reactions. The oligonucieotides used 
in this study are listed below. The positions within cdcl 7 are numbered according to 
Appendix 1. Restriction sites are underlined. F refers to forward primer and R to 
reverse primer. Oligonucieotides used for site-directed mutageneses are listed in 
section 6.11. 
name description sequence 
#1 cloning of cdcl 7 by PCR, F, GATCGGATCCTTGTTATGCGAACAGTATTT 
introduction of BamHI site TCG 
#2 cloning of cdcl 7 by PCR, R, GATCGGATCCCAAACTTAATAATCTTCGGC 
introduction of BamHI site AGCTGGGGAC 
#3 for cdcl7 deletion, F, 1 141-1219F + CGTACACGTGTTACTTGTTCTTCAGGTGTAC 
20 bp of pFA6a (upstream of CCTCACTATTGTCAAATCTTATGAAATTCTT 
kanMX6 module) (Bähler et al., TACTCGUGACTTGATTCGGATCCCCGGGT 
1998) TAATTAA 
#4 for cdcl7 deletion, R, 3719-3637R + ATTCATATTAGCCTCTTTGGGCAAATTTTAG 
20 bp of pFA6a (downstream of CCGAACATTACCCTTTATTATGACAGTAGC 
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kanMX6 module) TCTCAGCAGTAACTCTCAGAATTCGAGCTC 
(Bähler et al., 1998) GTTTAAAC 
#5 verification of cdcl 7 deletion, cdcl 7 GAGACAAGGAACACTCATACTATATCAATG 
5' sequence, 1006-1035F 
#6 verification of cdcl 7 deletion, GCTAGGATACAGTTCTCACATCACATCCG 
kanMX6 module sequence F 
#7 verification ofcdcl7 deletion, AATAGCCATCAGCTAGAGCA 
cdcI73' sequence, 3769-3750R 
#8 verification of cdcl 7 deletion, GATCGCAGTGGTGAGTAACCATGCATCATC 
kanMX6 module sequence R 
#OSeq cdcl 7 sequence, 1511-1492R TCCAGTGTCGTCGTGGTTGT 
#1 Seq cdcl 7 sequence, 1622-1641 F GGCATCTACTCCAATACCT 
#2Seq cdcl 7 sequence, 2033-2052F GGTGATCTTGGTCTTGTAILL 
#3 Seq cdcl 7 sequence, 2427-2446F TGATTGAGCATGGACTTGGT 
#4Seq cdcl 7 sequence, 2816-2835F GACATTAAGGTCCGAGCATG 
#5Seq cdcl 7 sequence, 3364-3383F GCATCAGCCTGACGTCTGGT 
#6Seq cdcl 7 sequence, 1713-1695R CAGCAAATGTTGCATGACC 
#7Seq cdcl 7 sequence, 2671-2652R GATGTCCGGATAGCGAACAG 
#8Seq cdcl 7 sequence, 2197-2177R CAATAGCCGCTTGATCACTCC 
#9Seq cdcl7 sequence, 3602-3623F GAAGGGTCCCCAGCTGCCGAAG 
#pTZH pTZ19R forward primer GTAAAACGACGGCCAGT 
#pTZE pTZ 1 9R reverse primer TAATACGACTCACTATGG 
#nmt5' pREP3X forward primer GGAATCCTGGCATATCATCAATTG 
#nmt3' pREP3X forward primer GCAGCTTGAATGGGCTTCCATAGT 
#MTI S. pombe mating type AGAAGAGAGAGTAGTTGAAG 
#MP S. pombe mating type ACGGTAGTCATCGGTCTTCC 




The following plasmids were used in this work. 
name 	 description 	 reference 
contains the kanMX6 module, which was 
used to replace cdcl 7 in order to generate 
Bähler etal., 1998 
cdcl 7A, used as template in PCR reaction 
to amplify kanMX6 with suitable 5' and 3' 
ends (see section 6.6. 10) 
E. co/i expression vector 
basis for cloning of Cdc I 7-GFP-fusions 
S. pombe expression vector (section 6.3.2) 
S. pombe expression vector (section 6.3.2) 
S. pombe expression vector (section 6.3.2) 
general purpose cloning vector 
contains bp 1218-3636 of the 4176 bp 
	
this work 
HindIII-BglII fragment encoding full-
length cdcl 7, cloned into BamHI site, used 
as basis for construction of mutants' 
contains 4176 bp HindIlI-BgIII fragment 
	
Stuart MacNeill 
encompassing the entire cdcl 7 ORF 
recovered from library as rescuer of cdcl 7-  Barbet etal., 1992 
K42, map not known 
pFA6a-kanMX6 










pURl 9-cdc 17 
modified from Clontech 
Stuart MacNeill 
Maundrell, 1990, Forsburg, 1993 
Basi et al., 1993, Forsburg, 1993 
Basi etal., 1993, Forsburg, 1993 
A DNA fragment carrying the cdc17 gene was amplified by PCR from the template pTZI9R-
cdc17[1-4176] with primers #1 and #2. The PCR fragment was digested with Barn/Il and cloned into 
the Barn/-IT site of pTZI9R. The resultant pTZ19R-cdcl7 was sequenced with primers #pTZH, 
#pTZE, #OSeq, #lSeq, #2Seq, #3Seq, #4Seq and #5Seq to confirm an error-free cdcl7 copy. 
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6.3.2 pREPX plasmids 
6.3.2.1 Introduction 
The pREP plasmids are the most commonly used S. pombe expression vectors and 
they contain the thiamine-regulatable nmt promoter (Maundrell, 1990). There are 
three versions of the nmt promoter: in addition to the original, two attenuated 
versions with reduced activity have been constructed through mutations in the TATA 
box. The respective plasmids are called pREP41 and pREP81 (Basi etal., 1993). The 
original polylinker sequence containing an ATG codon was altered, and the resulting 
plasmids were are from the pREPX series (Forsburg, 1993, see Figure 6.1). In this 
work the following designation is used: 
promoter 	 description 
nmt] 	 nmt promoter in pREP3X 	 full strength 
nmt4l 	 nmt promoter in pREP41X 	 medium strength 
nmt8l 	 nmt promoter in pREP8 I 	 low strength 
The promoter are fully induced in the absence of thiamine and fully repressed when 
thiamine was added to media to a final concentration of 5 ig/ml (stock 5mg/ml in 
H20, store at room temperature). The expression levels differ approximately ten-fold 
between usage of different promoters and approximately 100-fold between induced 
and repressed conditions (Basi et al., 1993) 
139 
Xho i/Sal /BamHi /Smal 










induced: [MM 	 EcoRl 
repressed: [MM + Sug/ml 
EcoRl 	'-'\ 	thiemine 
HindlIl 	
/ 
predicted sequence of poIyiinker 	
nd 
TOG C CTCG A 6 GT C GACT CT AGA 66 AT CCC CG GO 
NOTE: Xba is not unique; there are two Xbai sites in the are. 
REPs 41 X/42X/8 1 X/82X have no Sal site in the polylinker 
predicted sequence is CATAC CTCGAGGGATCCCC666 
REPK is derived from original REPS series by addition of a Tho linker between Ball and Sall; this 
deletes the ATG W thin the poIlinker, destroys Bal I, and recreates Sail. Weaker RE Fs (41,8 I etc) 
v?ele constructed by putting the )(ho linker between BarnHland Ndel; the Ndel, Sail aimd XbaI sites ate 
lost but BamI-liis recreated. 
Erivatives of the REP family: 
R1P3, RI PA (m ars, LEU2); RI P4, RIP4X (m at's, ura4+) 
RE P41 and REP41X(wkerpnJmoter, LEU2) 
REP81 and REP81X (weakest promoter, LEUZ) 
RE P42 and 42X (week uia4+), REP82 aid 82X(wkest, ura4+) 
Fbl)lirler for 41X/81X is XIiof Barn /na 
Poiylirkerfor4l/81 is NdefSai/ Barn /iia 
Fprter ccnsinjcts: REP3 X-IaeZ. RE P41 X -IacZ. R EP81 X-lacZ 
References: 
REPS, parent vectors MaLndreii (19 93) Gene 12 3:12 7 
REP41/42/81/82: bas iet al (19 93) Gene 123:1 31 
REK cons tructs: For'sbur (199 NAR 21:2 95 5 
Figure 6.1: Map of pREP3X. The polylinker sequence for pREP3X as well as for pREP4IX and 
pREP81X is given. The construction of pREP3X (-41X, -81X) from the original pREP3 vector is 
described. Several related vectors are stated, among them pREP42X, which is identical to pREP41X 
except that it contains the ura4 marker gene instead of LEU2, and which is also used in this study. 
The diagram is taken from the Forsburg pombe page (pingu.salk.edu/-forsburgIimagesIREP3X.gif).  
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63.2.2 Constructs used in complementation experiments 
Most of the following cdcl7 constructs were engineered from pTZ19R-cdcl7 
through site-directed mutagenesis or sub-cloning from appropriate constructs (see 
section 6.11). After sequencing of the (mutagenic) cdcl 7 sequence, the BamI-lI 
fragment was subcloned into pREPX vectors. Positions of amino acids are as in 
Appendix 2. 
construct 	 encoding protein 
pREP3X-cdc17 	 full-length Cdcl7 (amino acids 1-768) (high levels) 
pREP4IX-cdcl7 	 full-length Cdcl7 (amino acids 1-768) (medium levels) 
pREP81X-cdcl7 	 full-length Cdcl7 (amino acids 1-768) (low levels) 
pREP4 1 X-cdc 1 7-NA3 I 	Cdc 17 lacking the N-terminal 31 amino acids 
pREP41X-cdc17-Nt65 - 	Cdcl7 lacking the N-terminal 65 amino acids 
pREP41X-cdc17-Nz96 	Cdcl7 lacking the N-terminal 96 amino acids 
pREP4 I X-cdc 1 7-Nix 125 
pREP4 1 X-cdc 1 7-NA390 
pREP4 1 X-cdc 1 7-CA378 
pREP4 I X-cdc I 7-K4 16A 
pREP4 I X-cdc 1 7-M20A 
pREP4 1 X-cdc 1 7-NA3 1 [1-
lOrfcl} 
pREP3X-lpp 1-CT 
Cdc 17 lacking the N-terminal 125 amino acids 
Cdc 17 lacking the N-terminal 390 amino acids 
Cdcl7 lacking the C-terminal 378 amino acids 
full-length Cdcl7 with a point mutation encoding an alanine at 
position 416 instead of a lysine 
full-length Cdcl7 with a point mutation encoding an alanine at 
position 20 instead of a methionine 
full-length Cdcl7 with point mutations encoding an alanine at 
position 20 instead of a methionine and alanines at positions 62-64 
instead of Lys-Arg-Lys 
Cdcl7 lacking the N-terminal 31 amino acids, which are replaced 
with amino acids 1-10 of S. pombe Rfcl 
catalytic domains of S. pombe DNA ligase homologue Lppl 
(provided by Stuart MacNeill) 
pREP42X-cdc 17-
M2OAL\N LS 
pREP4IX-1ppI-CT 	 catalytic domains of S. pombe DNA ligase homologue Lppl 
(provided by Stuart MacNeill) 
pREP3X-SsoLig 	 DNA ligase of the archaeon S. solfataricus (provided by Stuart 
MacNeill) 
- pREP4IX-SsoLig 	 DNA ligase of the archaeon S. solfataricus (provided by Stuart 
MacNeill) 
141 
6.3.2.3 Constructs used for localisation studies 
The relevant cdcl 7 sequence with an upstream XhoI site and a downstream EcoRI 
site, generated by PCR (see section 6.11), was cloned into pGEX4T-cdc17[1-175]-
GFP, where the existing cdc17 fragment had been excised with XhoIIEcoRI. 
Subsequently, the XhoTIBamI-II fragment encompassing cdcl 7-GFP sequences were 
subcloned into pREPX vectors. The cloning strategy is summarised in Figure 6.2. 
construct 
	
Cdc 17 sequence N-terminal to GFP 
pREP3X-GFP 
	
(provided by Stuart MacNeill) 
pREP3X-cdc 1 7[ 1-I 75]-GFP 
	
N-terminal 175 amino acids (provided by Stuart 
MacNeill) 
pREP3X-cdc I 7[20- 1 75]-GFP 
	
amino acids 20-175 
pREP3X-cdc I 7[32- 1 75]-GFP 
	
amino acids 32-175 
pREP3X-cdc 1 7[66- I 75]-GFP 
	
amino acids 66-175 
pREP3X-cdc 1 7[97- 1 75]-GFP 
	
amino acids 97-175 
pREP3X-cdc I 7[ 126-1 75]-GFP 
	
amino acids 126-175 
pREP3X-cdc 1 7[ 1-1 75]M2OA-GFP 
	
amino acids 1-175, but alanine replacing methionine 
at position 20 
pREP3X-cdc17[1-175]M20ANLS-GFP 	amino acids 1-175, but alanines replacing methionine 
at position 20 and Lys-Arg-Lys at positions 62-64 
pREP3X-cdcl7[1-175]ANLS-GFP 	 amino acids 1-175, but alanines replacing Lys-Arg- 
Lys at positions 62-64 
pREP3X-cdc 17[32-651-GFP 
	
amino acids 32-65 
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XhoI 	 Ramka  
nmfterm nmtprom 
L EUU2 
Figure 6.2: Cloning strategy for pREP3X-cdc 17 [1-1 75]-GFP-constructs 
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6.4 Antibodies and dyes 
6.4.1 Antibodies 
6.4.1.1 Anti-Cdc17 antibodies 
Two different antibodies against Cdcl7 were raised. 
Antisera against a synthetic peptide corresponding to the C-terminal last 20 amino 
acids of Cdcl7 (see Appendix 2), conjugated to KLHIMBS, was produced by Sigma 
Genosys. Six immunisations and five bleeds were carried out on two rabbits. This 
antibody was used for Western blotting analyses in this work and will be referred to 
as anti-Cdc 1 7-peptide antibody. Prior to usage the antiserum was affinity-purified as 
described in section 6.12.4. 
In addition, rabbit antibodies were raised against a GST-fusion of amino acids 391-
768 of Cdcl7, by Diagnostics Scotland. Testing of the resultant antisera showed that 
the quality of the anti-Cdcl7 antibodies was not as good as the anti-Cdcl7-peptide 
antibodies. Therefore, these antibodies were used only as controls. The generation of 
the GST-fusion protein, which was used to affinity-purify the above described anti-
Cdcl7-peptide antibody, is described in section 6.12.4. 
6.4.1.2 Secondary antibodies for immunofluorescence 
Anti-rabbit Cy3 (code no. 711-166-152) was purchased from Jackson 
Immunoresearch Laboratories. A1exa488 was a gift from Dr. Hiro Ohkura. 
6.4.2 Dyes 
Mito-Tracker® Red CM-H2Xros was obtained from Molecular Probes (cat.-no. M-
7513) and was used to stain S. pombe mitochondria. 
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6.5 Bacterial methods 
6.5.1 Bacterial strains 
strain 	 genotype 	 reference 
JMIO9 	 endAl, recAl, gyrA96, thi, hsdR17 (rK, MK'), Yanisch-Perron etal., 1985 
re/Al, supE44, A(lac-proAB), [F', traD36, 
proAB, lacl"Z AM] 5] 
CJ236 	 F, cat(pCJ105 ; M13SCmI)dut l ,  ungl, thi-1, 	Kunkel etal., 1987 
re/Al, spoTl, mcrA 
BL2 1 (DE3)pLysS 	F, ompT, hsdSB, (rd, mn), dcm, gal, X(DE3), 	Studier and Moffat, 1986 
pLysS, Cm' 
JM109 was used for propagation of plasmids, CJ236 for oligonucleotide-directed 
mutagenesis (see section 6.11) and BL21(DE3)pLysS for expression of a GST-fusion 
protein (see section 6.12.4). 
6.5.2 Bacterial media 
LB (Luria broth): 	10 g/l bacto-tryptone 
5 g/l bacto-yeast extract 
5 g/l NaCl, 	pH 7.0 (NaOH), 
autoclaved and stored at room temperature 
For solid media agar was added to a final concentration of 2%. 
6.5.3 Antibiotics 
Where appropriate antibiotics where added to the growth medium as follows: 
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antibiotic 	 stock solution 	working concentration 
ampicillin 100 mg/ml in H20 100 jig/ml 
chloramphenicoi 34 mg/ml in ethanol liquid media: 15 jig/ml 
solid media: 30 jig/ml 
kanamycin 10 mg/ml in H20 10 jig/ml 
tetracycline 5 mg/ml in ethanol 5 jig/ml 
6.5.4 Transformation 
Unless otherwise stated bacteria were routinely transformed with plasmid DNA 
using the DMSO method. Cells were grown to an OD of 0.5, spun down for 10 
minutes at 3000 rpm, resuspended in 1/10 volume of TSB and stored on ice for at 
least 10 minutes. 100 jil competent cells were added to 0.1-200 ng of DNA and 
incubated on ice for 30 minutes. 200 jil TSBG were added and the cells were 
incubated at 37 °C shaking for 1 hour. 100-200 jil were spread on the appropriate 
media. Transformants containing cloned sequences into pTZ19R were plated out on 
LB containing ampicillin, X-gal (2% (w/v) stock in DMF, final concentration 
0.005%) and IPTG (stock 100 mM, final concentration 100 jiM) for blue-white 
selection. 
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6.6 Fission yeast methods 
6.6.1 Introduction 
Many of the fission yeast methods are based on protocols described in the fission 
yeast handbook (accessible online: www.bio.uva.nl/pombe/handbook) and Moreno et 
al., 1991. Further fission yeast methods are described in Alfa et al., 1993, MacNeill 
and Fantes, 1993 and MacNeil! and Fantes, 1997. 
6.6.2 Strains 
The following fission yeast strains were used in this work. 
strain 	genotype 	 reference 
cdcl7-K42 	cdcl7-K42 leu 1-32 	 Nasmyth, 1977 
cdcl7-L16 	cdcl7-LI6leu 1-32 	 Nasmyth, 1977 
cdcl7-M75 	cdcl7-M75 leu 1-32 	 Nasmyth, 1977 
Sp5 	leu 1-32 h 	 this lab 
Sp201 	leul-32 ura4-D18 his7-366 ade6-M210 h 	 this lab 
Sp202 	leuI-32 ura4-D18 his7-366 ade6-M216 h 	 this lab 
cdcl 7' Icdcl 7A: :kanMX6 leul-32/leuI-32 ura4-D18/ura4-D18 this work 
his7-366/his7-366 ade6-M2 1O/ade6-M2 16 h7h 
cdc17L::kanMX6 leul-32 his7-366 ade-M2JX ura 4- this work 
D18/pUR19-cdcl7 
6.6.3 Media and growth conditions 
YE (yeast extract) 
Fission yeast strains were routinely grown in YE. It is a complex medium and 
inhibits conjugation and sporulation. 
5 g/l Oxoid yeast extract 
30 g/l glucose 
120 mg/1 adenine, histidine, leucine, lysine hydrochloride and uracil 
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EMM (Edinburgh minimal medium) 
EMM was used as minimal medium for vegetative growth. 
3 g/l potassium hydrogen phthallate 
2.2 g/l Na2HPO4 
5 g/l NaCl 
2% (wlv) glucose 
20 mIll salts (50x stock) 
1 mi/l vitamins (1000x stock) 
0.1 mill minerals (I 0,000x stock) 
salts (50x stock) 
	
vitamins (1,000x stock) 
52.5 9l1MgC12 6H20 
	
1 g/l pantothenic acid 
0.735 mg/i CaC12 2HO 
	
10 g/l nicotinic acid 
50 g/l KC1 
	
10 g/l myo-inositol 
2 g/l Na2SO4 	 10 mg/l biotin 
minerals (10,000x stock) 
5 g/l boric acid 	 0.4 g/l molybdic acid 
4 g/l MnSO4 	 1 g/l KI 
4 g/l ZnSO4 . 71-10 	0.4 g/l CuSO4 • 5H20 
2 g/l FeCl2 . 6H20 	10 g/l citric acid 
ME (malt extract) 
ME is a nitrogen limiting medium and plates containing 30 g/l malt extract were used 
for the induction of conjugation and consequent sporulation. 
Phloxin B 
To check the ploidy of cells, phloxin B was added to solid media. Phloxin B (stock: 5 
g/l in dH20, filter-sterilised) was added to YE after it has cooled below 60°C to a 
final concentration of 1.75 .Ig/ml. Phloxin B is a stain that accumulates in dead cells. 
Since diploid colonies, because less viable, contain a higher number of dead cells, 
these colonies will be stained dark pink, whereas haploid colonies appear light pink. 
Solid media was prepared by adding 2% Difco Bacto Agar. 
6.6.4 Storage of S. pombe strains 
For short term storage S. pombe strains were kept as patches on solid media at 4°C. 
For long term storage, glycerol stocks were prepared. Cells are grown up in complete 
medium to stationery phase. An equal volume of the cell suspension is mixed with 
30% glycerol in YE in a cryotube and stored at -70°C. 
For re-isolation, material of the glycerol stock is scraped off with a sterile spatula, 
placed onto a YE plate and incubated at the appropriate temperature. When growth is 
visible, the material is streaked out to single colonies. 
6.6.5 Phenotypical analyses 
Re-isolated strains need to be checked for their phenotype before carrying out any 
genetical analyses. 
6.6.5.1 Mating type 
To determine the mating type of a strain it was crossed (section 6.6.6.1) to h and h 
tester strains. After incubation for 3 days the plate was held over iodine crystals. 
Where sporulation has occurred the cross will be stained black due to the presence of 
starch in the spores. Also, PCR using mating type specific primers can be used (see 
section 6.9.3). 
6.6.5.2 Temperature sensitivity 
Temperature-sensitivity was tested by replica-plating patches of the re-isolated strain 
onto YE and incubating at the permissive and restrictive temperature. After 
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incubation for several days, the plates are examined for growth. The permissive 
temperature for used cdcl 7" strains is 25°C and the restrictive temperature is 36°C. 
6.6.5.3 Auxotrophy 
To test for auxotrophy patches of the re-isolated strain on YE were replica-plated 
onto minimal medium with and without the appropriate supplement. After incubation 
for several days, the plates are examined for growth. The auxotrophic markers used 
in this study are leucine, adenine, histidine and uracil. Where appropriate, stock 
solutions (adenine, leucine: 7.5 gIl and histidine, uracil 3.75 gIl) were added to media 
to a final concentration of 112.5 mg/l. 
6.6.6 Genetic analyses 
6.6.6.1 Genetic crosses 
Strains were crossed by mixing together freshly isolated cells of opposite mating 
type on a ME plate. A loopful of sterile H20 is then used to thoroughly mix the cells. 
The plate is incubated at 25°C for several days until zygotic asci are visible under the 
microscope and/or the mating mix turns blue black upon exposure to iodine vapour 
(see section 6.6.5.1). The progeny of the crosses are examined by tetrad analysis or 
random spore analysis. 
6.6.6.2 Diploid construction 
In this work, the isolation of diploids was aided by the use of two complementing 
adenine mutants. Strains bearing the ade6-M210 or ade6-M216 alleles are adenine 
auxotroph and colonies appear pink due to the accumulation of a metabolic 
precursor. A heterozygous diploid carrying both alleles is prototrophic for adenine 
and colonies appear white. 
If",] 
6.6.6.3 Random spore analysis 
A loopful of 2-3-day-old mating mix was resuspended in 500 .xl sterile H20, 10 il of 
a 1:10 dilution of helicase (Helix pomatia juice) is added and the mixture is 
incubated overnight at 28°C. The mix was checked microscopically for ascus wall 
breakdown and 10' - 104 dilutions were plated out on YE. The arising colonies 
were then analysed further. 
6.6.6.4 Tetrad analysis 
A loopful of a 2-day-old cross was streaked out in a line at one side of a YE plate. 
The asci of the cross were pulled using a micromanipulator (Singer Instruments, 
UK). The plate was incubated for several hours at 32°C or overnight at 16°C, until 
the asci walls have broken down. Each ascus was then dissected and the four spores 
were separated and placed into a line using the micromanipulator. The spores are 
incubated at the appropriate temperature until colonies form. 
6.6.7 Physiology 
6.6.7.1 Growth of liquid cultures 
Exponentially growing cells were obtained by inoculating a freshly growing, single 
colony into 10 ml of appropriate medium and incubating for 2-4 days until the cells 
are in stationery phase. This preculture was then diluted into fresh media so that 
overnight incubation with agitation yields a culture with an OD of 0.2 - 0.4. (an OD 
of 0.05 corresponds to 106  cells/mi.) Exponentially growing cells usually have an 
OD of between 0.1 and 0.5. Incubation temperature is generally 32'C, but can vary 
between 25°C and 36'C. 
6.6.7.2 Measurement of cell numbers 
Cell numbers were determined using a Beckman Coulter Counter Z2. 100 t1 cell 
suspension was added to 10 ml of Isoton and mixed. The sample was sonicated for 
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10 seconds at 5% with a high intensity ultrasonic processor (Sonics & Materials), 
mixed again and counted with the Coulter Counter according to the manufacturer's 
instructions. The average of two counts was used for calculation of cell number. 
6.6.7.3 Measurement of cell lengths 
1 ml of exponentially growing cells were spun down for 10 seconds and the 
supernatant was discarded. 2 ptl of cell suspension was pipetted onto a glass slide, left 
to dry briefly before covering. Cells were viewed at 40x magnification. For cell 
length measurement an eyepiece graticule was used, where the smallest unit 
corresponds to 2.5 gm. Cell length was measured at division, i.e. those cells, that had 
clearly formed a septum, but had not yet undergone cytokinesis, were considered. 25-
35 cells were examined and average cell length and standard deviation were 
calculated using Microsoft Excel. 
6.6.8 Preparation of S. pombe chromosomal DNA 
Fission yeast chromosomal DNA was prepared essentially as described in the fission 
yeast handbook (www.bio.uva.nl/pombelhandbook).  
10 ml of the appropriate media was inoculated with a single yeast colony and 
incubated for 1-2 days at the required temperature until the culture reaches stationary 
phase. Cells were harvested and resuspended in CPS buffer containing 2.5 mg/ml 
Zymolase 20-T (ICN). The cells were transferred to a 1.8 ml microfuge tube and 
incubated at 37°C for 60 minutes. Cells were harvested and resuspended in 300 j.tl 5x 
TE. 35 t1 10% SDS (w/v) was added and the suspension was incubated at 65°C for 5 
minutes. 100 p1 SM potassium acetate was added and incubated on ice for 30 
minutes. After centrifugation for 15 minutes at 4°C the supernatant (--400 j.il) was 
added to 1 ml ice-cold ethanol and mixed. It was centrifuged for 10 minutes at 4°C 
and the pellet was resuspended in 400 p1 of 5x TE containing 100 tg/ml bovine 
pancreatic RNAse A and incubated at 37°C for 2-4 h. The DNA was extracted once 
with 400 0  phenol, once with 400 tl phenol-chioroform-isoamylalcohol (25:24:1) 
and once with 400 p1 chloroform. Approximately 400 p1 of the aqueous layer was 
transferred into a new tube and 40 .tl 5 M potassium acetate, pH 5.6, and imi ice-
cold ethanol was added and mixed. The DNA was precipitated with a centrifugation 
for 30 minutes at 4°C and it was washed once with 200 jil 70% ethanol. The pellet 
was dried under vacuum and routinely resuspended in 100 jil of TE, pH 8.0. 
6.6.9 S. pombe transformation 
Routinely S. pombe was transformed by electroporation based on the method 
described by Prentice (1992). 
200 ml cultures of S. pombe strains to be transformed were grown to late-logarithmic 
phase (OD 0.4), washed three times in ice-cold sorbitol and resuspended in ice-cold 
sorbitol at 1 x 109 cells/ml. 200 tl of cell suspension was mixed with 0.5-1 jig of 
plasmid DNA and immediately transferred to an ice-cold electroporation cuvette (0.2 
cm electrode gap). Cells were pulsed at 2.5 kV (11.25 kV/cm), 20M and 25 jiF in a 
Bio-Rad Gene PulserTM  II. Immediately after the pulse 0.5 ml of ice-cold sorbitol 
was added to the cuvette. 200 jil were plated on selective media and incubated at 
32°C for five days. Usually >1000 transformants are obtained with this protocol. 
6.6.10 Gene replacement 
Deletion of chromosomal cdc 17 was carried out according to the method of Bähler et 
al., 1998. In a diploid S. pombe strain, one cdcl7 allele was replaced with kanMX6, 
the gene product of which confers resistance to the antibiotic G418 (Gibco-BRL). 
The kanMX6 module was amplified from plasmid pFA6a-kanMX6 by standard 
Deep Vent-PCR with primers that terminate in short stretches of homology (79 bp) to 
the genomic sequences immediately upstream and downstream of the cdcl 7 coding 
sequence (primers #3 and #4, respectively, see section 6.2). 15 jig of PCR product 
was ethanol-precipitated, resuspended in 10 jil TE and transformed into the diploid 
strain of genotype leu 1 -32/leu 1-32 ura4-D1 8/ura4-D1 8 his 7-366/his 7-3 66 ade6-
M210/ade6-M216 h7h, which was obtained by crossing the strains Sp201 and 
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Sp202 (see section 6.6.2) and selecting for ade diploids. The transformation 
protocol was based on the lithium acetate procedure (Keeney and Boeke, 1994). For 
this, a 20-ml-culture was grown to mid-log phase (-10 cells/ml) at 32°C. Cells were 
washed once in 20 ml H20, the pellet was resuspended in lml H20, transferred to an 
Eppendorf tube and washed once with 100 mM LiAc/TE (pH 7.5). The cell pellet 
was resuspended in LiAc at 2 x i09 cells/ml. 100 .tl cells were mixed with 2 jil 
salmon sperm carrier DNA (10 mg/ml, Clontech) and 15 tg of transforming DNA 
and incubated at room temperature for 10 mm. 260 .tl of 40% PEG/LiAc/TE (PEG 
4000) was added, the cell suspension mixed gently and incubated at 30°C for 30-60 
mm. 43 tl of DMSO were added and the cells were heat-shocked at 42°C for 5 mm. 
Cells were washed with lml H20, resuspended in 0.5 ml H20 and 2 x 250 jil were 
plated onto YE. The plates were incubated for 18 h at 32°C resulting in a lawn of 
cells and then replica-plated on YE containing 100 mg/I G418. The plates were 
incubated for 3 days at 32°C and appearing big colonies were re-streaked onto YE + 
G418. 
Verification of correct integration events was carried out by standard Taq-PCR. 
Genomic DNA from four stable transformants and the corresponding wild-type strain 
was prepared (section 6.6.9) and used as a template in a PCR reaction with different 
combinations of primers. Two primers corresponded to sequences within the 
transforming fragment going in either direction (primers #6 and #8) and two primers 
(primers #5 and #7) covered a region upstream and downstream of the cdcl 7 coding 
sequence to be replaced (see also Chapter 2, primers see section 6.2). 
6.6.11 Plasmid shuffle 
The basis for the plasmid-shuffle experiments would be a haploid cdcl 7A which is 
maintained by a wild-type copy of the gene on a plasmid carrying the ura4 gene 
complementing the uracil auxotrophy of the strain. After transformation of 
pREP41X-cdcl7-constructs (leu) into cdcl7A/pUR19-cdcl7 (ura) cells carrying 
both plasmids can be plated out on 5-FOA (5-fluoroorotic acid). 5-FOA selects 
against ura cells (Boeke et al., 1984, Grimm etal., 1988) and therefore the ability of 
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truncated or mutated cdcl7 versions, expressed from pREP41X, to rescue the 
deletion can be assessed. Solid 5-FOA was added to agar media, held at 55°C, and 
dissolved for 10 minutes at 55°C (final concentration 1 mg/ml). 
The spores from the heterozygous deletion diploid cdcl 7'icdcl 7A: :kanMX6 leul-
32/leu 1-32 ura4-D1 8/ura4-D1 8 his 7-366/his 7-366 ade6-M21 O/ade6-M2 16 h7h * that 
had been plated out on EMM + supplements lacking leucine in the presence or 
absence of thiamine were tested for their phenotype. An isolate which was G4 1 8, 
1eu, ade (i.e. haploid) was transformed with pUR19-cdcl7 and it was selected for 
ura leu colonies. The resulting isolate cdcl7A::kanMX6 leul-32 his 7-366 ade-M21? 
ura4-D]8/pUR19-cdc17 was used for complementation experiments. 
After transforming in pREP41X-cdcl7-constructs, cells were plated out on media 
selecting for both plasmids and either containing or lacking thiamine, corresponding 
to subsequent culturing and plating steps. Well-isolated transformants were 
replicated at least twice on uracil containing medium in order to dilute out the ura4 
gene product before growing up in liquid culture and plating out 1000 cells on media 
containing 5-FOA and uracil, either with or without thiamine (as before) and 
supplemented with histidine and adenine. 
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6.7 Fluorescence microscopy 
6.7.1 GFP-fusion proteins 
GFP is a protein from the jellyfish Aequorea victoria which fluoresces green (green 
fluorescent protein) and it is widely used as a marker for gene expression in vivo and 
as a cytological marker fused to protein-coding sequences (Sawin, 1999). For 
example, GFP-fusion genomic DNA libraries were constructed and screened for 
intracellular protein localisation in S. pombe as a means of identifying the function of 
unknown proteins (Sawin and Nurse, 1996, Ding et al., 2000). 
In this work, a mutant form of GFP, namely GFP[S65T], was used, which results in a 
six- to ten-fold enhanced fluorescence compared to the wild-type GFP protein (Heim 
et al., 1995, Sawin, 1999). For convenience, GFP[S65T] will be referred to simply as 
GFP throughout this work. 
Expression of GFP-fusion proteins were undertaken in S. pombe leul-32 h cells 
(strain Sp5). Precultures of cells carrying the respective expression vectors (see 
section 6.3.3.2) contained thiamine in order to avoid toxic effects due to 
overproduction. After inoculating a main culture, cells were grown to an OD of 0.1-
0.2. For viewing under the microscope, 1 ml of cell suspension was spun down 
briefly and -2 p1 of the loose pellet was pipetted onto a glass slide, dried and covered 
with a cover slip. 
When staining with Mito-Tracker® was carried out, 1 ml cell suspension was spun 
down, resuspended in 200 nM Mito-Tracker® (in EMM) and incubated in the dark 
for 30 minutes. Cells were washed once in EMM and prepared for microscopy as 
above. Cells were viewed, using green and red filter, under a Zeiss Axioplan 2 
microscope with a lOOx oil-immersion objective. Photos were taken using the 
OpenLab software and images were processed in AdobePhotoshop. 
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6.7.2 Immunofluorescence 
S. pombe Sp5 cells transformed with pREP41X vectors encoding several versions of 
cdcl 7 and grown in the absence of thiamine, were subjected to immunofluorescence. 
Generally, this method involves fixation of cells, cell wall digestion, primary and 
secondary antibody application and microscopy. Cells were viewed under a Zeiss 
Axioskop microscope with a 66x oil-immersion objective. Pictures were taken using 
the Smart Capture VP software and processed in Adobe Photoshop. 
Whenever cells were spun down in microfuge tubes in the following protocol, the 
double spin technique was used in order to minimise cell loss: cells were spun down 
for one minute, then the orientation of the tube was reversed, and cells were spun 
down again for one minute. 
Solutions 
PEM: 100 mM Pipes 	 PEMBAL: PEM 
1 mM EGTA +1%BSA 
1 mM MgSO4,pH 6.9 	 + 0.1% sodium azide 
+ 100 mM L-lysine HCI 
PENIS: PEM + 1.2 M sorbitol 
Formaldehyde solution (for fixation, prepare freshly, TOXIC): 
For 10 ml of a 30% solution, 3 g para-formaldehyde was placed in a 50 ml tube and 
10 ml 65°C-prewarmed PEM was added. The solution was incubated at 65°C for 5 
minutes and 12 drops of 5 M NaOH were added. The solution was mixed, incubated 
at 65°C until all of the formaldehyde has gone into solution, cooled on ice to 32°C 
and spun down briefly before use. 
Fixation 
2.5 ml formaldehyde solution was placed in a 50 ml tube and 20 ml cell culture (OD 
was added quickly and mixed thoroughly. 0.5-1 minute later glutaraldehyde 
was added to a final concentration of 0.2%, the tube was mixed well and incubated 
on a shaker for 90 minutes. Fixation was stopped by spinning down the cells. The 
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cells were resuspended in 1 ml PEM, transferred to a microfuge tube and washed 
three times in PEM. 
Cell wall digestion 
Cells were resuspended in 1 ml PEMS + 2.5 mg Zymolase-20T and incubated at 
37°C until 90% of cells have become spheroplasts. Cells are pelleted and 
resuspended in 1% Triton-X100 in PEMS. After 0.5 minute cells are washed three 
times in PEM. 
Quenching 
This procedure is aimed at reducing free aldehyde groups available to interact with 
the incoming antibodies. A little sodium borohydride was placed in a 50 ml tube, 5 
ml PEM was added and mixed (solution will bubble extensively). 500 jtl sodium 
borohydride solution was added to the cell pellet and incubated at room temperature 
for five minutes with the caps left open. Cells were pelleted and washed twice in 
PEM, resuspended in PEMBAL and incubated on a rotating wheel at room 
temperature for 30 minutes. 
Staining 
An aliquot of cells was pelleted, resuspended in 100 p1 of a primary antibody 
solution in PEMBAL at the desired dilution and incubated overnight on a rotating 
wheel. The cells were pelleted, washed three times in PEMBAL, resuspended in 100 
p1 of secondary antibody solution at the desired dilution and incubated five hours on 
a rotating wheel. 
Microscopy 
Cells were pelleted, washed once in PEMBAL, once in PBS and resuspended in PBS 
containing 0.2 jig/ml DAPI (stock: 20 jig/ml). Cells were pelleted and resuspended 
in PBS + 0.1% sodium azide. The cells are mounted on poly-lysine coated coverslips 
and left to air-dry. The coverslips are placed onto a glass slide with 5 jtl mounting 
medium (10 pA of 10 mg/ml paraphenylene diamine in PBS + 90 pA glycerol). 
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6.8 General DNA methods 
6.8.1 Phenol-chloroform extraction 
DNA was extracted from proteinaceous solutions with phenol/chloroform. 
An equal amount of phenol was added to the DNA solution, vortexed for one minute 
and spun down at max. speed in a microfuge for 5 minutes. The upper aqueous layer 
was transferred to a tube containing an equal amount of 
phenol: chloroform:isoamylalcohol (25:24:1) and treated as above. The upper 
aqueous layer was then added to a fresh tube with the same volume of chloroform. 
The aqueous layer was transferred in a fresh tube and the DNA was recovered by 
ethanol precipitation. 
6.8.2 Ethanol precipitation 
DNA solutions were concentrated and/or purified by precipitation. 2.5 volumes of 
ethanol (-20°C) and 0.1 volume of 3M sodium acetate, pH 5.2, was added to the 
DNA, mixed thoroughly and precipitated at —20°C for 30 minutes. The DNA was 
pelleted by centrifugation at max. speed for 30 minutes at 4°C in a microflige. The 
DNA was then washed in 70% ethanol, dried under vacuum and resuspended in a 
suitable amount of TE, pH 8.0, or H20. 
6.8.3 Preparation of plasmid DNA 
Small scale plasmid preps were routinely prepared with the Promega Wizard plasmid 
prep kit (cat.-no. #A1460). Typically, 100 p.1 at 100 ng/p.l were obtained. Plasmid 
DNA which is to be subsequently sequenced is prepared using the Promega syringe 
barrel columns (cat.-no. #A7510) followed by an ethanol precipitation. The DNA is 
typically resuspended in 30 p.1 sterile dH20 and the yield usually is 50 ng/p.l. The 
QIAGEN filterMidi (cat.-no. 12243) or filterMaxi (cat.-no. 12262) kits were 
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routinely used for large scale plasmid preps, yielding 100 p1 at between 1-5 tgIjtl. In 
all cases, plasmid DNA was prepared according to the manufacturer's instructions. 
6.8.4 Restriction enzyme digests of DNA 
Restriction endonuclease digestion of DNA was carried out in 20-pd-reactions for 
analytical digests and 100-p i-digests for preparative digests. The restriction enzymes 
were used as recommended by the manufacturers with a digest typically containing 
between 200 ng and 3 tg of DNA and between 2 and 5 units of restriction enzyme in 
the supplied lx reaction buffer. The digest was incubated at the recommended 
temperature, normally for a period of 2 h. The products of the digestion were either 
analysed by agarose gel electrophoresis (section 6.8.7) or purified using a 
QlAquick® gel extraction column (cat.-no. 28704). 
6.8.5 Removal of phosphates from DNA ends 
The removal of 5' phosphate groups of linearised plasmid DNA was carried out to 
avoid re-circularisation of the plasmid vector DNA in subsequent ligation reactions. 
Typically, 0.5 p1 of Shrimp Alkaline Phosphatase (USB, 1 unit/jil) was added to 2-
3tg digested plasmid DNA and incubated for 30 minutes at 37°C. The digested and 
phosphatased vector was purified as described in the previous section. 
6.8.6 Ligations 
Ligations were routinely carried out in a final volume of 10 Pd,  containing 0.5-1.0 ig 
total DNA with T4 DNA ligase (Roche) in the supplied reaction buffer. Vector and 
insert DNA were present in an approximately 1:3 molar ratio. Ligation reactions 
were incubated overnight at 16°C and stopped by freezing at -20°C. 
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6.8.7 Agarose gel electrophoresis 
DNA fragments produced by restriction enzyme digest or by PCR amplification was 
analysed in 0.8-1.5% (w/v) agarose gels. Gels were prepared by melting the 
appropriate amount of agarose in lx TAE and adding ethidium bromide to a final 
concentration of 0.1 jig/mi. The gel running buffer consisted of lx TAE with 0.02 
jig/ml ethidium bromide. Gels were run at a voltage of 4-8 V/cm for 1.5 h. DNA 
samples were mixed with 6x loading buffer. 
The size of the DNA fragments and its quantity was compared to molecular weight 
markers. Typically, 10 jil of Gibco-BRL 1 kb DNA ladder (cat.-no. 15615-016, 
prepared according to the manufacturer's instructions) was loaded alongside the 
samples (1.6 kb band contains 100 ng DNA). 
The DNA was visualised using a UV-transilluminator and pictures were taken with a 
UVP DOC-IT'M camera (Ultra-violet Products). 
6.8.8 Purification of DNA from agarose gel slices. 
DNA was purified from agarose gels using the QlAquick® Gel Extraction Kit 
(Qiagen). DNA fragments were separated by agarose gel electrophoresis and the 
bands visualised on a UV transilluminator (set to low intensity). The band of interest 
was excised with a clean scalpel and purified according to the manufacturers' 
protocol. DNA was typically eluted in 30jil of sterile, distilled water. 
6.9 DNA amplification by PCR 
6.9.1 General 
olymerase chain reaction (PCR) was routinely used to amplify DNA fragments 
from template DNA, which either was plasmid DNA or S. pombe genomic DNA. 
Routinely, reaction volumes were 20 j.tl for analytical and 100 jil for preparative 
PCR reactions. If the PCR products were to be analysed for the presence of a specific 
DNA fragment the robust Taq DNA polymerase (Roche, cat.-no. 1146165) was used. 
In case the amplified DNA fragment was subsequently to be cloned into a vector the 
Deep Vent DNA Polymerase (NEB, cat.-no. #M0258), which possesses exonuclease 
activity and therefore minimizes errors during the amplification procedure, was used. 
If Deep Vent was the polymerase of choice the amount of additional M92SO4 to add 
to the reaction mixture had to be optimized for each DNA template. 0.5 units Taq 
Polymerase was used and DeepVent Polymerase was added at 0.4 units. 
A typical 20 i.il reaction was set up as follows: 
DNA 20-200 ng 
5' oligonucleotide primer [10tM] 1 jil 
3' oligonucleotide primer [10iM] 1 p1 
10 x polymerase buffer 2 	tl 
dNTPs [10 mM] 0.4 il 
M92SO4 (if using Deep Vent) 0-6 mM 
DNA Polymerase: Deep Vent 0.2 	tl 
or 	 Taq 0.1 p1 
dH20 ad2Ojtl 
0.2 ml tubes were used for the PCR reaction mix and the reactions were carried out 
in a "Genius" PCR machine from Techne. The standard PCR programme was as 
follows: 
Step 1 Denaturation 
	
94 °C for 1.5 minutes 
Step 2 Primer annealing 
	
55 °C for 1.5 minutes 
Step 3 Extension 
	
72 °C for 3.0 minutes, 	30 cycles 
6.9.2 Colony PCR 
If E. coli or S.pombe colonies are to be screened directly for the presence of a certain 
DNA fragment a crude DNA preparation as template for a PCR reaction can be made 
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as follows: The equivalent of a 1-2 mm colony was denatured in 10 jil H20 or 0.02 N 
NaOH at 95 °C for 5 minutes. 2 t1 were used in a PCR reaction. 
6.9.3 Mating type PCR 
The mating type of a fission yeast strain can be determined using matl-P and mati-
M specific primers. Common primer #MT1, the mat 1-P specific primer #MP and the 
matl-M specific primer #MM produce characteristic PCR products of 987 bp and 
729 bp for h and K cells, respectively. The sequence of the mating type primers can 
be found in section 6.2 and the conditions for the PCR reaction are detailed below. 
PCR reaction mixture PCR cycle 
DNA 2.0 	tl Step 1 94 °C for 4.0 minutes 
#MT1 [lOjiM] 2.0 	tl Step 2 94 °C for 0.5 minutes 
#MP [lOjiM] 2.0 p1 Step 3 52 °C for 0.5 minutes 
#MM [10tM] 2.0 	tl Step 4 72 °C for 2.0 minutes 
10 x polymerase buffer 2.0 .il step 2 - 4 for 30 cycles 
dNTPs [10 mM] 0.4 	tl Step 5 72 °C for 5.0 minutes 
H20 9.4 	tl 
Taq polymerase 0.2 il 
Total 20 tl 
6.10 DNA sequencing 
6.10.1 General 
Plasmid DNA to be sequenced was prepared using the Promega syringe barrel 
columns and quantitated by visualisation on an agarose gel. Reactions were 
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performed with the dRhodamine or bigDye terminator cycle sequencing kit (Perkin 
Elmer). A typical reaction mix was set up as follows: 
Template DNA (100-250 ng) 
Terminator mix 
Primer (1.6 pmol) 
H20 
Step 1: 96°C for 30 seconds 




Step 3: 60°C for 4 minutes, 25 cycles 
 
DNA was precipitated from the reaction mix by adding 25p1 of ethanol and ipi of 
3M sodium acetate, pH 5.2, incubating on ice for 15 minutes followed by 
centrifugation at 14,000 rpm for 30 minutes at 4°C. The pellet was washed with 
125p1 of 70% (v/v) ethanol and dried under vacuum. Samples were run by the ICMB 
Sequencing Service (University of Edinburgh) on an ABI PRISM 377 DNA 
sequencer and the sequence analysed using the Gene Jockey II programme on a 
Macintosh computer. 
6.10.2 Sequencing of cdc17ts alleles 
Genomic DNA was prepared from the temperature-sensitive strains cdcl 7-K42, 
cdcl7-L16 and cdcl7-M75 strains. The cdcl7 gene was amplified from the genomic 
DNA by DeepVent-PCR using primer #1 and primer #2, which results in a DNA 
fragment carrying cdcl 7 with BamI-lI sites at either end. The PCR products were 
digested with BamHI and cloned into pTZ19R. The resultant plasmids were used as 
template for DNA sequencing with plasmid-specific primers #pTZH and #pTZE and 
cdcl 7-specific primers #OSeq, #lSeq, #2Seq, #3Seq, #4Seq and #5Seq. 
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6.11 Site-directed mutagenesis 
6.11.1/n vitro oligonucleotide-directed mutagenesis 
Most truncations and mutations were engineered using the MutaGene Phagemid Kit 
version 2 (Bio-Rad 170-358 1). 
pTZ19R-cdcl7 was transformed into the dut ung strain 0236. The dut mutation 
inactivates dUTPase and cells accumulate high levels of dUTP which is incorporated 
into nascent DNA. The ung mutation inactivates uracil N-glycosylase, which allows 
uracil to remain in the DNA. Phagemid particles, whose single-stranded DNA 
contains some uracils are produced from these cells by superinfection with the helper 
phage M13K07. This DNA is purified and used as the template in an in vitro 
mutagenesis reaction primed by an oligonucleotide containing the desired mutation. 
The resulting double-stranded DNA is transformed into JM 109 which contains a 
functional uracil N-glycosylase. The uracil-containing strand is strongly selected 
against and the non-uracil containing mutagenic survivor is left to replicate. 
Normally, mutation efficiencies were ~ 50%. 
Truncations of Cdc 17 were constructed by performing the in vitro mutagenesis 
reactions with oligonucleotides introducing BamHI recognition sequences at the 
appropriate sites within cdcl 7. After the mutations were confirmed by sequencing, 
BamI-JI restriction digests were performed and the desired fragment was subcloned 
from pTZ19R into pREPX vectors. Mutageneses reactions were performed 
essentially following the manufacturer's instructions. The oligonucleotides used to 
generate the different constructs are listed below. 
6.11.2 Mutagenesis by PCR 
PCR reactions generating mutagenic cdcl 7 sequences or introducing restriction sites 
were carried out as described in section 6.9.1. The PCR products were subsequently 
run on an agarose gel, excised from the gel and cleaned up. After restriction digest of 
the product fragment, it was cloned into the target vector using standard procedures. 
165 
6.11.3 Oligonucleotides used for mutageneses 
The following oligonucleotides were used to create truncations or mutations in the 
cdc] 7 sequence. Oligonucleotide sequences corresponding to the cdc] 7 sequence are 
indicated as numbers (see Appendix 1) and mutagenic sequences are written out. 
Restriction sites are underlined. Since the initial preparation of single-stranded 
phagemid DNA was generated from pTZ19R-cdcl7, where the insert was in the 
wrong orientation, primers used for in vitro mutagenesis are in the reverse direction. 
Constructs which are not mentioned below were engineered through subcloning of 
appropriate restriction digest fragments. 
construct 	 method tmpl 	 sequence 
cdc17-NM9 ivM 1) 1298-1280 AACAAGGATCC 1268-1247 
cdc 17-N65 ivM 1) 1478-1458 CATAACAAGGATCC 1443-1425 
cdc 1 7-N96 ivM 1) 1573-1551 CATAACAAGGATCC 1536-1515 
cdcl7-NM25 ivM 1) 1657-1638 CATAACAAGGATCC 1623-1603 
cdc17-N390 ivM 1) 2516-2495 AACAAGGATCC 2483-2460 
cdc l7-K416A ivM 1) 2587-2572 GC 2569-2559 
cdc l7-M2OA ivM 1) 1296-1282 GC 1279-1268 
cdc 1 7-A3 1 [1-1 Orfc 1] ivM  1374-1356 AAAGAAGCTTCGAATGTCAGAA 
TTACTCATAACAAGGATCCCCGGGTACCG 
cdc17-NA31 PCR  GATCGGATCCTTGTT 1356-1379, F 
GATCGGATCC 3636-3608, R 
cdc 1 7[32- 1 75]-GFP PCR  GGCCCTCGAGATTGTTATG 1356-1379, F 
GGCCGAATTC 1787-1763, R 
cdcl7[20-175]-GFP PCR  GGCCCTCGAGATACGG 1280-1300, F 
GGCCGAATTC 1787-1763, R 
cdcl7[1-175]-M20A- PCR  GGCCACTCGCCTCGAGTTGTT 1223-1241, F 
GFP GGCCGAATTC 1787-1763, R 
cdcl7[66-175]-GFP PCR 4) GGCCACTCGCCTCGAGATTGYTATG 1458-1478, F 
GGCCGAATTC 1787-1763, R 
cdc 1 7[97- 1 75]-GFP PCR 4) GCCACTCGCCTCGAGATTGTTATG 1551-1573, F 
GGCCGAATTC 1787-1763, R 
cdcl7[125-175]-GFP PCR 4) GCCACTCGCCTCGAGATTGTTATG 1638-1659, F 
GGCCGAATTC 1787-1763, R 
cdc17[32-65]-GFP PCR 3) GGCCCTCGAGATTGTTATG 1356-1379, F 
CCGGGTCGAC 1457-1429, R 
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cdcl7 [1-175] 	NLS- PCR 	3) 	initially two PCR reactions, which overlap at the 
GFP mutation site, where a NotI restriction site is introduced 
upper: GGCCACTCGCCTCGAGTTGTT 1223-1241, F 
GCACCATTACGCGGCCGC 1445-1421, R 
lower: GCGATTACCAGCGGCCGC 1454-1479, F 
GGCCGAATTC 1787-1763, R 
cdcl7 [1-175] PCR 	5) 	two PCR reactions, which overlap at the mutation site, 
M20AANLS-GFP where a Noti restriction site is introduced 
upper: GGCCACTCGCCTCGAGTTGTT 1223-1241, F 
GCACCATTACGCGGCCGC 1445-1421, R 
lower: GCGATTACCAGCGGCCGC 1454-1479, F 
GGCCGAATTC 1787-1763, R 
ivM = in vitro mutagenesis 
* templates: 
I) pTZ19R-cdcl7 was used to produce single-stranded phagemid DNA (ivM) for subsequent in vitro 
oligonucleotide-directed mutagenesis. 
For PCR reactions the following plasmids were used as templates: 
2) pTZI9R-cdcl7 	 3) pREP3X-cdcl7[1-175]-GFP 
4) pGEX4T-cdc 1 7[ 1-1 75]-GFP 	 5) pREP4 1 X-cdc I 7-M20A 
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6.12 Protein methods 
6.12.1 S. pombe small scale protein extracts 
S. pombe denatured protein extracts were routinely prepared using the RibolyserTM 
(Hybaid, cat.-no. 6000220/110). 
S. pombe cultures were grown to an 0D600 of 0.2 - 0.4. 
Samples with equal OD (usually 10 ml at 0D600 = 0.3) were taken and cells 
were pelleted at 3000 rpm for 4 minutes. 
Cells were resuspended in 5 ml ice-cold STOP buffer (see below) and spun 
down at 3000 rpm for 4 minutes. 
Cells (well drained) were resuspended in 100 j.tl buffer A (see below). 
Cell suspension was added to Ribolyser tube and vortexed 2 seconds to mix. 
Tubes were fitted in the Ribolyser and processed at 4.0 g for 20 seconds. 
100 p1 of 2x SDS sample buffer were added to the bottom of the tube, 
vortexed 2 seconds to mix and heated to 95 °C for 5 minutes. 
After tubes had cooled down their base was punctured, clipped into a 2 ml 
microfuge tube, placed into a 50 ml Falcon tube and centrifuged at 3000 rpm 
for one minute 
Prior to gel loading the protein sample was spun down for 3 minutes at 
maximum speed. 
STOP-buffer buffer A 
150 mM NaCl 10 mM sodium phosphate buffer, pH 7.0 
50 mM NaF 100 pJ Complete Inhibitors (I Ox) 
10 mM EDTA (Roche, cat.-no. 1 836 1563) 
1 mM NaN3  1% Triton X-100 
0.1% SDS 
1mM EDTA 
150 mM NaCI 
1mM PMSF (add immediately before use) 
H2O ad 1 ml 
6.12.2 SIDS-polyacrylamide gel electrophoresis (SIDS-PAGE) 
Discontinuous SDS polyacrylamide gels based on the method described by Laemmli 
(1970) were used to separate proteins electrophoretically. Gels were poured using the 
Mini-PROTEAN II slab cell for miniature polyacrylamide gels (BioRad 165-2940). 
Discontinuous polyacrylamide gels consist of an upper stacking gel, where the 
proteins become concentrated, which results in a better resolution in the lower 
separating gel. The separating gels had acrylamide concentrations of between 7% 
and 12% depending on the molecular weights of the proteins to be separated. Below 
the recipes for 7% and 12% separating gels and the stacking gel are given, which is 
enough to pour two mini-gels. The acrylamide solution contained 30% (w/v) 
acrylamide mixed with bis acrylamide at a ratio of 37.5:1 (Severn Biotech Ltd). 
separating gel, 7% separating gel, 12% stacking gel, 5% 
1.5 M Tris-HC1, pH 8.8 2.5 ml 2.5 ml 
0.5 M Tris-HC1, pH 6.8 --- --- 2.5 ml 
acrylamide solution 2.5 ml 4 ml 1.33 ml 
10%(wlv)SDS 100 pl 100 p1 100 p1 
H2O 4.85 ml 3.35 ml 6.1 ml 
10% (w/v) AMPS SO p! SO p! SO p! 
TEMED Sjii 5 jil 10 	tl 
10 ml 10 ml 10 ml 
The gel apparatus was assembled according to the manufacturers instructions. The 
separating gel solution was mixed and poured. To assure the formation of an even 
surface the separating gel is overlayed with some drops of H20. The gel was allowed 
to polymerise for ca. 45 minutes. After removal of H20 the prepared stacking gel 
solution was poured and the combs fitted. After 45 minutes the combs were removed 
and the wells were washed with protein gel running buffer. The gels were fitted in 
the buffer tank and the tank was filled with protein gel running buffer. 
169 
Protein samples were mixed with an equal volume of 2x SDS sample buffer, boiled 
for 5 minutes, cooled down and briefly spun down before loading on the gel. 
As a molecular marker broad range pre-stained protein standards (NEB, cat.-no. 
7708S ,size range 6.5-175 kDa) was used. 
6.12.3 Western blotting 
The Mini Trans blot cell (BioRad, cat.-no. 170-3930) was used for 
electrophoretically transferring proteins from SDS polyacrylamide gels to PVDF 
membranes (BioRad, 162-0184). The pads, blotting paper (Whatman 3MM), 
membranes and gels were soaked in chilled Transfer buffer for 15 minutes. The 
blotting apparatus was assembled according to the manufacturers' instructions and 
fitted into the tank. A cooling block was added and the tank was filled with transfer 
buffer, which was stirred throughout the transfer, The transfer was allowed to 
proceed for one hour at 100 V. The proteins immobilized on the membranes were 
detected using the ECL Chemi luminescence system (Amersham Pharmacia, RPN 
2209). After electroblotting the membranes were treated as follows: 
The membranes were incubated in 5% (wlv) dried milk in PBST for one hour 
with agitation 
The membranes were briefly rinsed twice with PBST and washed in large 
volumes (approx. 50 ml) of PBST: 1 x 15 minutes, 3 x 5 minutes. 
The membranes were transferred in small perspex trays and incubated in 10 
ml primary antibody solution (antibody diluted in PBST). Incubation was 
allowed to proceed overnight at 4 °C with gentle shaking. 
The membranes were briefly rinsed twice with PBST and washed in large 
volumes (approx. 50 ml) of PBST: 1 x 15 minutes, 3 x 5 minutes. 
The membranes were transferred in small perspex trays and incubated in 10 
ml secondary antibody solution (antibody diluted in PBST) for one hour with 
gentle agitation. Routinely, the anti-rabbit secondary antibody supplied with 
the ECL kit (Amersham, cat.-no. NA934) was diluted 1:2000. 
The membranes were briefly rinsed twice with PBST and washed in large 
volumes (approx. 50 ml) of PBST: 1 x 15 minutes, 3 x 5 minutes. 
The membranes were washed in dH20 twice for 2 minutes. 
Excess liquid was removed from the membranes. The membranes were 
placed on cling-film, covered with the detection mix (1:1 mixture of supplied 
solutions 1 and 2) and incubated for exactly one minutes 
Excess detection reagent was removed and the membranes were wrapped in 
cling-film and placed in a film cassette. 
The blot was exposed to Hyperfilm-ECL autoradiography film and 
subsequently developed. Exposure times varied from a few seconds to 10 
minutes. 
6.12.4 Immuno-affinity purification of anti-Cdcl7-peptide antibody 
A protein fusion of the catalytic domains of Cdcl7 (amino acids 391-768) C-terminal 
to GST had been used to raise antibodies as part of this work. Although the 
antibodies were not employed for the results presented here, the GST-fusion was 
used to affinity-purify the anti-Cdc 1 7-peptide antibody. The following section 
describes the production of GST-Cdc17-NA390 and after that the purification 
procedure is described. 
6.12.4.1 Production of GST-Cdcl7-NA390 
The GST-fusion was created as follows. cdcl7-Nz1390 was subcloned from pTZ19R-
cdcl7-NA390 into the BamHI site of pGEX6P-1B to produce pGEX6P-1B-cdcl7-
NA390. Alongside pGEX6P-1B as a control this plasmid was transformed in E.coli 
BL21(DE3)pLysS. Cells were grown to an OD of 0.5 at 37°C, induced with 0.1 mM 
IPTG and harvested after 3 hours. Since it was only possible to obtain very little 
soluble fusion protein a protocol for the purification of inclusion bodies was used 
(Yasuhisa Adachi, personal communication). Harvested cells were frozen, thawed, 
resuspended in TBS,1 mM -mercaptoethanol, 0.2 mM PMSF and sonicated at 10% 
for 20 seconds with a high intensity ultrasonic processor (Sonics & Materials). The 
cells were spun down and resuspended in TBS,1 mM -mercaptoethanol, 0.2 mM 
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PMSF, 2M urea, 2% Triton-X100 and sonicated at 5% for 10 seconds. The cells were 
peileted, washed in same buffer and resuspended in TBS, 1 mM -mercaptoethano1. 
This crude protein extract was mixed with one volume of SDS sample buffer and run 
on a small preparative gel. The gel was stained with Coomassie Blue in 20% 
methanol, destained in 10% methanol and the protein band corresponding to GST-
Cdcl7-NA390 was excised. The gel was squashed, transferred to a microfuge tube, 1 
ml of Protein Elution Buffer was added (15 mM NH4HCO3, 0.025% SDS, 1 mM 
DTT, 0.1 mM PMSF) and incubated overnight on a rotating wheel at room 
temperature. The gel squash was washed once with fresh protein elution buffer. The 
supernatants were pooled, lyophilised and the protein concentration was determined 
according to Bradford (Bio-Rad Protein Assay, cat.-no. 500-0002, Bradford, 1976). 
6.12.4.2 Purification 
The purification procedure is based on a protocol described in Harlow and Lane, 
1988. 
Approximately 20 tg of GST-fusion protein was loaded on a mini preparative gel 
(SDS-PAGE) and run as normally. The proteins were blotted onto a PVDF 
membrane as described previously. The blot was washed in PBS for 5 minutes, then 
incubated in Ponceau S (Sigma) for 5 minutes. After destaining for a maximum of a 
few seconds, the visible protein band was excised and the membrane strip was 
blocked in milk for one hour. After washing in PBS, the strip was cut into pieces and 
transferred into a microfuge tube containing 1 ml of the antiserum (final bleed). The 
tube was incubated overnight at 4°C on a rotating wheel. The membrane pieces were 
washed 5x in PBS followed by elution of the antibody from the membrane: 500 tl of 
1M NaSCN were added to the tube and incubated on a wheel for 10 minutes at room 
temperature. The solution was neutralised by the addition of 5 ml PBS. Finally, 
sodium azide was added to a final concentration of 0.02%. The purified antibody was 
stored at 4°C and is usable for up to two months after purification. 
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Appendix 1: Nucleotide sequence of cdc17 
10 	 20 	 30 	 40 	 50 	 60 	 70 
I I I I I 
AAGCTTCCAATGACGGAGAAAGIthATTGCCATTTGAAGAGCCAGAGCTGGTAGATTGAAAACGTACAGAGGAGCGCTT 
80 	 90 	 100 	110 	120 	130 	140 	150 
I I I I 
TAAACCCTGAGCGACACCGCGAAACAAAGATCGTTGATACATTTTAGTATTTTTAATAGTTCGGCTTATA 
160 	170 	180 	190 	200 	210 	220 	230 
I I I I I 
ATTTTCAAAACGAATTGAAAAAAATATGAATGATAAAATAATAAAATGAAGTTTTAT1ATAGTTTATGCTTAATATA 
240 	250 	260 	270 	280 	290 	300 	310 
I I I I I I I 
TTTAAACACCAGTTTTTTTCCP.PACACAACAAACCC1AGAAAAAATAAACAGAACCAAAAAATAAAAATATGGATTTA 
320 	330 	340 	350 	360 	370 	380 	390 
I I I I I I I 
AGGATCAGAACAGAATCGTCAATCCGTTTCTTTATCCACCTAGAGACPAGAAGTGTTAATTTATATAAAATGGAGAAC 
400 	410 	420 	430 	440 	450 	460 
I I I I 
TTGGTTCTAATAAGATTTCAACGAAAACAAAGATTTCAGAACCGAAAAAATTTCTCCAAGTGCTAGCAGAGGTATATT 
470 	480 	490 	500 	510 	520 	530 	540 
I I I I I I I I 
CTCTGAGAAAGAACAAAAATCAAAAATTGAATGTTTATATTGAATGTTACCTGTAACAGGTAACATGTTTTTTTAGTA 
550 	560 	570 	580 	590 	600 	610 	620 
I I I I I I I 
ATGCCGGGCTGTCGAAATTTGACTATGAGTTTTGTAAATAAAGCGATGGTTATAAACAATTTTATGATAGTTTTTGCT 
630 	640 	650 	660 	670 	680 	690 	700 
I I I I I I I 
TTCGAATTAACATTTCATAAAAAATTTGAAAAAGAAAAATTTTAAAAATTTAAGGACAAAATCCACTTGAAAA\CAAG 
710 	720 	730 	740 	750 	760 	770 	780 
I I I I I I 
TGCGAACAGCTTTTTGCAAA7AAACTACAAACCACTACACATTAGCGAATAAGCCTATTAGGAATTTATTTTAATTTT 
790 	800 	810 	820 	830 	840 	850 
I I I I I I I 
TGTTGATTTAAATTTCTTTTTTTTTTAAATGGTTAGAATCTAGTTGATAAACTTCTAGCAATGTATTTCCAAATTGTT 
860 	870 	880 	890 	900 	910 	920 	930 
I I I I I I I I 
TCTATTACGTTCGTTGATACAGGCAATTGTTCATTTCTGGTATGACTAAAGCATTTCTATACAATTCAACTTCTCATT 
940 	950 	960 	970 	980 	990 	1000 	1010 
I I I I I I 	 I 
TTTTCTAGCTGTATTTATGATGTACAGAGCGTTGGGAGAGAGTTGATTAAGTCAATAGTATTTATGAATGAGACAAGG 
1020 	1030 	1040 	1050 	1060 	1070 	1080 	1090 
I 	 I 	 I 	 I 
AACACTCATACTATATCAATGATAAATAGCTTTTATATTATCCTGTTATAATCATAAAAATTAATTTCATCTATATAG 
1100 	1110 	1120 	1130 	1140 	1150 	1160 	1170 
I 	 I 	 I 	 I 	 I 	 I 	 I 	 I 
ACTTAGAAAAAAATGGTTTCGTTTTCACTGTCCTTAAACTACAAATATCGTACACGTGTTACTTGTTCTTCAGGTGTA 
1180 	1190 	1200 	1210 	1220 	1230 	1240 
I 	 I 	 I 	 I 	 I 	 I 
CCCTCACTATTGTCAAATCTTATGAAATTCTTTACTCGTTGACTTGATTGTTATGCGAACAGTATTTTCGC1ATTCC 
MR TV F S 	I P 
1250 	1260 	1270 	1280 	1290 	1300 	1310 	1320 
I 	 I 	 1 	 1 	 I 	 1 	 1 	 I 
TCGTTTTAAACAAGTCAATCAGTACATACGGATGTCGACAAGGCAGTCAGACATTAGGTTTGTTAGATAGAAGACAGA 
R F K Q V N Q Y I R MS T R Q SD I 
1330 	1340 	1350 	1360 	1370 	1380 	1390 	1400 
I 	 I 	 I 
CGTTGACTAACCCATATAGCAACTTCTTCATTTCTTCTGCTTCGCACAAAAGCGAGCACGTGGAGGTTTCTCJTCGT 
S 	F F IS SASH K SE H V E VS Q S S 
1410 	1420 	1430 	1440 	1450 	1460 	1470 	1480 
I 	 I 	 I 	 I 	 I 	 1 	 I 
CTTCTGATTCCAAAAATGTTGATGGGAGAAGCACAAGCGAAAAGAGAAAGGTCGAATCAGTGAAATTAGTCGACGAGT 
SD S K NV D G R ST SE KR K V ES V K L 	DES 
1490 	1500 	1510 	1520 	1530 	1540 	1550 	1560 
I 	 I 	 I 	 I 	 I 	 1 	 1 	 I 
CGAAACACAACAACCACGACGACACTGGAACTCAAAATGTTGAGCGTGAAATAATATTGTGTCTGAGGCAAAAGC 
K H N N H D D T G T Q N V ER EN N IV SEA K K Q 
1570 	1580 	1590 	1600 	1610 	1620 	1630 
I 	 I 	 I 	 1 	 I 	 I 	 I 
AAAAGACTT TAGGTTCATC CTC CT CTTCTTCAGATGC C GTATCTAGTAACAACGAT T C TGGGGCATCTACTCCAATAC 
K T L G SS S S S SD A V SS N ND S GAS T PIP 
1640 	1650 	1660 	1670 	1680 	1690 	1700 	1710 
I 	 I 	 I 	 I 	 I 	 1 	 I 
CTTTGCCAATCAAAGAACCACCGTTAGAGTCCAATGCTCGCAATGATAAGTTAAAAGGTCATGCAACATTTGCTGAAA 
L PIKE PP L ES N A RN D K L KG HAT F A EM 
1720 	1730 	1740 	1750 	1760 	1770 	1780 	1790 
I 	 I 	 I 	 I 	 I 	 I 	 1 	 I 
TGGTAAAAGCATTCACAAAAATAGAGAATACTAGCAAACGGTTGGAAATCATTGATATAATGGGGACTTACTTTTTTG 
V K AFT K I EN T SK R L Eli DING T Y F F G 
1800 	1810 	1820 	1830 	1840 	1850 	1860 	1870 
I 	 1 	 I 	 1 	 I 	 I 	 I 	 I 
GAATTCTTCGCGACCATCCCAGCGATTTACTGGCCTGTGTGTATTTAAGTATCAATAAGGTATGAACGTTTGGTTTTA 
IL RD H P SD L LA CV Y L SINK 
1880 	1890 	1900 	1910 	1920 	1930 	1940 	1950 
I 	 I 	 1 	 I 	 1 	 I 	 I 
AAGGATTTCTCCTTCTCAGTACTAACGTCTTTTTTTACATTAGTTGGGCCCAGATTACTCGGGACTAGAGCTAGGAAT 
L G PD Y S G L EL G I 
1960 	1970 	1980 	1990 	2000 	2010 	2020 
I 	 I 	 I 	 I 	 I 	 I 
TGGCGAAAGCATTATAATGAAGGCTATTGGAGAGTCTACAGGGCAAACGCTTCAACAGATTAAACTATCGTTTCACAJ 
GE SlIM K Al GE ST G Q T L Q Q 1K L SF H K 
2030 	2040 	2050 	2060 	2070 	2080 	2090 	2100 
I 	 I 	 I 	 1 	 I 	 I 
AGTTGGT GAT C TT GGT C TTGTAGCTCAAACATC C C GT CAAAATCAAC CCACTATGTTTAAACCTGCAGCGC TGACAAT 
V G 	L G L 	A Q T S R Q N Q PT N F K PA AL TI 
2110 	2120 	2130 	2140 	2150 	2160 	2170 	2180 
I 	 I 	 I 	 I 	 I 	 I 
TCCATTTTTATTTGACTCATTAAAAAAAATTGCTCAAATGAGCGGAAACCAATCCCAAAATAGAAAAATTGGAGTGAT 
P FL F D S L K K IA Q MS G N Q S 	N R K I G VI 
2190 	2200 	2210 	2220 	2230 	2240 	2250 	2260 
I 	 I 	 I 	 I 	 I 	 1 	 I 
CAAGCGGCTATTGAGTTCCTGTGAAGGTGCAGAACCTAAATATTTGATTCGAGCTTTGGAAGGCAAGCTACGCCTCCA 
KR L L SS CE GA E P KY L 	R A LEG K L R L Q 
2270 	2280 	2290 	2300 	2310 	2320 	2330 	2340 
I 	 I 	 I 	 I 	 I 	 I 	 I 	 I 
ACTTGCCGAAAAAACCATTTTAGTAGCATTAGCAAATGCCACCGCTCAATATCATGCTGATAAGAATGGAGAAAAACT 
LA E K TI L 	A L A N A TA Q Y HAD K N GE K L 
2350 	2360 	2370 	2380 	2390 	2400 	2410 
I 	 I 	 I 	 1 	 1 	 I 	 I 
TTCGCAACAAGACAGGATTGAAGGAGAGCAGATTCTTCGAGATGTTTACTGTCAACTGCCTTCATACGACCTTATCGT 
S 	Q DR I E GE Q IL RD V Y C Q L PS Y D L I V 
2420 	2430 	2440 	2450 	2460 	2470 	2480 	2490 
I 	 I 	 I 	 I 	 I 	 I 	 I 	 I 
TC CTCACT T GATTGAGCATGGACTTGGTACT T T GCGTGAAACTTGTAAATTAACAC C T GGAATCCCAACAAAAC C CAT 
PH LIE HG L G T L R E T C K L T PG I PT K PM 
2500 	2510 	2520 	2530 	2540 	2550 	2560 	2570 
I 	 I 	 1 	 I 	 I 
GCTGGCTAAGCCGACGAAACAAATTTCAGAAGTTTTGAATACGTTTGATCAAGCCGCATTTACATGTGAATACAAATA 
LA K PT K Q IS E V L NT F D Q A AFT CE Y KY 
2580 	2590 	2600 	2610 	2620 	2630 	2640 	2650 
I 	 I 	 I 	 I 	 I 	 I 	 I 	 I 
C GATGGCGAGC GCGCCCAAGT TCATTT TACCGAAGATGGGAAGT TTTATGTATT TT C TAGGAATTCTGAACAT GT C 
D GE R A Q VHF TED G K F Y V F SR N S E N MS 
2660 	2670 	2680 	2690 	2700 	2710 	2720 	2730 
I 	 I 	 I 	 I 
TGTTCGCTATCCGGACATCTCTGTTTCTGTATCGAAGTGGAAAAAACCAGATGCTCGTTCTTTTATTCTCGATTGCGA 
V R Y PD I S V S VS K W K K PD AR SF1 L DC K 
2740 	2750 	2760 	2770 	2780 	2790 	2800 
I 	 I 	 I 	 I 	 I 	 I 	 I 
A V G W DR DEN K IL P F Q K LA T R KR K DV K 
2810 	2820 	2830 	2840 	2850 	2860 	2870 	2880 
I 	 I 	 I 	 1 	 I 
AATTGGGGACATTAAGGTCCGAGCATGCCTTTTCGCTTTTGACATTTTATACCTTGGGCAACCTCTTTTGGAJ.pC 
I G 	1KV R A CL F A F DI L Y L N G Q P L LET 
2890 	2900 	2910 	2920 	2930 	2940 	2950 	2960 
I 	 I 	 1 	 I 	 1 	 I 
CCCACTCAACGAGCGTCGAAAACTACTTTACTCAATGTTTCAACCAAGTACTGGAGACTTTACTTTTGCTCATAG 
P L N ERR K L L Y S 	F Q PS T G 	FT F A K H S 
2970 	2980 	2990 	3000 	3010 	3020 	3030 	3040 
I 	 1 	 I 	 I 	 I 	 I 	 I 	 I 
CGATCAAAAGTCTATTGAATCCATTGAAGAATTCCTTGAAGAATCTGTCAJJGATTCTTGTGAGGGTTTAATGGTCJ 
O Q K S 1K S 	E E FLEES V K OS CE G L MV K 
3050 	3060 	3070 	3080 	3090 	3100 	3110 	3120 
I 	 I 	 I 	 I 	 I 	 I 	 I 	 I 
AATGCTTGAAGGCCCGGATTCTCATTATGAACCGTCAAAACGTTCCAGGCATTGGCTGTTJAAAGACTATCT 
ML E G PD SHY E PS KR SR H ML K V K K D 	L 
3130 	3140 	3150 	3160 	3170 	3180 	3190 
I 	 I 	 I 	 I 	 I 	 1 	 I 
TTCTGGTGTTGGAGATTCTCTGGATTTGATTGTAATTGGCGCATACTACGGAAAGGGTCGTACTTCTGTTTATGG 
S G V G 	S L D L I V I GAY Y G KG KR T S V Y G 
3200 	3210 	3220 	3230 	3240 	3250 	3260 	3270 
I 	 1 	 I 	 I 	 I 	 I 	 I 	 I 
TGC CT T T C T TTTGGGCTGCTACGATCCAGATAC C GAAACAGT TCAATCGATTTGCAAACTCGGGACT GGTT TT TCAGA 
A FL L G C Y D PD T K TV Q SICK L G T G F SE 
3280 	3290 	3300 	3310 	3320 	3330 	3340 	3350 
I 	 I 	 I 	 1 	 I 	 1 	 I 	 I 
GGAGCATTTAGAAACTTTTTACAATCAACTTAGACATTGTTATATCTAAAAAGMAGATTTTTATGCTCATAGCGA 
E H LET F Y N Q L K D I V I S K K K D F Y AN SD 
3360 	3370 	3380 	3390 	3400 	3410 	3420 	3430 
I 	 I 	 1 	 I 	 I 	 I 	 I 	 I 
TGTACCTGCGCATCAGCCTGACGTCTGGTTTGAGCCTAAGTACTTGTGGGAAGTCTTAGCTGCCGATTTATCTTTGTC 
VP AN Q PD V W FE P KY LW E V LA AOL S L S 
3440 	3450 	3460 	3470 	3480 	3490 	3500 	3510 
I 	 I 	 I 	 I 	 I 	 I 	 1 	 I 
TCCGGTTTACAAAGCTGCAATTGGATATGTTCAAGAGGACAAAGGAATCAGTTTACGTTTTCCAAGATTCATTCGTAT 
P V Y K A Al G Y V Q ED KG IS L R F PR F I RI 
3520 	3530 	3540 	3550 	3560 	3570 	3580 
I 	 I 	 I 	 1 	 1 	 I 
TCGGGAAGACAAGAGCTGGGAGGATGCTACAACAAGTGAACAGGTTTCAGAATTCTATCGTTCGCAGGTGGCTTACAG 
RED K SW ED AT T S E Q V SE F Y 	S 	V A Y S 
3590 	3600 	3610 	3620 	3630 	3640 	3650 	3660 
1 	 1 	 1 	 1 	 1 
TCAAAGGAAAAAGAAGGGTCCCCAGCTGCCGAAGATTATTAAGTTTGTAGCTGAGAGTTACTGCTGAGAGCTACTGT 
Q K EKE G SPA A ED Y I 
3670 	3680 	3690 	3700 	3710 	3720 	3730 	3740 
CATAATAAAGGGTAATGTTCGGCTAAAATTTGCCCAAAGAGGCTAATATGAATTATGTTAAAGAGACAGACAAATTGA 
I 	 I 	 I 	I 	 I 	 I 
3750 	3760 	3770 	3780 	3790 	3800 	3810 	3820 
I 	 I 	 I 	I 	 I 	I 
GT TTATGCTC TAGC T GAT GGCTATTT CT C TAGC TTACTACTATTTATTTTT TTCTAAT T GTAATCC C CTGTGGCTAAA 
3830 	3840 	3850 	3860 	3870 	3880 	3890 	3900 
I 	 I 	I 	I 	I 	 I 	I 
AAAAAATTAATAATAAACAACATTGAAT TTCCAAATTATAACATTAGAT TGAAAATT T GAAT CTTAT T TAT C C C TT T T 
3910 	3920 	3930 	3940 	3950 	3960 	3970 
I 	 I 	I 	 I 
TATTATCCTTTTTATATGATTTTATACATTGTATTACCATTTTACGTTCGTACCAAGCCTTACTCTATTTTGCCGTCA 
3980 	3990 	4000 	4010 	4020 	4030 	4040 	4050 
I 	 I 	I 	 I 	I 
TATTCCTCCTTACAGTGGATTACGAATGCTTGGTGTTCATTACCGTCCATATACATTTTATGTCACTGTAGC1JCAC 
4060 	4070 	4080 	4090 	4100 	4110 	4120 	4130 
I 	 I 	I 	I 	I 	I 	I 
CAAGAAGAAATTACAATATTGGCTTTAAAGCCATTAATTGCTATGAATTTCAGJGAATGGCCATTGpCATGTG 
4140 	4150 	4160 	4170 
CAACCGCCCAAATTGTCATTTCGTCATTTGCTATCGAGATCT 
Appendix 2: Protein sequence of Cdc17 
1 	 11 	21 	31 	41 	51 	61 
MRTVFSQIPR FKQVNQYIRN STRQSDISNF FISSASHKSE HVEVSQSSSD SKNVDGRSTS EKRKVESVKL 
71 	81 	91 	101 	111 	121 	131 
VDESKI-iNNHD DTGTQNVERE NNIVSEAKKQ KTLGSSSSSS DAVSSNNDSG ASTPIPLPIK EPPLESNARN 
141 	151 	161 	171 	181 	191 	201 
DKLKGHATFA EMVKAFTKIE NTSKRLEIID IMGTYFFGIL RDHPSDLLAC VYLSINKLGP DYSGLELGIG 
211 	221 	231 	241 	251 	261 	271 
ESIIMKAIGE STGQTLQQIK LSFHKVGDLG LVAQTSRQNQ PTMFKPAALT IPFLFDSLKK IAQMSGNQSQ 
281 	291 	301 	311 	321 	331 	341 
NRKIGVIKRL LSSCEGAEPK YLIRALEGKL RLQLAEKTIL VALANATAQY HADKNGEKLS QQDRIEGEQI 
351 	361 	371 	381 	391 	401 	411 
LRDVYCQLPS YDLIVPHLIE HGLGTLRETC KLTPGIPTKP MLAKPTKQIS EVLNTFDQAA FTCEYKYDGE 
421 	431 	441 	451 	461 	471 	481 
RAQVHFTEDG KFYVFSRNSE NNSVRYPDIS VSVSKWKKPD ARSFILDCEA VGWDRDENKI LPFQKLATRK 
491 	501 	511 	521 	531 	541 	551 
RKDVKIGDIK VRACLFAFDI LYLNGQPLLE TPLNERRKLL YSMFQPSTGD FTFAKHSDQK SIESIEEFLE 
561 	571 	581 	591 	601 	611 	621 
ESVKDSCEGL MVKMLEGPDS HYEPSKRSRH WLKVKKDYLS GVGDSLDLIV IGAYYGKGKR TSVYGAFLLG 
631 	641 	651 	661 	671 	681 	691 
CYDPDTETVQ SICKLGTGFS EEHLETFYNQ LKDIVISKKK DFYAHSDVPA HQPDVWFEPK YLWEVLAADL 
701 	711 	721 	731 	741 	751 	761 
SLSPVYKAAI GYVQEDKGIS LRFPRFIRIR EDKSWEDATT SEQVSEFYRS QVAYSQKEKE GSPAAEDY 
Appendix 3: Data for growth curves of CdCl7ts strains 
described in section 2.2.2 
cdcl 7-K42 












OD 25°C 	OD 36°C 	cell no. 25°C (xl 
0,055 0,045 0,5403 
0,062 0,055 0,5438 
0,074 0,071 0,5002 
0,079 0,103 0,4655 
0,099 0,124 0,8238 
0,127 0,166 0,9145 
0,147 0,193 1,35 
0,2 0,237 1,756 
0,263 0,284 2,233 
0,342 0,31 3,334 
0,434 0,374 3,912 













time I h OD 25°C OD 36°C cell no. 25°C [xlOE6] cell no. 36°C [xlOE6] 
0 0,050 0,040 0,5366 0,4670 
1 0,071 0,063 0,6654 0,4381 
2 0,072 0,071 0,4745 0,3045 
3 0,080 0,093 0,4536 0,4637 
4 0,094 0,120 0,7045 0,5541 
5 0,118 0,151 0,8905 0,7327 
6 0,143 0,190 1,1670 0,7667 
7 0,181 0,243 1,4710 0,8708 
8 0,235 0,307 1,7200 1,0379 
9 0,288 0,349 2,3780 1,2160 
10 0,356 0,406 2,9590 1,2250 
cdcl7-M 75 
time / h OD 25°C OD 36°C cell no. 25°C [xlOE6] cell no. 36°C [xlOE6] 
0 0,054 0,053 0,5262 0,5652 
1 0,063 0,079 0,5823 0,5908 
2 0,075 0,089 0,5317 0,4763 
3 0,087 0,118 0,5005 0,5195 
4 0,109 0,162 0,8473 0,8696 
5 0,145 0,208 1,1020 1,0330 
6 0,165 0,270 1,3660 1,3890 
7 0,206 0,346 1,7930 1,6580 
8 0,274 0,450 2,4670 1,9190 
9 0,331 0,543 3,4050 2,3020 
10 0,425 0,639 4,2720 3.0870 
Appendix 4: Overview of Cdcl7[1-175]-GFP fusions, 
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